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1 Introduction  
1.1 The impact and drawbacks of assisted reproduction techniques 
Assisted reproduction techniques (ARTs) become more and more important both in veterinary 
and in human medicine. While in veterinary medicine the focus of ARTs clearly lays in the 
improvement of characteristic features of productive livestock, in human medicine ARTs 
mainly address infertility treatment. ARTs generally comprise the in vivo or in vitro maturation 
of oocytes, followed by their in vitro fertilization and cultivation of the developed embryos until 
they are transferred into the uterus. This procedure is generally referred to as “in vitro 
production of embryos” (IVP) [1, 2].  
Although the first human test-tube baby was already born in 1978 [2], ARTs in human medicine 
are still associated with several major drawbacks: Due to questions of efficiency it is still 
common to mature oocytes in vivo, which needs the women’s exposure to supraphysiological 
levels of gonadotrophins. This can lead to the so called “ovarian hyperstimulation syndrome” 
(OHSS) [3]. Furthermore multiple gestations induced by the common implantation of more than 
one embryo often represent a risk for the mother’s health and lead to pre-term delivery 
associated with low birthweight foetuses, suffering from neonatal and perinatal problems. 
Especially specific syndromes such as omphalocoele, Beckwith–Wiedeman, Prader–Willi, 
Angelman and retinoblastoma have been observed in ART-derived babies with increased 
frequency and seem to be associated with epigenetic alterations induced by the IVF procedure 
[2]. 
In bovine the first calf from IVP was born in 1981 [4]. In 2007 already more than 200,000 
embryos have been in vitro produced and transferred to recipients [5]. The primary target of 
IVP in bovine livestock is the improvement of selection intensity by increasing the number of 
offspring from a female cow of a desirable genotype. Additionally, ARTs are employed to 
increase pregnancy rates in herds with low fertility. However, also in cattle IVP is associated 
with developmental abnormalities in embryos, foetuses and calves such as increased rates of 
early embryonic death and abortion, production of large size foetuses and calves as well as 
abnormalities of placental development, summarized as the large offspring syndrome (LOS) [1]. 
These drawbacks are in large parts not understood and possibilities to avoid the occurrence of 
these problems are limited. Most common methods successfully applied to assess the embryo’s 
developmental competence are based on morphological criteria and on the determination of 
cleavage and blastocyst rates [6]. However, to improve the understanding of biochemical 
processes underlying oocyte maturation and early embryonic development, comprehensive 
analyses of the events taking place on the molecular level are indispensable. 
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1.2 The cow as a model for female human reproduction 
The bovine model system reflects crucial parameters of the female human reproductive biology. 
Both species are monovulatory and non-seasonal polycyclic [7]. In both species the duration of 
pregnancy is about nine months. Further similarities can be found in size and anatomical 
structure of the ovaries. The follicle containing cortical region lies outwards and ovulation can 
occur at any point over the ovarian surface [7]. Moreover, the mechanisms of follicular wave 
emergence, selection of a dominant follicle and ovulation are fundamentally similar in cattle 
and women [8]. Even pathologic conditions, like follicular cysts, luteinized anovulatory follicles 
and lactation- or stress-related suppression of follicle growth and ovulation, occur in human and 
cows [7]. Using the cow as a model for female human reproduction has especially led to the 
discovery of follicular wave development in women [9, 10]. Also, examples like the use of the 
bovine in studies of reproductive aging in women, demonstrate that it is increasingly accepted 
as a model for human female reproduction [11, 12]. 
 
1.3 Oocyte and early embryonic development 
Mammalian oocyte and early embryonic development comprises several crucial steps. A short 
description of these steps placing an emphasis on bovine development will be given in the 
following chapters. 
 
1.3.1 Oogenesis and folliculogenesis  
The development of female gametes is usually referred to as oogenesis: primordial germ cells 
(PCGs), specified to become the founder population of the germline, are initially identifiable in 
the posterior primitive streak before they begin to become a polarized morphology and extend 
cytoplasmic protrusions as they initiate their migration through the primitive streak into the 
adjacent posterior embryonic endoderm (yolk sac wall) where they can already be found at the 
28th day of pregnancy in the cow [13]. Subsequently they migrate in the hindgut during its 
anterior extension and reach the mesodermal tissues, followed by their bilateral migration into 
the genital ridges, which are the precursors of the gonads [14]. A scheme of this oocyte 
migration in the mouse embryo is shown in Fig. 1. PCGs can be distinguished from somatic 
cells by their large round shape and the high expression levels of tissue-nonspecific alkaline 
phosphatase as well as by high levels of Pouf5f1 mRNA [14, 15]. It is known from the mouse 
embryo that the forming of PCGs is partially induced by “Bone morphogenetic protein” (BMP) 
signalling. This induction leads to the transcriptional regulation of epiblast cells, mediated by 
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the transcriptional repressor “B lymphocyte induced maturation protein1” (BLIMP1) which 
promotes the expression of PGC specific genes such as stella (also known as Dppa3) and 
represses the expression of somatic cell genes, in particular members of the Hox gene family 
[14]. The knowledge about how PCG migration is initiated in mammals is rather limited up to 
today, yet, a regulation by “Interferon induced transmembrane protein 1” (IFITM1) is 
controversially discussed and also the Receptor tyrosine kinase (KIT) and its ligand Steel also 
called "KIT ligand” (KITLG) are required for general PGC motility [14]. Removal of these 
factors leads to PGCs that migrate in the proper direction but at a greatly reduced rate. During 
the migration process, in particular the gut seems to be important for proper migration since 
removal of the Y box 17 (SOX17) transcription factor prevents expansion of the hindgut 
endoderm and PGCs fail to migrate to the genital ridges [14]. Moreover, the proteins “Stromal 
cell-derived factor 1” (SDF1), expressed in the genital ridges, and the C-X-C chemokine 
receptor type 4 (CXCR4), expressed in the PCGs, are required for later stages of migration to 
the genital ridge. Finally, also disruption of E-cadherin function results in PCGs which stop 
their migration just before reaching the outside gonad [14].  
During the migration phase a period of mitosis and proliferation occurs [13] and simultaneously 
DNA methylation is significantly reduced and imprinted genes become biallelically expressed 
[16, 17]. By this decrease of epigenetic marks, germ cells are distinguished from somatic cells. 
Fig. 1: Stages of primordial germ cell migration 
PGCs in mice, specified in the proximal epiblast, migrate from the primitive streak to the endoderm (future 
hindgut) at embryonic day 7.5 (E7.5; step 1). A close-up is shown. At E8, PGCs migrate along the endoderm 
(step 2). At E9.5, PGCs migrate bilaterally towards the dorsal body wall (step 3). At E10.5, PGCs reach the 
genital ridges to form the embryonic gonad (step 4). Source of picture and legend: Richardson, B.E. and R. 
Lehmann, Mechanisms guiding primordial germ cell migration: strategies from different organisms. Nat Rev 
Mol Cell Biol. 11(1): p. 37-49. 
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The oocyte development is continued by multiple changes in chromatin structure. DNA 
remethylation occurs and genomic imprints are acquired in a sex specific manner, meaning that 
DNA methylation is targeted specifically to paternally and maternally DNA-methylated 
“imprinting control regions” (ICRs). ICRs are cis active DNA sequences which regulate the 
imprinting of specific gene clusters. The majority of these genes is known to be involved in 
foetal and placental growth as well as somatic differentiation [18, 19]. Interestingly, the 
imprints are re-established during distinct time windows in the male and female germlines. 
While in male germs cells the remethylation takes place during prenatal sperm development, in 
female germ cells this process happens during postnatal oocyte maturation [18].  
At the 57th day of the bovine pregnancy the germ cells form the so-called “oogonia”, initially 
located in the cortical region of the ovary. They are surrounded by somatic cells, which are the 
progenitors of granulosa cells. Subsequently, the mitotically active oogonia, containg KIT, 
interact with adjacent mesonephric cells, containing the “KIT ligand”, to form the ovigerous 
cords isolating the oogonia from the interstitium. In the following, tight junctions between the 
oogonia and the mesonephric cells that subsequently become pre-granulosa cells are formed. 
Then the female germ cells pass through the leptotene, zygotene and pachytene stage until they 
become arrested in the diplotene stage of the first meiotic division as so called “primary 
oocytes”. During the first meiotic division at least 80 % of the germ cells, but not their pre-
granulosa cells, undergo apoptosis. In the following, also the somatic cells proliferate, surround 
the oocytes and form primordial follicles which are enclosed in basal membranes. Connective 
tissue grows between them and separates them from each other. First primordial follicles can be 
found at the 90th day of pregnancy in the cow [13, 20, 21]. 
The primordial follicles are located in the ovarian cortex where they are stored during the 
complete fertile lifespan. Although many of the processes, controlling activation of the primary 
follicles, remain to be elucidated it is assumed that inhibitory factors from the ovary as well as 
the anti-Müllerian hormone play a role in inhibiting too early follicle activation [21]. With the 
occurrence of oestrous cycles several resting primordial follicles are activated independently of 
gonadotrophins. The mechanisms regulating follicle activation are still only poorly understood 
[13, 20].  
Activated follicles start to grow and become to the so-called primary follicles [13]. The oocytes 
increase three to ten folds in volume of smooth endoplasmic reticulum, mitochondria, 
ribosomes and lipid droplets, and the zona pellucida, absent in primordial follicles, is formed 
[21]. During this growing period the oocytes already start to acquire their developmental 
competence [22]. The developmental competence includes characteristics like (i) the ability to 
Introduction     5 
resume meiosis, (ii) to cleave upon fertilization, (iii) to develop into a blastocyst, (iv) to induce 
pregnancy and (v) to generate a healthy offspring [23].  
By intense mitotic proliferation of granulosa cells which change their shape to cubical, the 
follicles become multilayered, marking the secondary also called preantral follicle. The primary 
and small secondary follicles are sometimes also named “commited follicles”. Within the 
secondary follicle, the oocyte reaches its final size. In the end of the secondary follicle stage, 
surrounding cells start to develop into the “theca folliculi”. By the secretion of liquor folliculi 
into intercellular spaces, a lumen (antrum) is formed and the secondary becomes to the tertiary 
follicle (antral follicle), while it develops from the gonadotrophins-independent stage over a 
stage of gondadotropin-responsiveness to a stage of gonadotrophin-dependence [21]. The 
transition from the stage of gondadotropin-responsiveness to the stage of gonadotrophin-
dependence is known to be at least partly induced by the “Insulin-like growth factor 1” (IGF1). 
Interestingly the supply of IGF1 is primarily controlled by the “IGF binding proteins” 
(IGFBPs) rather than by its total concentration [21]. After the switch to the stage of 
gonadotrophin-dependence the further follicular development is controlled by the 
neuroendocrine system [13, 24]. During the development from the secondary to the tertiary 
follicle also the granulosa cells differentiate into two anatomically and functionally distinct 
lineages; the mural granulosa cells that line the wall of the follicle which have a steroidogenic 
role and the cumulus cells, forming an intimate life-support association with the oocyte. 
Simultaneously the oocyte is shifted to the follicle edge, forming a small protrusion called the 
cumulus oophorus, and the theca folliculi develops into an 
inner layer, the “theca interna”, and an outer layer the “theca 
externa” [13]. The granulosa cell differentiation is known to 
be driven by the oocyte secreting so called “Oocyte secreted 
factors” (OSFs). These factors, closely related members of 
the TGF- superfamily, are the “Growth differentiation factor 
9” (GDF9) and the “Bone morphogenetic protein 15” 
(BMP15) [21, 25]. They regulate several important functions 
of granulosa and cumulus cells; including regulation of 
cellular growth, enhancement of cell survival, modulation of 
steroidogenesis, regulation of the expansion of cumulus cells 
and the metabolism of cumulus cells [25, 26]. In particular 
the OSFs direct the lineage of its neighbouring granulosa 
cells towards the cumulus cell phenotype and prevent their 
Fig. 2: Small antral/tertiary follicle 
(A) antrum, (B) the oocyte is located 
on the follicle edge within the 
cumulus oophorus surrounded by (C) 
cumulus granulosa cells, (D) mural 
granulosa cells, (E) theca cells; 
Source of picture: Rüsse I, S.F., 
Lehrbuch der Embryologie der 
Haustiere. 1998 
A
B
C
D
E
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luteinisation (transition to granulosa lutein cells after ovulation). The cumulus cells in turn are 
believed to regulate the special oocyte microenvironment to keep it distinct from the rest of the 
follicle [21]. A typical small tertiary follicle is shown in Fig. 2. 
From the occurrence of the tertiary follicle onwards, a dominant follicle (DF) is selected which 
can in the following either undergo atresia or become ovulated. This process happens in so-
called “waves of folliculogenesis”, which emerge in cows at regular intervals. In the bovine 
cycle mostly two or three of these waves are observed [24, 27, 28]. Only the last follicular wave 
leads to an ovulatory follicle. A follicle cohort typically consists of 5–20 tertiary follicles being 
larger than 5 mm in diameter. The wave emergence is correlated with a transient increase in 
FSH concentrations, inducing cellular growth and proliferation of granulosa cells [24, 29, 30]. 
There are hints that this FSH action is mediated by an increase of the “Pregnancy associated 
plasma protein-A” (PAPP-A) which induces increased rates of proteolytic degradation of the 
IGFBP protein thus leading to higher IGF1 activity [21]. Moreover, like in the earlier stage of 
follicular development OSFs also play a critical role by inhibiting luteinisation and promotion 
of mitotic activity of granulosa cells. As the DF follicle emerges from the cohort, it increases in 
size, which leads to an increase in oestradiol and inhibin concentrations due to the fact that these 
hormones are produced in granulosa cells. The intensive production of oestradiol is a defining 
characteristic of the DF which occurs already prior to visible differences in follicle size [24, 31]. 
In the following, the increase of oestradiol concentrations in concert with inhibin suppresses the 
FSH release from the pituitary gland by a direct inhibitory action on the expression of mRNA 
for FSH, while the selected DF becomes increasingly responsive to LH through the augmented 
presence of LH receptors (LH-R) [24, 30, 32, 33]. This puts the DF on a beneficial growing 
position due to the facts that (i) the FSH concentration is pushed below the threshold needed to 
sustain other tertiary follicles and that (ii) the synthesis of oestradiol is dependent on the LH 
stimulated production of androgens in the theca cells and their subsequent aromatisation to 
oestradiol in granulosa cells. Oestradiol in turn induces further proliferation of granulosa cells 
what again leads to an enhancement of the follicle’s dominance. Since oestradiol also provokes 
an enhanced LH release from the pituitary gland this process leads to an LH peak which induces 
(i) the resumption of meiosis in the nucleus involving the dissolution of the nuclear (germinal 
vesicle (GV)) membrane and condensation of chromatin as well as separation of the 
homologous chromosomes and emission of the first polar body, (ii) the final growth spurt and 
(iii) ovulation of the oocyte when the metaphase of the second meiotic division is reached. The 
second meiotic division is completed after fertilization [13]. A scheme of the model for 
folliculogenes, originally generated and based on the ewe by Scaramuzzi et al. [34], similar to 
that from the cow is shown in Fig. 3. 
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1.3.2 Preimplantation embryonic development 
During mammalian early embryonic development the zygote, respectively the early embryo, 
cleaves completely, leading to evenly divided blastomeres. The first three cell divisions occur 
within the oviduct. In the 8-cell stage, the bovine embryo is transported into the uterus where 
the further embryonic development takes place [13]. The phase between the 8- and the 16-cell 
stage is crucial for bovine embryonic development, since the maternal-embryo transition (MET) 
takes place [35, 36]. During the MET, the embryo’s own genome is activated leading to 
increased transcription activity. A failure in embryonic genome activation leads to irreversible 
arrest of the embryo, because it can no longer support basic metabolic processes. The further 
embryonic development relies on its own genome [36, 37]. During the time of MET often a 
phenomenon known as “developmental block” occurs. It becomes very obvious during in vitro 
Fig. 3: A model for folliculogenesis initially generated and based on the ewe by Scaramuzzi et al. 
Folliculogenesis is illustrated as a cascade of development during which follicles emerge from a pool of primordial 
follicles to enter a process of growth and development that is continuous and ends in either atresia or ovulation. In 
most mammals this process is approximately linear to the gonadotrophin-responsive stage and, especially in 
ruminants, becomes wave like in the gonadotrophin-dependent stage. Source of picture and legend: Scaramuzzi, 
R.J., et al., Regulation of folliculogenesis and the determination of ovulation rate in ruminants. Reprod Fertil Dev . 
23(3): p. 444-67. 
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embryo production. Many in vitro produced embryos fail to develop beyond the 8-cell stage, 
what is considered to be the reason for blastocyst rates of only 30 % to 40 % of in vitro 
fertilized oocytes. The embryos ability to perform the MET is likely correlated with oocyte 
quality. Although the mechanisms behind the developmental block are not fully understood, it is 
believed that they are based on inability (i) to overcome the chromatin repression and/or (ii) to 
react to injuries caused by the environment [23, 36]. 
During the next cell divisions, the embryo forms into a morula, which usually occurs on day 
five post insemination (p.i.) in the cow [13]. Within the morula, blastomeres gain a tighter 
contact to each other by an increase of intercellular adhesions and adopt a more flattened 
morphology, a process known as compaction [38]. It is unclear how compaction is initiated 
[39]. However, it is already known from the mouse model that E-cadherin, a major component 
of adherens junctions, switches to regions of cell-cell contact at the 8-cell stage [40]. 
Furthermore, compaction can be inhibited by removal of Ca2+ ions or addition of E-cadherin 
specific antibodies. Interestingly, compaction is also processed when mRNA or protein 
synthesis is blocked from the mouse 4-cell stage onwards, indicating that necessary factors have 
been produced earlier in development. This suggests that posttranslational mechanisms play an 
important role in the induction of compaction, possibly by maintaining the E-cadherin complex 
in an inactive state until it is needed for compaction [39]. 
At the morula stage, the first cell fate decisions are made between inside and outside located 
cells. During the following blastocyst development, the outer cells develop into trophectoderm 
(TE) cells, which are progenitor cells of the placenta while the inner cells form the inner cell 
mass (ICM) from which the embryo develops. Furthermore, a fluid-filled cavity, the blastocoel, 
is formed by merging of intercellular spaces and water movement into the embryo. The 
blastocyst usually occurs around day seven p.i. in the cow [13, 38]. The knowledge about how 
these cell lineages develop during the preimplantation period is considered to have a major 
impact for increasing the success of ARTs. The understanding of these processes is rather 
limited until today although early information on cell fate specification has already been 
provided by cell-lineage studies performed in ascidians at the turn of the last century by 
Conklin. Until today, much research concerning mammalian lineage decisions has been 
performed on the mouse model [38, 39]. Some of these insights will be described in the 
following: 
It is generally assumed that the forming of cell polarities is of fundamental impact for cell fate 
decisions [38]. With the increase in cell adhesions blastomeres rapidly polarize along the axis 
perpendicular to cell contact so that outward facing (apical) regions become distinct from 
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inward facing (basolateral) regions [39]. The polarization involves the redistribution of 
membrane, cytoskeletal and organelle components [41]. Cell nuclei move to a basolateral 
position [42] while the endosomes [41] as well as cytoplasmic actin [43] and the membrane 
protein ezrin [44] become localized apically. Microvilli accumulate at the apical pole and are 
almost completely eliminated basolaterally [45, 46]. 
The establishment of cell polarity in organisms like C. elegans and Drosophila has been widely 
studied. For example the so-called “par” (partitioning defective) genes are known to be 
involved in the establishment of polarity in the zygote of C. elegans [47, 48]. The proteins 
PAR3, PAR6 and aPKC are known to form a complex involved in the establishment of polarity 
in the oocyte, in epithelial differentiation and in asymmetric divisions of delaminating 
neuroblasts in Drosophila [49]. Therefore, these proteins were also characterised in mouse early 
embryonic development and it was revealed that the polarity proteins PAR3 [50], PAR 6 [51], 
and “atypical protein kinase” [50] become localized to the apical domain of blastomeres, while 
the polarity protein PAR1 [51] accumulates basolaterally.  
However, it is still unclear how de novo polarisation is initiated. On the one hand, various 
studies suggest that cell-cell contact is somehow important for the establishment of the apical 
and basolateral domains [52, 53]. On the other hand, polarisation is also observed in 
blastomeres isolated from cell contacts or prevented from compacting, coming along with a 
microtubule-mediated interaction between the nucleus and the cell cortex. Therefore, it is 
assumed that at least these two possibilities for polarization initiation exist [54].  
The polarity of blastomeres seems to be important for early cell fate decisions since they are 
divided by mitosis either perpendicular or parallel to its axis of polarity, resulting in two 
separate groups of apolar inside and polar outside cells [55]. In the following the outer cells are 
becoming fully committed to the TE lineage and the blastocoel begins to form.  
It is assumed that these first lineage decisions are made due to some cell fate determinants, 
being segregated specifically into, or out of, polarized cells during mitosis. For example the 
pluripotency markers Octamer 3/4 (OCT4, now POU5F1) [56] and NANOG [57] are restricted 
in their expression to the inside, future ICM cells. In contrast, the mRNA of the TE specific 
transcription factor “Caudal type homeobox 2” (CDX2) is localized to the apical domain of 
blastomeres at the 8-cell stage and becomes restricted to the outside, progenitors of the TE, cells 
in later stages [58, 59]. CDX2 is thought to repress POU5F1 and NANOG [60]. Embryos 
missing CDX2 cannot maintain epithelial integrity after blastocysts formation and fail to 
implant [60]. Knockout experiments suggested, that the transcription factor “TEA domain 
family member 4” (TEAD4) acts upstream of CDX2 in TE specification. TEAD4-/- embryos do 
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not express CDX2, but do express POU5F1 and NANOG [61, 62]. Since they do not produce 
trophoblast stem cells, trophectoderm or blastocoel cavities, they are not able to implant into the 
uterine endometrium. However, they can produce embryonic stem cells. Disrupting the tead4 
allele after implantation leads to normal completion of embryo development [62]. Interestingly, 
in ES cells TEAD4 is not required for expression of CDX2 and other trophoblast genes as long 
as POU5F1 levels are reduced. Moreover, it is known that TEAD4 cannot act alone, instead it 
requires the “yes-associated protein 1” (YAP1) to act as a transcriptional activator. Although 
TEAD4 is similarly distributed in all cells of the embryo YAP1 is only localized to the nuclei of 
outer cells, indicating that these proteins can only cooperatively activate CDX2 expression in 
outside cells. The translocation into the nucleus was shown to be prevented through its 
phosporylation by the Hippo pathway members LATS1 and LATS2. Given that cell contact can 
lead to Hippo pathway activation in cell cultures, the authors of these results supposed that 
increased intercellular cell contacts, like established in the embryo during compaction, leads to 
Hippo activation, followed by nuclear exclusion of YAP1 in inner cells. However, authors took 
into consideration that an involvement of cell polarity in YAP1 localisation is not ruled out by 
these results. Cell polarities could influence YAP1 localisation restricting the activity of Hippo 
signalling components, too. In support of this, dissociated blastomeres, without cell contact 
information and polarity, did not exhibit nuclear YAP1 [63]. 
 
1.4 The impact of proteome analyses on reproductive research 
Several OMICS tools are available for embryonic analyses. While the use of genomic tools 
mainly focuses on the inherited genome itself and on chromosome aberrations, results from 
transcriptome, proteome and metabolome analyses can provide information about gene activity 
and reflect the environment composition due to epigenetic modifications and substrate 
availability [6]. Compared to a large number of genome and transcriptome approaches, only few 
holistic proteome studies concerning oocyte and embryonic development have been performed 
so far. Yet, results obtained by the analysis of mRNA cannot provide information about the 
instantaneous proteome status of a cell like the rate of translation or occurring post-translational 
modifications as well as protein secretion and proteolytic processes. Moreover, oocytes and 
early embryos contain not only a maternal messengerRNA (mRNA) but also a protein storage, 
which functions in fertilization and regulates preimplantation early embryo development [22]. 
The fact that only proteome analysis can provide insights into usage and assembly of this 
protein storage makes it even more promising. For example, it is still not known whether the 
above mentioned Cdx2 expression on the apical embryonic cells of mice 8-cell embryos is also  
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reflected on the protein level [39]. Therefore, proteome techniques which can be applied for 
these efforts as well as the results obtained so far, will be described in the following chapters. 
 
1.5 The two strategies for proteome analyses 
For proteome analyses mainly two different strategies can be applied. On the one hand, the 2D 
gel based approach, which has the advantage of facilitating a very sensitive quantification and 
the effective detection of protein isoforms. On the other hand, the nano LC-MS/MS approach, 
which enables accurate and sensitive protein identification and has furthermore become more 
and more employed for protein quantification during the last years. 
 
1.5.1 2D gel based techniques 
The 2D gel based proteome analyses was independently introduced by Klose and O´Farrell in 
1975 [64, 65]. On 2D polyacrylamide (PAA) gels proteins are separated in two dimensions 
according to their physicochemical parameters isoelectric point (IP) and molecular weight 
(MW). Theoretically the separation strength of a typical 12 % PAA gel facilitates the separation 
of 100 proteins in each dimension, leading to 10,000 proteins in total. Practically proteins are 
not evenly distributed in the dimensions so that the number of proteins visible on 2D gels is 
around 2000 [66]. An important advantage of 2D gel electrophoresis is that different protein 
isoforms can usually clearly be separated. 
For a long time protein visualization on 2D gels was limited to (i) the autoradiography of 
metabolically labelled proteins and (ii) to staining procedures, e.g. with silver [67], coomassie 
blue [68, 69] or sypro ruby [70] which could be either seen directly by the eye (silver, 
coomassie blue) or as fluorescent images after scanner-based absorbance spectroscopy 
(coomassie, sypro ruby). The silverstaining method is highly sensitive, yet due to its low 
dynamic range it is not appropriate for quantification [71]. Although the dynamic range of 
quantification was enhanced by the fluorescent sypro ruby staining, the quantification from 2D 
gels stayed associated with reproducibility problems which impaired inter-gel comparisons. In 
1997, quantitative 2D gel electrophoresis was further improved by the introduction of the 
“difference gel electrophoresis” (DIGE) technique. It significantly enhanced the dynamic range 
of detection as well as the reproducibility of quantification on 2D gels [72]. In the 2D DIGE 
approach, fluorescent labels are attached to the proteins. The first labelling procedure 
introduced within the 2D DIGE approach is referred to as “minimal labelling”, since the 
fluorescent dyes are attached to only a small fraction of all -amino groups of lysines and free 
N-terminal residues, so that approximately 3 % of proteins in a sample are labelled. Currently 
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three fluorophores Cy2, Cy3 and Cy5 are available for minimal labelling. One of these dyes 
(usually Cy 2) is attached to a so-called “internal pooled standard” (IPS) consisting of an 
aliquot mixture from all samples included in the analysis. The remaining dyes are attached to 
different samples from the analysis. Prior to gel electrophoresis, samples and IPS are combined. 
Since the IPS is co-separated with each sample on one gel, it enables normalization and inter-
gel comparisons leading to an enormous increase of reproducibility [66].  
In 2003, an extremely sensitive modification of the DIGE concept, the “saturation labelling” 
which reduced the protein amounts needed for 2D gel based quantification by two orders of 
magnitude, was developed [73]. In contrast to the minimal labelling procedure, all proteins of a 
sample are labelled in the saturation DIGE approach. Instead to amino groups, the label is 
covalently linked to the sulfhydryl residues of cysteines. A crucial step for saturation DIGE 
analysis is the determination of an appropriate dye/protein ratio prior to the labelling procedure 
which must be strictly adhered to. In case of a too high dye/protein ratio (overlabelling) the  
amino group of lysines and free N-terminal residues are unspecifically labelled. This induces 
changes in the IP, leading to horizontal stripes on the gels. In case of a too low dye/protein ratio 
(underlabelling), proteins are incompletely labelled, what affects their molecular weight and 
induces vertical stripes on the gel. Currently only two fluorophores, Cy3 and Cy5, are available 
for saturation labelling, what doubles the number of gels to be prepared in contrast to a minimal 
DIGE experiment. The saturation labelling approach facilitates quantification of protein spots 
from gels containing only 500 ng protein, yet it has to be considered that for identification of 
differentially abundant spots preparative gels containing a protein amount of approximately 
300-400 g protein are necessary [66, 74].  
 
1.5.2 Nano LC-MS/MS based techniques 
The history of mass spectrometry (MS) started at the end of the 19th century with the 
development of the first MS instrument by Thomson who was honoured by the Nobel Prize in 
1906. In the following century, protein chemistry was mainly performed by N-terminal Edman 
degradation due to the lack of non-destructive ionisation techniques for the polar and 
zwitterionic peptides [75-77]. The first possibility enabling a “soft ionization” process was 
developed as “fast atom bombardment” (FAB) in the early eighties [78-80]. A decade later, 
protein identification by mass spectrometry was enabled through the invention of two non-
destructive ionisation techniques for peptides, referred to as electrospray ionisation (ESI) [81] 
and matrix-assisted laser desorption ionisation (MALDI) [82]. Both approaches were published 
in the end of the eighties and made their inventors to Nobel Prize laureates in 2002. Today these 
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techniques are routinely employed in many labs for protein identification, representing a fast 
and sensitive method in many instances. A combination of high performance liquid 
chromatography (HPLC) for prefractionation and the so-called tandem mass spectrometry is 
generally referred to as LC-MS/MS [77]. 
A common strategy for LC-MS based proteome analysis is the so called ‘‘bottom-up’’ 
approach: In a first step, proteins are cleaved by sequence specific endopeptidases and the MS 
analysis is performed exclusively on the peptide level. Since this leads to an enormous increase 
of complexity it is often necessary to prefractionate the samples on the protein level, which is 
commonly performed by 1D SDS PAA gel electrophoresis [77]. In contrast, the so-called ‘‘top-
down’’ approach enables a direct analysis of intact protein molecules [83].  
One method for protein identification, applicable in cases where only a single or a few proteins 
are expected to be contained in a sample, is “peptide mass fingerprinting” (PMF). This 
technique is based on exact measurement of peptide masses, followed by a comparison of these 
values with theoretical peptide masses in protein databases [84, 85]. Since a PMF based protein 
identification cannot be applied for protein mixtures, additional information of the peptides is 
needed. Therefore, single peptides, referred to as “precursor ions”, providing a distinct MS 
spectrum are isolated and fragmented by collision with gas atoms or molecules which is called 
“collision-induced dissociation” (CID). The fragments of the precursor ions generate the so-
called MS/MS spectra. These MS/MS spectra are then correlated with theoretical MS/MS 
spectra calculated from sequence databases. Due to the subsequent generation of MS and 
MS/MS spectra this method was named “Tandem MS” or “MS/MS” analysis [66].  
Concerning protein quantification by nano LC-MS/MS, it is distinguished between “label free” 
approaches and such approaches wherein samples are labelled.  
Label free approaches mainly comprise the method of “precursor ion intensity monitoring”, in 
which distinct precursor ions, for which reliable peptide matches have been established, are 
taken as a measure for the peptides’ abundances and the method of spectral counting. The 
“spectral counting” approach is based on the connection between a protein’s abundance and the 
number of MS/MS spectra assigned to an identified protein [66, 86, 87] 
A common strategy in labelling approaches is (i) to label the samples with chemically identical 
reagents differing in their isotopic composition but not in their molecular weight, (ii) to pool 
samples after labelling and (iii) to perform LC-MS experiments with these pools. Since this 
procedure ensures that the retention time of differentially labelled peptides remains unaffected, 
peptides derived from different samples co-elute and reach the mass spectrometer at the same 
time. In the mass spectrometer, the signals from labels with different isotope composition are 
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detected individually and can then be quantitatively compared by their intensities [77]. There 
are several possibilities of sample labelling, differing in the level of sample procession at which 
the label is attached. If the label is introduced as isotope coded amino acid at the time of protein 
synthesis, the process is called metabolic labelling, also referred to as “stable isotope labelling 
by amino acids in cell culture” (SILAC) [88]. However, SILAC can be only applied to cell 
culture and small animal experiments due to cost reasons. In the so called “isotope-coded 
affinity tag” (ICAT) [89] and in the “isotope-coded protein labelling” (ICPL) [90] approach, the 
label is attached to the protein after sample lysis. The advantage of these two approaches is that 
labelled samples can be pooled prior to further digestion and preparation steps so that no more 
artificial differences are induced. Yet, a drawback in the ICAT system is, that the label is 
attached to cysteine residues which is problematic because only about 1.5 % of all amino acids 
within all known proteins are cysteines, so that often only very few peptides can be acquired for 
quantification. In the ICPL approach, the label is instead attached to lysine residues which 
indeed leads to more quantified peptides but comes with the problem that the major enzyme 
used for protein cleavage prior to mass spectrometry, namely trypsin, cannot cleave ICPL-
modified lysine sites [77]. Hence, trypsin digestion leads to rather long peptides being difficult 
to analyse in the mass spectrometer. Using the so-called “isobaric tag for relative and absolute 
quantification” (iTRAQ) approach, the label is introduced on the peptide level on each lysine 
chain and on each N-terminal group so that the trypsin cleavage process is not impaired. It has 
been introduced 2004 by Ross et al. [91]. Advantages of the iTRAQ approach are (i) that in 
contrast to the ICPL approach the cleavage process is not biased since it is performed prior to 
the labelling procedure and (ii) that in contrast to the ICAT approach nearly all peptides are 
labelled which enhances the comprehensiveness of the quantitative analysis significantly [77]. 
For targeted, instead of holistic protein quantification, the “selected reaction monitoring” 
(SRM) technology can be employed. Although it has already been applied for small molecule 
quantification for several decades, it just started to be increasingly used for protein mass 
spectrometry in the last years [92]. Quantification by SRM can be performed in a mass 
spectrometer consisting of three quadrupole units usually referred to as “Triple Quad”. A 
peptide ion, the “precursor ion” is selected in the first quadrupole (Q1). It then enters the second 
quadrupole (Q2), where it undergoes collision-induced dissociation. In the third quadrupole 
(Q3), one or more fragment ions are selected for quantification by the detector [66]. This 
method can also be employed for absolute protein quantification, using isotopically labelled 
peptides which have been spiked into a sample in a known concentration prior to analysis [93, 
94]. 
 
Introduction     15 
1.6 Holistic proteome analyses of mammalian oocytes and preimplantation embryos 
There are numerous publications concerning oocyte and embryo development available, yet 
only few holistic proteome approaches have addressed mammalian oocytes and preimplantation 
embryos. Most likely, the reasons for the small number of proteomic publications can be found 
in the necessity of much higher amounts of sample material needed for a successful analysis as 
for example compared to transcriptomic experiments. A brief overview of these publications 
will be given in the following chapters. 
 
1.6.1 Proteome analyses of oocytes 
Since oocytes are cells with unique features (for example, they are able to undergo a transition 
from a fully differentiated stage to a stage of total pluripotency) and contain a protein storage 
which functions in fertilization and early embryonic development, the analysis of their proteome 
seems promising (see chapter 1.4). Therefore, several proteomic studies address both their 
qualitative proteome profile as well as quantitative alterations during the maturation process.  
A very early protein analysis of mouse oocytes was published in 1977, when mass spectrometry 
was far away from being used for proteome analysis, thus limiting the authors in protein 
identification. Yet some important observations for oocyte biology were made by resolving 
[35S]-radiolabelled proteins of different developmental oocyte stages on 1D PAA gels and 
subsequent imaging of the labelled proteins using fluorography. Oocytes were collected from 
juvenile (oocytes are growing and partly not able to undergo meiotic maturation) and from adult 
mice. The patterns of protein synthesis during different stages of growth and maturation were 
compared. The results demonstrated, that (i) the patterns of protein synthesis are very similar in 
individual oocytes at the same stage of growth or of meiotic maturation, indicating a high 
degree of biochemical homogeneity in a given population of isolated oocytes, (ii) that the linear 
increase in protein content of growing mouse oocytes is accompanied by significant qualitative 
changes of proteins synthesized, and that (iii) meiotic maturation is characterized by several 
discrete qualitative changes in the pattern of protein synthesis. Furthermore, it could be 
demonstrated by culturing oocytes with inhibitors of meiotic maturation that (i) protein 
synthesis is not required for germinal vesicle breakdown (GVBD) and that (ii) after GVBD has 
occurred, a programme of changes in protein synthesis is initiated, which takes place 
independently from the completion of nuclear progression to metaphase I [95]. 
In 2003, a 2D gel based study was performed to identify oolemmal mouse oocyte proteins. The 
authors separated the proteins from 2850 MII mouse oocytes on a 2D gel and identified some of 
the most intensive protein spots by mass spectrometry. In addition, 800 zona pellucida free 
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oocytes were surface labelled by biotinylation and also separated on a 2D gel. Spots were 
matched to the initial coomassie-stained reference gel and identified as molecular chaperones. 
The presence of HSP90, GRP94, GRP78 and Calreticulin on the oocyte surface was validated 
by immunofluoresence [96]. In 2010, a review was published by the same group in which it was 
stated that the potential functions of the molecular chaperones on the egg surface are still 
unclear. Yet they pointed out a report, which indicated that oolemmal Calreticulin likely plays a 
role in sperm–egg binding and signal transduction events during fertilization [97, 98]. 
In a quantitative analysis between GV and MII mouse oocytes by two silver stained 2D gels, 
one containing the proteins from 500 GV and one containing the proteins from 500 MII oocytes, 
12 proteins appeared to be differentially expressed. Spot identification showed that TACC3, 
HSP 105, STI1, ADSS, Lipocalin and Lysozyme 1 were lower in abundance in MII oocytes, 
while one protein, TCTP was of higher abundance in MII oocytes. Since five proteins, 
PDCD6IP, Importin-a2, Nudix, Nucleoplasmin2 and Spindlin, were identified in both samples, 
but from spots of different mass and isoelectric points in the two gels, authors concluded that 
these proteins were posttranslationally modified during maturation [99]. Later it was revealed in 
different publications that TACC3 is required for microtubule anchoring at the centrosome 
[100] and that it is essential for spindle assembly and cell survival [101]. 
Another 2D gel based but qualitative mouse oocyte proteome study was published in 2008. 
From a gel of zona pellucida free MII mouse oocytes, 869 selected protein spots, corresponding 
to 380 unique proteins, were identified. A total of 90 protein spots, representing 53 unique 
proteins, were stained with Pro-Q Diamond, indicating that the contained proteins are in 
phosphorylated forms [102]. 
The next study also targeting qualitative mouse oocyte protein expression was performed in 
2009. In an LC-MS/MS approach, 625 proteins were identified from 2700 zona free MII mouse 
oocytes proteins. By comparing the identified proteins to mRNAs known to be expressed at 
high levels both in oocytes and fertilized eggs, a subset of 76 proteins was pointed out. It 
contained nine proteins (MATER, STELLA, DNMT1, ZAR1, NPM2, PADI6, TLE6, TCL1, 
FILIA) of which the corresponding genes were described as “maternal effect genes” due to their 
characteristic as to be absolutely necessary for oogenesis, fertilization or early embryonic 
development. Consequently, these proteins were named “maternal effect proteins”. 
Additionally, identified proteins were compared to a proteome analysis of mouse embryonic 
stem cells (ESCs) and an overlap of 371 proteins was found. Besides the identification of some 
pluripotency markers, this group of proteins included many uncharacterized proteins, which 
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were supposed to be good candidates for studying the mechanism of reprogramming by the 
authors [103]. 
For studying the mouse oocyte proteome at different developmental stages, the proteins from 
7000 GV oocytes as well as 7000 MII oocytes and 7000 zygotes were qualitatively analysed in 
2010. 2781 proteins were identified from GV oocytes, 2973 proteins from MII oocytes, and 
2082 proteins in zygotes by LC-MS/MS analysis. An abundance comparison of the proteins 
identified from the three developmental stages to each other as well as to proteins identified 
from ESCs was performed by taking the identified peptides per protein as indication for its 
abundance. The comparison revealed that GV and MII oocytes are more similar than zygotes 
and ESCs. Compared with oocytes, ESCs expressed some specific or highly abundant proteins, 
mostly involved in metabolism. Oocytes and zygotes possessed specific protein families, which 
are involved in self-renewal and cell cycle regulation, more than ESCs. In a pathway analysis of 
the developmental stages, it was revealed that GV oocytes contained a greater number of 
metabolism-related proteins responsible for supporting oocyte maturation, while MII oocyte 
proteins were more involved in the regulation of cell cycle events and epigenetic modifications. 
Taken together it was pointed out that different protein compositions are correlated with oocyte 
characteristics at different developmental stages [104].  
Very recently the catalogue of identified mouse MII oocytes was extended to 3699 proteins, 
identified from 1884 zona free mouse MII oocytes. This large number of identifications was 
facilitated by the use of a mass spectrometer of the latest generation (Orbitrap Velos XL), 
demonstrating how the technical development in mass spectrometry is correlated with insights 
in biology. This protein catalogue was comparable by size to an ESC protein catalogue. Hence, 
a valid comparison between the MII oocyte proteins to the proteins from ES cells could be 
performed, leading to 2556 proteins contained in both cell types. Since the oocyte has been 
proposed to hold enough reprogramming factors for up to 100 nuclei, this subset of proteins was 
screened for such factors by looking for proteins which are (i) localized in the nucleus, (ii) 
having chromatin as substrate, and (iii) acting catalytically. The list of 28 proteins which 
matched those criteria was named “Reprogrammome” by the authors, since they considered 
them to belong to the set of molecules that enable reprogramming [105]. 
The bovine oocyte proteome has been addressed by fewer publications. In 2010, a qualitative 
proteome analysis of bovine GV oocytes, containing 811 identified proteins, was published. 
Additionally, authors analysed cumulus cells and identified 1247 proteins. A qualitative 
comparison of both datasets revealed that 352 proteins were common to both cell types. A 
quantitative comparison based on a spectral count approach led to 371 proteins differentially 
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expressed between oocytes and cumulus cells. Gene Ontology and a pathway analysis showed 
that cumulus cells have higher numbers of proteins involved in cell communication, generation 
of precursor metabolites and energy, as well as into transport than GV oocytes [106]. 
The pattern of newly synthesized proteins during in vitro maturation of bovine oocytes was 
addressed by a study published in 2004. Oocytes were in vitro matured with [35S]-methionin for 
four hour periods from time zero to 28 hours. Pools of ten oocytes were then prepared for 2D 
gel electrophoresis. For each time interval, three gels were obtained, digitalized, and analysed. 
Three major patterns of protein synthesis were observed during bovine oocyte maturation in 
vitro: one at the beginning of maturation (0–4 hr), another one in the middle (4–16 hr) and the 
last one after the completion of MI stage (16–28 hr) [107]. Although this study revealed 
differences in the qualitative pattern of newly synthesized proteins during maturation, protein 
identifications were not provided.  
The improvement in the development of 2D gel based techniques as well as their impact on 
developmental biology has been impressively demonstrated by an analysis of the bovine oocyte 
in vitro maturation process. The application of the saturation DIGE technique enabled 
quantification from 2D gels containing 500 ng proteins corresponding to only five oocytes. Six 
biological replicates from in vivo and in vitro matured oocytes were analysed and enabled a 
valid statistical evaluation of differentially abundant spots. Ten differentially abundant proteins 
could be unambiguously identified from a preparative gel containing 2200 bovine GV oocytes, 
including the “Translationally controlled tumor protein”, enzymes of the Krebs and pentose 
phosphate cycles, Clusterin, 14-3-3 , Elongation factor-1 gamma, and redox enzymes. 
Especially interesting was the new detection of three Glutathione S-transferase Mu 5 (GSTM5) 
isoforms whose abundances were moreover altered in opposing directions between GV and MII 
oocytes [74].  
The pig oocyte proteome was addressed by a 2D gel study published in 2004. Proteins from 600 
GV oocytes were separated on a 2D gel from which 35 protein spots were identified. 
Additionally, from the GV, the MI and the MII stage, 200 oocytes each were separated on 2D 
gels followed by silver staining. The quantitative comparison of these spots revealed six 
differentially abundant proteins, however, only one of these spots could be unambiguously 
identified [108]. The same group deepened these insights into porcine oocyte in vitro maturation 
by another 2D gel based study published in 2007. Four replicates of GV oocytes were in vitro 
matured and labelled with [35S]-methionin at time points 0 (GV stage), 24 h (MI stage) and 40 h 
(MII stage) during in vitro culture. Autoradiography revealed between 240 and 120 protein 
spots at the indicated developmental stages, demonstrating the complexity of de novo protein 
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biosynthesis during oocyte maturation. In total 16 spots were found to be significantly altered in 
intensity between the GV and the MII stage, among which four spots showed an increased rate 
of biosynthesis and the contained proteins were therefore supposed to play an essential role in 
meiosis. The role of one of these spots, identified as “Ubiquitin C-terminal hydrolase-L1” 
(UCH-L1), was further studied and it was revealed that UCH-L1 inhibitor treated oocytes were 
impaired in their capacity to reach the MII stage during meioisis. In addition, the inhibition of 
UCH-L1 resulted in elevated M-phase promoting factor (MPF) activity and a low level of 
Monoubiquitin. The metaphase I to anaphase transition needs a decrease in MPF activity by 
degradation of its regulatory subunit cyclin B 1 over the ubiquitin–proteasome pathway. This 
supported the hypothesis that UCH-L1 might play a role in metaphase I-anaphase transition by 
regulating ubiquitin-dependent proteasome mechanisms [109].  
Just recently, a nano LC-MS/MS based quantitative proteome analysis of high and low quality 
porcine oocytes was published. High quality oocytes were produced by in vitro maturation with 
gonadotrophins and low quality oocytes by in vitro maturation without gonadotrophins. The 
oocytes were labelled with different isobaric tags and subjected to mass spectrometry. In total 
503 proteins were identified, from which 16 proteins differed in their abundance between two 
replicates of low and high quality oocytes. From the fact that differences between the first and 
the second replicate were significantly more pronounced in the first replicate, authors concluded 
a general quality difference between the oocytes for each replicate based on conditions and 
timing of oocyte collection. To find out whether the differentially abundant oocyte proteins are 
secreted, the maturation media were also qualitatively analysed by nano LC-MS/MS, leading to 
110 identified proteins which were not detected in a control medium. Eight of these proteins 
belonged to the group of differentially abundant proteins between low and high quality oocytes. 
More abundant proteins in the high-quality oocyte proteome included “Kelch-like ECH-
associated protein 1” (an adaptor for ubiquitin-ligase CUL3), “Nuclear export factor CRM1” 
and “Ataxia-telangiectasia mutated protein kinase”. Dystrophin (DMD) was more abundant in 
low-quality oocytes and was also identified from the media [110].  
 
1.6.2 Proteome analyses of preimplantation embryos 
Up to today the number of published data of holistic proteome analyses from preimplantation 
mammalian embryos is rather limited. This might be due to the time consuming process of 
collecting sufficient amounts of sample material. A method to address the proteome from very 
limited sample amounts is to employ the “surface enhanced laser desorption ionisation time-of-
flight” (SELDI-TOF) technique. It is a variation of the MALDI technique (see chapter 1.5.2) but 
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has the disadvantage of a low resolution and accuracy. Therefore, this technique is indeed 
capable to recognize patterns of proteins expression, but cannot provide valid protein 
identifications and is regarded as to have a very limited potential to enhance biological 
knowledge [66]. For this reason, publications based on the SELDI-TOF technique will not be 
described in detail. Examples of its application are the comparisons of in vivo and under 
different oxygen concentrations in vitro cultured mice embryos [111] as well as the comparison 
of early, expanded and degenerated human blastocysts [112]. 
A very early approach to analyse bovine embryo proteins was published in 1989. Although 
protein identifications could not be provided, the results had an impact on the understanding of 
bovine embryo biology. The authors cultured bovine oocytes and preimplantation embryos with 
[35S]-methionin and separated their protein lysates of different developmental stages by 1D-
PAA-SDS gel electrophoresis. The protein patterns detected by autoradiography were 
compared. While minor differences were detected between the lanes from oocytes, zygotes, 2-
cell-stage and 4-cell stage embryos the pattern of those stages is obviously different from the 
embryos collected when they showed between 8-16 blastomeres. The patterns of the embryos 
collected between the 16- to 32-cell stages and blastocysts were similar to each other but both 
were distinct from those produced by embryos before the 8-cell stage. Additionally, embryos of 
different developmental stages were incubated with [3H]-uridine to measure rates of RNA 
synthesis. Incorporation of radiolabelled uridine into RNA was first detected at the 16-cell 
stage. These results suggested to the authors that protein synthesis is programmed by maternal 
mRNA up to the 8-cell stage but switches to mRNA derived from the zygote genome between 
the 8- and 16-cell stages. This suggestion was confirmed by several publications later on and 
allowed to time the MET to occur between the 8- and 16-cell stage [35]. 
Seventeen years later, when proteome techniques were far more developed, the patterns of 
newly synthesized proteins during embryo development were addressed again by radiolabelling 
of proteins: An above mentioned study [107] concerning patterns of newly synthesized proteins 
during bovine in vitro maturation, was continued by identifying proteins which are not only 
translated throughout in vitro maturation of bovine oocytes but also in the 2-cell, 4-cell and 8-
cell stage of in vitro cultured bovine embryos. Three replicates of 2-cell, 4-cell and 8-cell stage 
embryos were cultured with -amanitin in order to repress transcription and with [35S]-
methionin and [35S]-cystein to reveal newly translated proteins. Embryos were lysed and 
separated by 2D-gel electrophoresis. Autoradiography of these gels revealed 291 (2-cell stage), 
373 (4-cell stage) and 252 (8-cell stage) spots on each gel. Of these spots 70, 83 and 28 
contained proteins which are exclusively translated at the 2, 4 and 8-cell stage respectively, 
while 123 spots were continuously present during all three stages. These spots were matched to 
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the 92 spots from the previously performed in vitro maturation experiment (see previous 
chapter), revealing that 46 spots are shared in position. Of these 46 proteins, 32 spots could be 
matched to their position on a preparative gel from 3000 bovine GV oocytes. Ten of these spots 
were successfully identified by MALDI-TOF (HSC71; HSP70; CYPA; UCH-L1; GSTM5; 
CCT5; E-FABP; 2,3-BPGM, Ubiquitin-conjugating enzyme E2D3; and Beta-actin/Gamma-
actin). Due to their characteristic features of being newly synthesized in all the above mentioned 
stages, the authors named them “maternal house keeping proteins” (MHKPs) [113]. 
A dedicated proteomic comparison between porcine IVF and parthenogenetic zygotes was 
published in 2009. Protein lysates of 6000 IVF zygotes and 6000 parthenogenetic zygotes were 
separated on 1D-PAA-SDS gels, from which gel slices were analysed by nano LC-MS/MS. In 
total 735 proteins were identified. Only 51.3 % (377) proteins were identified in both the IVF 
and PA zygotes, indicating major alterations of their protein composition. The relative 
abundance of proteins in each sample was estimated by a spectral count approach. 90 % of the 
proteins turned out to be differentially abundant with an abundance ratio of > 2, among which 
abundance ratios of > 10 were observed for 410 proteins. To verify the quantitative 
measurements, SRM assays confirmed the tendency of abundance alteration for nine proteins 
(JAK2, STAT1, STAT2, Calpastatin, Complement cytolysis inhibitor, Plakoglobin, 
Serotransferrin, Epsilon-globin, Acetyl-CoA C-acetyltransferase) from the spectral count 
approach. These results provided putative markers of embryo quality and strengthened the 
hypothesis that, besides genomic imprinting, aberrant protein expression in PA embryos could 
be a reason for their developmental failure [114]. 
 
1.7 Aim of the thesis 
The aim of this doctoral thesis was to analyse both the qualitative and quantitative proteome 
profile of oocytes and of preimplantation embryos. Due to the fact that the cow represents an 
excellent model for human reproduction, all analyses were performed on bovine samples.  
To reflect the situation of ARTs embryos were produced in vitro. In a first step a qualitative 
protein profile of GV oocytes was produced to obtain an insight into the protein storage of 
oocytes. In the following, proteomic approaches were scaled down to face the small sample 
amounts available for comparative analyses of a sufficient number of biological replicates from 
oocytes and early embryos. This enabled to address several crucial steps of embryonic 
development on the protein level. Since the in vitro maturation process of oocytes is associated 
with major drawbacks [115], the differences between in vivo and in vitro matured oocytes were 
analysed. To encompass the maternal embryo transition (see chapter 1.3.2), 2-cell stage 
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embryos were compared with morulae. During the morula to blastocyst transition, the first cell 
differentiations become morphologically obvious, while major changes in the embryonic 
structure occur (see chapter 1.3.2). Therefore, this developmental period was addressed in a 
comprehensive way, by analysing morulae and blastocysts using two complementary 
approaches. An illustration of this subsequent proteome analysis of bovine oocytes and early 
embryonic stages as performed in this doctoral thesis is shown in Fig. 4. 
 
 
 
 
. 
 
 
 
Fig. 4: Illustration of the subsequent proteome analyses of bovine oocytes and early embryonic stages as 
performed in this doctoral thesis 
(A) Qualitative proteome profile of 900 GV oocytes; (B) Method adaptation to the analysis of small sample 
amounts; (C) Comparison of in vitro and in vivo matured oocytes (D) Comparison of 2-cell stage embryos and 
morulae; (E) Comparison of morulae and blastocysts; Embryo pictures were taken by Myriam Reichenbach. 
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2 Materials and Methods 
2.1 Sample Generation  
2.1.1 Generation of GV ooocytes 
Ovaries were collected from a local slaughterhouse and stored for approximately three hours in 
phosphate buffered saline (PBS) at 30°C. To remove blood and debris ovaries were washed 
three times in PBS at 30°C. Cumulus oocyte complexes (COCs) were obtained by aspirating 2–
8 mm follicles with a 20-gauge needle and a vacuum pressure of approximately 100 mm Hg. 
COCs which had at least one layer of compact cumulus cells were selected and denuded 
mechanically by vortexing for four minutes. Denuded oocytes were washed three times in PBS 
+ 0.1 % Polyvinylpyrrolidon (PVP) before they were transferred into a sample cup. The 
remaining buffer was extracted by suction with a capillary. Buffer free oocytes were frozen on 
dry ice and stored at -80°C until analysis. 
 
2.1.2 Generation of early embryos 
Embryos were prepared according to a modified procedure as primarily described by Berg and 
Brem [116]. COCs were obtained from slaughterhouse ovaries as described above. COCs which 
had at least one layer of compact cumulus cells were selected and washed three times in oocyte 
maturation medium. The COCs were matured for 22 hours in four-well dishes in 400 l droplets 
of oocyte maturation medium in an incubator with 5 % CO2 and 39.0°C. Matured COCs were 
washed three times in fertilization medium and transferred to 400 l droplets of fertilization 
medium in four-well dishes. Frozen-thawed spermatozoa were prepared in a procedure called 
“swim up” according to a method developed by Parish et al [117]. For all experiments, sperm 
from the same bull (Mindel) was used. Sperm straws containing 20*106 sperms were thawed for 
ten seconds at 37°C. Approximately 5*106 thawed sperms were layered under 1 ml sperm talp 
medium in centrifugal tubes and incubated at 5 % CO2 and 39.0°C for capazitation. After one 
hour incubation time, the supernatant containing the healthy and mobile sperm was collected 
and centrifuged for 10 minutes with 1800 g at 26 °C. The supernatant was removed and about 
5*106 sperms were co incubated with 20 to 40 oocytes in 400 l fertilization medium for 18 
hours at 5 % CO2 and 39 °C. Presumptive zygotes were mechanically denuded by vortexing for 
four minutes, washed three times in synthetic oviductal fluid (SOF) and transferred to 400 l 
droplets of SOF under mineral oil in four-well dishes. They were incubated with 5 % CO2 and 5 
% O2 at 39°C. 2-cell-stage embryos were collected 27 hours post fertilization, morulae were 
collected five days post fertilization (day of fertilization = day 0) and blastocysts were collected 
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seven days post fertilization. Morulae were collected when they had at least 32 blastomeres. 
Blastocysts were collected both in the early and the expanded stage. All embryos were 
microscopically evaluated to their blastomeric structure prior to collection. Embryos were 
washed three times in PBS + 0.1 % PVP before they were transferred into a sample cup. The 
remaining buffer was extracted by suction with a capillary. Buffer free embryos were frozen on 
dry ice and stored at -80°C until analysis.  
 
2.1.3 Generation and processing of in vivo aspired oocytes by ovum pick-up (OPU) 
The generation of in vivo aspired oocytes was performed by the group of Prof. Wolf at the 
Moorversuchsgut Badersfeld. For the aspiration of GV oocytes, OPU was carried out in three 
and four day intervals. For the aspiration of MII oocytes, OPU of superstimulated cows was 
carried out in four to five weeks intervals. For the exact procedure of OPU please refer to the 
process described in the publication of Machado et al. [118]. 
For superstimulation animals were treated according to the stimulation scheme in Table 1. 
Animals received a “controlled intravaginal progesterone-releasing device” (CIDR) between 
days 7-10 of the oestrous cycle (day 0 = oestrus) for nine days. On day six after the application 
of the CIDR the twice daily injection of “follicle stimulating hormone” (FSH) at 12 hours 
intervals in decreasing doses was started and carried on for four days. The total dose was 500 
I.U. for heifers and 750 I.U. for cows. PGF2 was injected twice at day eight and day nine of the 
FSH injections (61 and 49 h prior to OPU). The CIDR was removed at the second PGF2 
administration. Additionally 18 to 20 h before the particular OPU, 5 ml of a GnRH analogue 
was injected. 
 
Table 1: Scheme of superstimulation for the generation of in vivo matured oocytes 
Day of 
stimulation 1 to 5 6 7 8 9 10 
CIDR CIDR CIDR CIDR CIDR  
 FSH FSH FSH FSH  Administered drug  
   PGF2 PGF2 GnRH 
Day 
of 
OPU 
 
The in vitro maturation (IVM) of GV oocytes was performed as described in chapter 2.1.2. 
Matured oocytes were microscopically evaluated for the presence of a polar body and 
mechanically denuded by pipetting. Denuded MII oocytes were washed three times in PBS + 
0.1 % PVP before they were transferred into a 0.5 ml sample cup. The remaining buffer was 
extracted by suction with a capillary. Buffer free oocytes were frozen on dry ice and stored at -
80 °C until analysis.  
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2.2 Nano-LC-MS/MS analyses  
2.2.1 Qualitative proteome profile of 900 GV oocytes 
2.2.1.1 Lysis 
70 l Laemmli buffer was added to 900 GV oocytes. Oocytes were pre-lysed by pipetting up 
and down before they were heated at 95°C for five minutes. In the following, they were frozen 
on dry ice for five minutes and sonicated in a water bath for five minutes. The procedure of 
freezing and sonication was repeated three times in total. The lysate was centrifuged for 15 
minutes with 14,000 g. The supernatant was collected and stored at -80°C. 
 
2.2.1.2 1D polyacrylamide SDS gel electrophoresis 
SDS gel electrophoresis was performed using a 0.5 cm 4 % stacking gel and a 12 %, 
respectively a 6 % separation gel. The overall gel size was 7 cm (L) × 8.5 cm (W) × 0.75 mm. 
On each gel, half of the protein lysate of 900 GV oocytes was separated. Separation was 
performed for 20 minutes at a voltage of 100 V and for additional 60 min at 200 V in SDS 
running buffer. The gels were stained overnight with coomassie staining solution and destained 
for at least eight hours with coomassie destaining solution. 
 
2.2.1.3 Gel slicing and tryptic in-gel digestion 
The gel lanes were cut into 23 (12 % gel), respectively 14 (6 % gel) gel slices using a scalpel. 
The positions and size of the gel slices are indicated in Fig. 5. Slices were transferred in 1.5 ml 
sample cups filled with 500 µl bidest H2O. To reduce and block the cystein residues gel slices 
were incubated with 45 mM dithioerythritol (DTT) and 50 mM ammonium hydrogen carbonate 
(NH4HCO3) for 30 min at 55 °C followed by two 15 minutes incubation steps with 100 mM 
iodacetamide in 50 mM NH4HCO3. Prior to digestion, gel slices were washed twice for 15 min 
in 50 mM NH4HCO3 and minced with a pipette tip. Tryptic hydrolysis was performed overnight 
at 37 °C in 30 l 50 mM NH4HCO3 with 100 ng modified porcine trypsin per gel slice. The 
supernatant was collected and preserved. The peptides were further extracted by a ten minute 
treatment with 100 l 70 % acetonitril (ACN). The NH4HCO3 and ACN fractions were pooled 
and dried using a vacuum centrifuge. Samples were stored at -80 °C. Prior to LC-MS/MS 
analysis, the peptides were solved in 0.1 % formic acid (FA). 
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2.2.1.4  1D-LC MS/MS analysis 
The 1D-liquid chromatography (1D-LC) was performed on a multi-dimensional nano-liquid 
chromatography system. Peptides of each gel slice were loaded separately on a trap column at a 
flow-rate of 10 µl per minute and subsequently separated with an analytical column (reversed 
phase column I) at a flow rate of 260 nl/min and the following consecutive gradients: I) 0–30 % 
B in 80 min, II) 30–60 % B in 30 min, III) 100% B for 10 min (A: 0.1 % FA, B: 84 % ACN and 
0.1 % FA). Mass spectrometry was performed on an LTQ mass spectrometer (Mass 
spectrometer I) online coupled to a nano-LC system (nano HPLC I). For electrospray ionization 
a “distal coated silica tip” and a needle voltage of 1.4 kV was used. The MS method consisted 
of cycles of one full MS scan (Mass range: 300–2000 m/z) and three data dependant MS/MS 
scans. MS/MS spectra were generated in the “collision induced dissociation” (CID) cell of the 
mass spectrometer with 35 % collision energy. Dynamic exclusion was set to 180s. 
 
2.2.1.5 Database search and data analysis 
The MS/MS data were searched with the mascot search software against the ipi_BOVIN_v362 
database using the following parameters: i) Enzyme: Trypsin, ii) Fixed Modification: 
Carbamidomethyl (C), iii) Variable modifications: Oxidation (M); iv) Peptide tolerance 2 Da, v) 
MS/MS tolerance 0.8 Da, vi) Peptide charge 1+, 2+ and 3+, vii) Instrument ESI-TRAP and viii) 
Allow up to 1 missed cleavages. For statistical validation of MS/MS based peptide and protein 
identifications, the scaffold software was used. Scaffold was set up to accept peptide 
identifications greater than 95 % probability as specified by the “peptide prophet” algorithm 
[119]. Protein identifications were accepted if they met the scaffold protein probability of 99 % 
and were identified by at least two peptides. Protein probabilities were assigned by the “protein 
prophet” algorithm [120]. To further confirm the probability calculated by scaffold, a so-called 
decoy version of the ipi_BOVIN_v362 database consisting of randomized sequences was 
generated. The database was also searched by the mascot search software using the same 
parameters as described above. Any protein hit derived from the decoy database was regarded 
as false-positive identification. 
 
 
 
 
 
Material and Methods     27 
2.2.1.6 Gene ontology analysis 
Prior to gene ontology (GO) analyses all protein IPI accession numbers were transformed into 
Uniprot accession numbers. The GO analysis was performed by a GO tool which clusters 
proteins according to terms provided by the GO project [121]. The mapping and analysis tools 
are provided online by the Uniprot community (UniProt Gene Ontology / UniProt KB, 
http://www.uniprot.org/). 
 
2.2.2 Qualitative and quantitative analyses from small sample amounts of oocytes and 
embryos 
2.2.2.1 Sample preparation and iTRAQ labelling 
Lysis was carried out by adding 8 M urea buffer to all samples in a concentration of 0.128 l 
per oocyte/embryo. Samples were pre-lysed by pipetting up and down followed by 15 minutes 
of sonication. To reduce and block the cystein residues samples were incubated with 45 mM 
DTT in 50 mM NH4HCO3 for 30 min at 55 °C, followed by 15 minutes incubation with 100 
mM iodacetamide in 50 mM NH4HCO3. Samples were diluted to a ratio of 1:8 with the 
NH4HCO3 to obtain a pH value of around eight suitable for activating trypsin. Modified porcine 
trypsin was added in a concentration of five ng per oocyte. Samples were incubated overnight at 
37 °C before they were dried in a vacuum centrifuge. Samples were stored at -80 °C.  
For quantitative iTRAQ analysis samples containing 25 embryos/oocytes each were 
additionally cleaned up using Zip Tips according to the manufacturer’s protocol. Zip Tips are 
pipette tips containing C18 material which binds peptides so that superfluous salts and urea 
which would disturb the labelling reaction can be washed off. 
The labelling procedure was performed according to the manufacturer’s protocol downscaled to 
small sample amounts. Samples were dissolved in dissolution buffer to a concentration of 168 
nl per oocyte/embryo. The iTRAQ reagent contained in a single vial (amount is not provided by 
the manufacturer) was reconstituted in 70 l high purity ethanol and vortexed for one minute. 1 
% of the reagent amount contained in a single iTRAQ vial was added to the samples per 
oocyte/embryo. After one hour incubation time samples were dried in a vacuum centrifuge and 
stored at -20 °C until analysis.  
iTRAQ labelled samples used for 1D LC-MS/MS analyses were cleaned up by “vivapure S 
mini M” devices according to the manufacturer’s protocol. In a 2D LC-MS/MS approach this 
was not necessary since the clean up procedure is performed by the “strong cation exchange” 
column.  
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2.2.2.2 1D and 2D liquid chromatography (LC) 
Prior to LC-MS/MS analysis the peptides were solved in 0.1 % FA. For 1D-LC MS/MS 
analysis, peptides were loaded on a trap column at a flow-rate of 10 µl per minute and 
subsequently separated with an analytical column (Reversed Phase column II) at a flow rate of 
260 nl/min and the following consecutive gradients: I) 0–30 % B in 80 min, II) 30–60 % B in 
30 min, III) 100 % B for 10 min (A: 0.1 % FA, B: 84 % ACN and 0.1 % FA). 
For 2D-LC MS/MS analysis peptides were additionally prefractionated using a “strong cation 
exchange” (SCX) column. Peptides were eluted from the SCX column with five different 
ammonium chloride (NH4Cl) solutions of (i) 10, (ii) 25, (iii) 50, (iv) 100 and (v) 500 mM.  
 
2.2.2.3 Mass spectrometry 
Mass spectrometry was performed on an LTQ Orbitrap XL mass spectrometer (mass 
spectrometer II) online coupled to the nano-LC (nano HPLC I) system. For electrospray 
ionization, a “distal coated silica tip” and a needle voltage of 1.4 kV was used. The MS method 
consisted of cycles of one full MS scan (Mass range: 300–1800 m/z) and five data dependent 
MS/MS scans. MS/MS spectra were generated in the CID cell of the mass spectrometer with 35 
% collision energy. Dynamic exclusion was set to 180s.  
 
2.2.2.4 Database search  
The MS/MS data were searched with Mascot against the ipi_BOVIN_v362 database using the 
following parameters: i) Enzyme: Trypsin, ii) Fixed Modification: Carbamidomethyl (C), iii) 
Variable modifications: Oxidation (M); iv) Peptide tolerance 50 ppm, v) MS/MS tolerance 0.8 
Da, vi) Peptide charge 1+, 2+ and 3+, vii) Instrument ESI-TRAP and viii) Allow up to 1 missed 
cleavages. For the database search of the iTRAQ labelled samples the parameter ii) (Fixed 
Modification) was modified and set to “iTRAQ (K)” and “iTRAQ (N-term)”. 
 
2.2.2.5 Generation of exclusion lists for quantitative iTRAQ analysis 
Exclusion lists (ELs) were generated by the proteome discoverer software. Time intervals were 
set to 30 minutes during the optimisation experiments (see chapter 3.4) and to ten minutes 
within the comparison of in vivo versus in vitro matured oocytes (see chapter 3.5) as well as 
within the comparison of morulae and blastocysts (see chapter 3.7.2). Each exclusion list was 
loaded into the Xcalibur software which is used for MS acquisition. 
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2.2.2.6 Data analysis for identification and quantification 
For protein identification, the scaffold software was used as described in chapter 2.2.1.5 with 
the additional modification that peptides had to be detected within a 10 ppm accuracy window, 
reflecting the high mass accuracy of the LTQ Orbitrap XL mass spectrometer. 
The quantification by “spectral count” applied to the analysis of 2-cell stage embryos and 
morulae (see chapter 3.6) was performed by the scaffold software. Only proteins for which (i) 
MS/MS spectra had been detected in each stage, (ii) the corresponding peptides were detected 
with at least ten MS/MS spectra in at least one of the two stages and (iii) which had a “spectral 
count abundance ratio” of at least 2 were considered as differentially abundant.  
For iTRAQ quantification, the scaffold’s quantification “Q+” module was used. For the 
comparison of in vivo versus in vitro derived oocytes, the peptide probability for quantification 
was set up to accept only peptides identifications greater than 80 % probability within 10 ppm 
mass tolerance and the minimum dynamic range was set to 1 %. For the comparison of morulae 
and blastocysts, the peptide probability for quantification was set up to accept only peptides 
identifications greater than 95 % probability within 10 ppm mass tolerance and the minimum 
dynamic range was set to 5 %.  
For all analyses the “normalization to the entire dataset average” feature was applied. All 
quantification data were exported to Microsoft office excel. To find out which proteins were 
identified and quantified in all runs the Microsoft office access software was used. For the 
comparison of in vivo versus in vitro derived oocytes the average fold change was calculated in 
Microsoft office excel. Proteins with an average log 2 fold change of > |1| were considered as 
differentially abundant proteins. For the comparison of morulae and blastocysts the calculations 
of student’s t-test p-values and the generation of a Volcano plot were performed by the R-
Software. Proteins which had a p-value of < 0.05 and an average log 2 fold change of > |0.6| 
were considered as differentially abundant proteins. 
 
2.2.2.7 Targeted quantification by Selected Reaction Monitoring (SRM) 
Targeted quantification of IMP3 and YBX2 was performed on a QTRAQ 5500 (mass 
spectrometer III) online coupled to a nano-liquid chromatography system (nano-HPLC II). 
Proteotypic peptides selected for quantification of IMP3 were the peptides IPVSGPFLVK 
(IMP3_1) and FTEEIPLK (IMP3_2). Proteotypic peptides selected for quantification of YBX2 
were the peptides GAEAANVTGPGGVPVK (YBX2_1) and TPGNPATAASGTPAPLAR 
(YBX2_2). Samples were loaded on a RP trap column at a flow-rate of 5 µl per minute and 
subsequently separated with an analytical column at a flow rate of 280 nl / min and the 
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following consecutive gradients: I) 0–30 % B in 80 min, II) 85 % B for 10 min, (A: 0.1 % FA, 
B: 100 % ACN and 0.1 % FA). The exact peptide transitions can be looked up in Table 2. The 
method for targeted quantification of these three proteins has been previously established by 
Thomas Fröhlich and Daniela Deutsch in the proteomics facility of LAFUGA.  
Table 2: Transitions for YBX2 and IMP3 Quantification 
Peptide name Sequence Charge 
state 
Q1 
[m/z] 
Q3 
[m/z] Ion 
Dwell 
time [ms] 
Collision 
Energy [V] 
YBX2_2 TPGNPATAASGTPAPLAR 2 825.43 940.52 y10 100 43 
YBX2_2 TPGNPATAASGTPAPLAR 2 825.43 869.48 y9 100 46 
YBX2_2 TPGNPATAASGTPAPLAR 2 825.43 1011.56 y11 100 46 
YBX2_1 GAEAANVTGPGGVPVK 2 712.38 811.47 y9 100 35 
YBX2_1 GAEAANVTGPGGVPVK 2 712.38 910.54 y10 100 35 
YBX2_1 GAEAANVTGPGGVPVK 2 712.38 343.23 y3 100 33 
IMP3_2 FTEEIPLK 2 488.77 728.42 y6 100 26 
IMP3_2 FTEEIPLK 2 488.77 830.43 b7 100 26 
IMP3_2 FTEEIPLK 2 488.77 599.38 y5 100 26 
IMP3_1 IPVSGPFLVK 2 528.83 747.44 y7 100 27 
IMP3_1 IPVSGPFLVK 2 528.83 846.51 y8 100 27 
IMP3_1 IPVSGPFLVK 2 528.83 660.41 y6 100 30 
YBX2_1_aqua GAEAANVTGPGGVPVK 2 716.38 819.47 y9 100 35 
YBX2_1_aqua GAEAANVTGPGGVPVK 2 716.38 918.54 y10 100 35 
YBX2_1_aqua GAEAANVTGPGGVPVK 2 716.38 351.23 y3 100 33 
IMP3_1_aqua IPVSGPFLVK 2 532.83 755.44 y7 100 27 
IMP3_1_aqua IPVSGPFLVK 2 532.83 854.51 y8 100 27 
IMP3_1_aqua IPVSGPFLVK 2 532.83 668.41 y6 100 30 
 
2.3 2D gel based Saturation DIGE analysis 
2.3.1 Sample lysis 
Lysis of morulae and blastocysts for analytical gels was carried out by adding 4 l DIGE lysis 
buffer to each pool of 25 embryos (containing 2.25 g protein), so that the final protein 
concentration was 0.55 µg/µl, which is the optimal protein concentration for the labelling 
reaction with CyeDye saturation Dyes. Lysis of GV oocytes for preparative gels was carried out 
by adding DIGE lysis buffer in a concentration of 0.03 µl per oocyte to pools of 186 to 495 GV 
oocytes.  
All samples were pre-lysed by pipetting up and down. Samples were sonicated for five minutes 
in an ice containing water bath, followed by five minutes of freezing on dry ice. The procedure 
of sonication and freezing on dry ice was repeated three times in total. Samples for the 
analytical gels were immediately processed. All GV oocyte samples for the preparative gel were 
pooled and the final protein concentration was determined by a standard Bradford assay before 
they were stored at -80 °C.  
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2.3.2 Labelling of proteins with fluorescent Cye Dyes for analytical gels 
15 µg of an “internal pooled standard” (IPS) was prepared by pooling 1.25 µg protein of each 
sample and was labelled with Cye Dye Cy3, the remaining 1 µg from each sample was labelled 
with Cye Dye Cy5. 
The labelling was performed according to the manufacturer’s protocol. Cystein residues were 
reduced with tris (2-carboxyethyl) phosphine hydrochloride (TCEP) which was added in a 
concentration of 0.5 nmol / µg to each sample. Samples were incubated at 37 °C for one hour in 
the dark. Cye Dyes were reconstituted in N,N-dimethylformamide (DMF) to a 2 mM solution 
and added to the samples in a concentration of 1 nmol / µg. Samples were incubated at 37 °C 
for 30 minutes in the dark. The labelling reaction was stopped by addition of an equal volume 
“stopping buffer for analytical labelling”. Samples were immediately processed.  
 
2.3.3 Labelling of proteins with fluorescent Cye Dye Cy3 for the preparative gel 
The labelling was performed according to the manufacturer’s protocol. The sample of 400 µg 
GV oocyte proteins (corresponding to 4444 GV oocytes) was diluted with DIGE lysis buffer to 
a protein concentration of 2 mg/ml. Cystein residues were reduced with 10 µl of a 25 mM 
TCEP solution. The sample was incubated at 37 °C for one hour in the dark. A total of 400 
nmol Cye Dye Cy3 was reconstituted in DMF to a 20 mM solution and added to the samples in 
a concentration of 1 nmol / µg. Samples were incubated at 37 °C for 30 minutes in the dark. The 
labelling reaction was stopped by diluting Samples with 165 µl “stopping buffer for preparative 
labelling”. Samples were immediately processed.  
 
2.3.4  2D polyacrylamide SDS gel electrophoresis 
For analytical gels IEF Immobiline DryStrips pH 4–7, 24 cm were rehydrated overnight in 450 
l rehydration buffer using a reswelling tray. Dry strips were overlaid with DryStrip Cover 
Fluid to prevent evaporation. Prior to isoelectric focusing (IEF) 0.25 µg of the Cy5 labelled 
samples were mixed with 0.25 µg Cy3 labelled IPS. IEF was performed using an Ettan 
IPGphor. Samples were applied to the first dimension gel using anodic cup loading. Focusing 
was done for a total of 38.25 kVh. Prior to SDS-PAGE, IEF strips were equilibrated for ten 
minutes in 15 l equilibration buffer containing 200 l saturated bromphenol blue (BPB) 
solution.  
For the preparative gel IEF Immobiline DryStrips pH 4–7, 24 cm were rehydrated overnight 
with the labelled GV oocyte sample as produced in chapter 2.3.3. Focusing was done for a total 
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of 56.5 kVh. Prior to SDS-PAGE, IEF strips were equilibrated for ten minutes in 15 l 
equilibration buffer containing 200 l saturated BPB solution.  
12 % SDS PAA gel solution was prepared and cooled to 8 °C prior to gel casting. Gels were 
casted in an Ettan Dalt twelve gel caster, overlaid with water and polymerized overnight. The 
overall gel size was 25.5 cm × 19 cm × 0.1 cm. 
IPG strips were loaded onto the second dimension gels and overlaid with 0.5 % w/v agarose in 
SDS running buffer. Electrophoresis was performed using an Ettan Dalt six electrophoresis unit. 
Gels were run in groups of six with 10 mA per gel for one hour and with 40 mA per gel for six 
hours in 1 x SDS running buffer for the anodic chamber and 2 x SDS running buffer for the 
cathodic chamber. 
 
2.3.5 Scanning and evaluation of 2D saturation DIGE gels 
Gels were scanned using a Typhoon 9400 fluorescence scanner with a photomultiplier voltage 
of 670 V. Pixel size was set to 100 µm. Images were visualized by scanning with a wavelength 
of 584 nm (Cy3) and 684 nm (Cy5) respectively.  
Images were manually cropped to the same size by the image editor software prior to the 
evaluation by the De Cyder 6.5 software. Spots were detected with the software’s “differential 
in gel analyses” (DIA) tool. The spot detection parameter “estimated number of spots” was set 
to 10,000 and spots with a volume lower than 30,000 were excluded. Spot matching and inter-
gel intensity comparisons and the statistical analyses were performed with the software’s 
“biological variation analysis” (BVA) tool. Spots which met the criteria of a p-value of lower 
than 0.05 in the student’s t-test while the software’s “FDR correction” feature is applied and 
which were moreover detected within all gel images were considered as spots from 
differentially abundant proteins.  
 
2.3.6 Identification of spots from differentially abundant proteins 
The preparative gel was scanned by the Typhoon 9400 fluorescence scanner and the 
fluorescence image was imported to the SPControl software used for set up of the spot picking 
robot. Spots from differentially abundant proteins were manually assigned and picked by the 
spot picker. The gel was rescanned by the Typhoon 9400 fluorescence scanner and controlled 
for the correct out-cuts of spots.  
The spots were washed four times in 50mM NH4HCO3. Tryptic hydrolysis was performed 
overnight at 37 °C in 20 l 50 mM NH4HCO3 with 100 ng modified porcine trypsin per spot. 
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The supernatant was collected and preserved. The peptides were further extracted by a ten 
minute treatment with 40 l 70 % ACN. The NH4HCO3 and ACN fractions were pooled and 
dried using a vacuum centrifuge. Samples were stored at -80 °C. Prior to LC-MS/MS analysis, 
the peptides were solved in 0.1 % FA. 
The Peptides were separated by a Reversed Phase column at a flow rate of 260 nl/min with the 
following consecutive gradients: I) 0–60 % B in 30 min, (II) 100 % B for 10 min (A: 0.1 % FA, 
B: 84 % ACN and 0.1 % FA). 
Mass spectrometry was performed on an LTQ Orbitrap XL mass spectrometer (mass 
spectrometer II) online coupled to the nano-LC system (nano HPLC I) For electrospray 
ionization a “distal coated silica tip” and a needle voltage of 1.4 kV was used. The MS method 
consisted of cycles of one full MS scan (Mass range: 300–1800 m/z) and five data dependent 
MS/MS scans. MS/MS spectra were generated in the CID cell of the mass spectrometer with 35 
% collision energy. Dynamic exclusion was set to 180s.  
 
2.3.7 Comparative David gene ontology analysis of the combined data from 
differentially abundant proteins of morulae and blastocyts  
The GO analysis was performed by the open access David software [122]. The GO clustering 
was performed according to the GOTERM_BP_FAT categorization. The threshold for the 
minimum numbers of proteins in a cluster was set to 2 and the maximum EASE score was set to 
0.01. 
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2.4 Buffers, media and solutions 
2.4.1 Buffers and media for sample generation 
Buffer / Medium Composition 
Fertilization medium 
  50 µg Heparin sodium salt 
110 µg Sodium Pyruvate 
 60 mg BSA 
in 10 ml TL Fertilisationsmedium 
Oocyte maturation medium 
5 % (v/v) Oestrus cow serum 
50 µg FSH 
50 µg LH 
in 10 ml TCM 199 Reifungsmedium 
Phosphate buffered saline (PBS) 
136.9 mM NaCl 
    2.7 mM KCl 
    6.5 mM Na2HPO4 
    1.5 MM KH2PO4 
Sperm Talp medium 
1.1 mg Sodium Pyruvate 
 60 mg BSA 
in 10 ml TL Medium für Spermienkapazitation 
Synthetic oviduct fluid (SOF) 
1 % (v/v) MEM Non-essential amino acids 
solution 
4 % (v/v) BME Amino acids solution 
5 % (v/v) Oestrus cow serum 
3.6 mg Sodium Pyruvate 
in 10 ml SOF Kulturmedium 
 
2.4.2 Buffers and solutions for analyses 
Buffer / Solution Composition 
8 M Urea buffer 8.0 M Urea 0.4 M NH4HCO3 
Agarose overlay solution 0.5 % (w/v) Agarose in SDS running buffer 
Coomassie destaining solution 5% (v/v) Methanol 7% (v/v) Acetic Acid 
Coomassie staining solution 
   50 % (v/v) Methanol 
   10 % (v/v) Acetic Acid 
0.05 % (w/v) Coomassie R-250 
DIGE lysis buffer  
30 mM Tris 
     7 M Urea 
     2 M Thiourea 
4% (w/v) CHAPS adjusted to pH 8.0 with HCl 
Equilibration buffer 
6 M Urea 
30 % (v/v) Glycerin 
  2 % (w/v) SDS 
0.1 M Tris-HCl pH 8.0 
Gel solution for 1D gel electrophoresis  
(12% gel) 
  0.375 M Tris-HCl pH 8.8 
12.0 % (w/v) Acrylamide/Bisacrylamide 
   0.1% (w/v) SDS 
   0.1% (w/v) APS 
0.05%  (v/v) TEMED 
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Buffer / Solution Composition 
Gel solution for 1D gel electrophoresis 
(6% gel) 
0.375 M Tris-HCl pH 8.8 
  6.0 % (w/v) Acrylamide/Bisacrylamide 
  0.1 % (w/v) SDS 
  0.1 % (w/v) APS 
0.05 % TEMED 
Gel solution for 1D gel electrophoresis stacking 
gel  
(4% gel) 
   0.125 mM Tris-HCl pH 6.8 
  4.0 % (w/v) Acrylamide/Bisacrylamide 
  0.1 % (w/v) SDS 
0.05 % (w/v) APS 
0.10 % TEMED 
Gel solution for 2D gel electrophoresis  
(12.5 % gel) 
0.375 M Tris-HCl pH 8.8 
 12.5 %  Acrylamide/Bisacrylamide 
    0.1% (w/v)  SDS 
    0.1% (w/v) APS 
0.014% TEMED 
Laemmli buffer 
62.5 mM Tris pH 6,8 
10% (v/v) Glycerin 
  2% (w/v) SDS 
  5% (w/v) ß-Mercaptoethanol 
Rehydration buffer 
13 mM DTT  
     7 M Urea 
     2 M Thiourea 
4% (w/v) CHAPS 
1% (v/v) Pharmalytes 
SDS running buffer 
  25 mM Tris 
192 mM Glycin 
0,1 % w/v SDS 
Stopping buffer for analytical labelling 
7 M Urea 
2 M Thiourea 
4 % (w/v) CHAPS 
2 % (v/v) Pharmalytes 
130mM DTT 
Stopping buffer for preparative labelling 
361mM DTT  
      7 M Urea 
      2 M Thiourea 
4 % (w/v) CHAPS 
3 % (v/v) Pharmalytes 
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2.5 Chemicals, kits and prefabricated buffers 
Substance Manufacturer 
3-[(3-Cholamidopropyl)dimethylammonio]-1-
propanesulfonate (CHAPS) Sigma-Aldrich, Deisenhofen 
Acetic Acid Roth, Karlsruhe 
Acetonitril (ACN) Merck, Darmstadt 
Acrylamide/bisacrylamide solution (37,5:1; 30% 
w/v) Serva, Heidelberg 
Agarose Serva, Heidelberg 
Ammonium chloride (NH4Cl) Merck, Darmstadt 
Ammonium hydrogen carbonate (NH4HCO3) Riedel-de Haën, Seelze 
Ammonium peroxide sulfate (APS) Merck, Darmstadt 
Bovine serum albumin (BSA) Sigma-Aldrich, Deisenhofen 
Bradford assay Kit Thermo Scientific, Dreieich 
Bromophenolblue (BPB) Sigma-Aldrich, Deisenhofen 
Calcium chloride (CaCl2) Roth, Karlsruhe 
Chromatography water Merck, Darmstadt 
Coomassie Brilliant Blue R250 Sigma-Aldrich, Deisenhofen 
CyDye DIGE Fluor, Cy3 saturation dye  GE Healthcare, Freiburg 
CyDye DIGE Fluor, Cy5 saturation dye  GE Healthcare, Freiburg 
Disodium hydrogen phosphate (Na2HPO4) Merck, Darmstadt 
Dissolution buffer AB SCIEX, Darmstadt 
Dithioerythritol (DTT) Roth, Karlsruhe 
Ethanol Agentur für Rohstoffe, Hohenzell 
Follicle stimulating hormone (FSH)  Sioux Biochemical inc., USA 
Follicle stimulating hormone (FSH) for injection 
(Pluset®) Pharmanovo, Spain 
Formaldehyde (37%) Sigma-Aldrich, Deisenhofen 
Formic acid (FA) Sigma-Aldrich, Deisenhofen 
Glycerin Roth, Karlsruhe 
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Substance Manufacturer 
Glycin Roth, Karlsruhe 
GnRH analogue (Receptal®)  Intervet, Unterschleißheim 
Heparin sodium salt Sigma-Aldrich, Deisenhofen 
High purity ethanol  AB SCIEX, Darmstadt 
Hydrogen chloride (HCl) Roth, Karlsruhe 
Iodacetamide Sigma-Aldrich, Deisenhofen 
iTRAQ™ Reagents AB SCIEX, Darmstadt 
Luteinizing hormone (LH) Sioux Biochemical inc., USA 
Magnesium chloride (MgCl2) Merck, Darmstadt 
Methanol Agentur für Rohstoffe, Hohenzell 
Modified porcine trypsin  Promega, Wisconsin, USA 
N,N,N,N-Tetramethylethylendiamine (TEMED) Roth, Karlsruhe 
N,N-Dimethylformamide (DMF) Sigma-Aldrich, Deisenhofen 
Pharmalytes GE Healthcare, Freiburg 
Polyvinylpyrrolidon (PVP) Sigma-Aldrich, Deisenhofen 
Potassium chloride (KCl) Merck, Darmstadt 
Potassium dihydrogen phosphate (KH2PO4) Merck, Darmstadt 
Sigma Wide Range marker Sigma-Aldrich, Deisenhofen 
Sodium chloride (NaCl) Merck, Darmstadt 
Sodium Dodecyl Sulfate (SDS) Serva, Heidelberg 
Sodium Pyruvate Sigma-Aldrich, Deisenhofen 
ß-Mercaptoethanol Sigma-Aldrich, Deisenhofen 
Thiourea Sigma-Aldrich, Deisenhofen 
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2.6 Software 
2.6.1 Analyses software 
Name Function Manufacturer 
DAVID Gene Ontology analysis Pathway analysis 
European Bioinformatics 
Institute (EBI), Swiss Institute of 
Bioinformatics (SIB) und Protein 
Information Resource (PIR) 
DeCyder 6.5 Analysis of 2D DIGE gels GE Healthcare, Freiburg 
Image editor Cropping of gel images GE Healthcare, Freiburg 
MASCOT Search Database search for mass 
spectrometry 
Matrix Science, Boston (MA), 
USA 
Microsoft Office Access Protein list comparison Microsoft, Unterschleißheim 
Microsoft Office Excel Statistical analyses  Microsoft, Unterschleißheim 
Proteome Discoverer 1.1 
Database search for generating 
exclusion lists in mass 
spectrometry 
Thermo Scientific, Dreieich 
R Statistical analyses  The R Foundation for Statistical Computing 
Scaffold_3_00_06 
Statistical evaluation of protein 
list; 
Calculation of protein fold 
changes 
Proteome Software, Portland 
(OR), USA 
UniProt Gene Ontology / UniProt 
KB 
Gene Ontology analysis; 
Transformation of protein IDs 
European Bioinformatics 
Institute (EBI), Swiss Institute of 
Bioinformatics (SIB) und Protein 
Information Resource (PIR) 
Substance Manufacturer 
Tetramethylethylendiamine (TEMED) Roth, Karlsruhe 
Tris Roth, Karlsruhe 
Tris-(2-carboxyethyl) phosphine hydrochloride 
(TCEP) Sigma-Aldrich, Deisenhofen 
Urea Roth, Karlsruhe 
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2.6.2 Instrument specific software 
Name Operated Instrument Manufacturer 
Analyst 1.5.1 QTRAP 5500 AB SCIEX, Darmstadt 
SPControl 3.1 PROTEINEER spII Bruker Daltonics, Bremen 
Typhoon Scanner Control, 
ImageQuant 5.2 Typhoon 9400 GE Healthcare, Freiburg 
UNICORN 5.01 Ettan MDLC Amersham Biosciences, Freiburg 
Xcalibur (inc. Dynamic exclusion 
software) Finnigan LTQ Thermo Scientific, Dreieich 
Xcalibur (inc. Dynamic exclusion 
software) LTQ Orbitrap XL Thermo Scientific, Dreieich 
 
2.7 Instruments 
Instrument Name Manufacturer 
2D electrophoresis gel caster Ettan DALTtwelve gel caster  GE Healthcare, Freiburg 
2D electrophoresis running 
chamber 
Ettan DALTsix electrophoresis 
unit GE Healthcare, Freiburg 
2D gel glass spacer no name provided Glaserei Brendle, Neuaubing 
2D gel glass plates no name provided Glaserei Brendle, Neuaubing 
Blank Casette inserts Blank Cassette Inserts GE Healthcare, Freiburg 
Incubator for Digestion Modell 400 Memmert, Schwabach 
1D electrophoresis gel caster Mini-PROTEAN 2 BioRad, München 
1D electrophoresis running 
chamber Mini-PROTEAN 2 BioRad, München 
1D gel glass plates glass plates  GE Healthcare, Freiburg 
1D gel spacer Plastic spacer BioRad, München 
Special accuracy weighing 
machine Sartorius Basic Plus Sartorius, Göttingen 
Fluorescent-Scanner Typhoon 9400 GE Healthcare, Freiburg 
Freezer HFU 686 Top (-80°C) Heraeus, Hanau 
Isoelectric focussing machine IPGphor Pharmacia Biotech, Freiburg 
Refrigerator (+4°C) Premium Liebherr, Ochsenhausen 
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Instrument Name Manufacturer 
magnetic stirrer MR 2000 Heidolph, Schwabach 
Mass spectrometer I Finnigan LTQ Thermo Scientific, Dreieich 
Mass spectrometer II LTQ Orbitrap XL Thermo Scientific, Dreieich 
Mass spectrometer III QTRAP 5500 AB SCIEX, Darmstadt 
Microwave no name provided Panasonic, Hamburg 
Microcentrifuge EBA 3S Hettich, Tuttlingen 
Nano-HPLC I Ettan MDLC Amersham Biosciences, Freiburg 
Nano-HPLC II Nano Acquity Waters, Eschborn 
pH meter 761 Calimatic Knick, Berlin 
Pick-Robot PROTEINEER spII Bruker Daltonics, Bremen 
Power-Supply for 1D gels Power Supply Model 200/2.0 BioRad, München 
Power-Supply for 2D gels EPS 3501 XL Amersham Biosciences, Freiburg 
Reswelling Tray Immobiline Dry Strip Reswelling Tray GE Healthcare, Freiburg 
Shaker Certomat U B.Braun, Melsungen 
Thermomixer Thermomixer 5436 Eppendorf, Köln 
Cooling unit for 2D gel 
electrophoresis no name provided Eppendorf, Köln 
Sonication Cleaner Sonorex RK 100 Bandelin, Berlin 
Vacuum centrifuge Vacuum Concentrator Bachofer, Reutlingen 
Vortexer Vortex Genie 2 Bachhofer, Reutlingen 
Scale Sartorius 2357 Sartorius, Göttingen 
Centrifuge I GS-15R Centrifuge Beckman, Krefeld 
Centrifuge II Heraeus Sepatech Megafuge Hareus, Hanau 
Transferpettor caps Transferpettor caps Brand, Wertheim 
Transferpettor Transferpettor Brand, Wertheim 
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2.8 Consumables 
Product Name Manufacturer 
4 well dishes 4 well Multidish Nunc/Thermo Scientific, Dreieich 
Aluminium foil Alu-Folie Roth, Karlsruhe 
Aspiration pump  Electronic aspiration pump, 
modell 3014 Labotect, Göttingen  
Canules 1.2 x 40mm Sterican Einmal-Injektionskanülen B.Braun, Melsungen 
Canules, 0.45mm x 25mm Sterican Einmal-Injektionskanülen B.Braun, Melsungen 
Collection plate DigestPro MS 96 well collection plates Intavis, Köln 
Electrospray needle Distal coated Silica Tips New Objectiv, Woburn (MA), USA 
Falcon Tube 15ml and 50ml Falcon-Röhrchen TPP, Trasadingen, Schweiz 
Filter paper Whatman Filterpapier Whatman / Schleicher & Schuell, Dassel 
IPG-stripes for IEF Immobiline DryStrips, pH 4-7, 24cm GE Healthcare, Freiburg 
LC Glass vials I Glass vial, 1,5ml Amersham Biosciences, Freiburg 
LC Glass vials II 12x32 mm glass screw neck vial Waters, Eschborn 
Mineral oil for embryo culture Mineral oil, embryo culture tested Sigma 
Oil for IEF DryStrip Cover Fluid  GE Healthcare, Freiburg 
Petri dishes 94mm  Petri dishes  Roth, Karlsruhe 
Pipette tips (0,5 – 10 l) DIAMOND 10µl Gilson, Villiers Le Bel, Frankreich 
Pipette tips (2 – 200 l) PLASTIBRAND 200µl Brand, Wertheim 
Pipette tips (50 – 1000 l) PLASTIBRAND 1000µl Brand, Wertheim 
Plastic wrap Saran Dow, Schwalbach 
Progesterone releasing device Intravaginal progesterone-
releasing device (CIDR®)  Pfizer, Berlin 
Reversed Phase Column I C18 PepMap100 LC Packings Dionex, Idstein 
Reversed Phase Column II Reposil-Pur-C18-AQ Dr. Maisch GmbH, Ammerbuch-Entringen 
Sample Cups (0.5 ml,1.5 ml and 
2 ml) Safe-Lock Tubes  Eppendorf, Köln 
Sample Cups for IEF IPGphore Sample cups  GE Healthcare, Freiburg 
SCX Column Biobasic  Thermo Scientific, Dreieich 
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Product Name Manufacturer 
Syringes, 10 ml Omnifix 10ml B.Braun, Melsungen 
Trapping Column C18 PepMap100 LC Packings Dionex, Idstein 
Vivapure S mini M clean up 
devices 
Vivapure S mini M clean up 
devices Vivascience AG, Hannover 
Wash dishes (40 mm x 12 mm) 40 mm tissue culture dish Nunc/Thermo Scientific, Dreieich 
Zip tips Zip Tips µ-C18 Millipore, Schwalbach 
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3 Results 
3.1 Preparation of GV oocytes 
Several experiments required the availability of germinal vesicle (GV) oocytes, which were 
obtained by the aspiration of cumulus oocyte complexes (COCs) from slaughterhouse ovaries. 
One ovary delivered on average 10 COCs each. All oocytes were denuded and washed. In total, 
5900 GV oocytes were prepared from 590 ovaries. Aliquots comprising 25 to 400 oocytes each 
were stored in 0.5 ml sample cups at – 80 °C. These samples are referred to as “denuded GV 
oocytes” throughout this work.  
 
3.2 Qualitative proteome profile of bovine GV oocytes 
For a qualitative proteome profile, 900 denuded GV oocytes were lysed. Half of the protein 
lysate (40.5 µg total protein), was prefractionated on a 12 % 1D SDS polyacryamide (PAA) gel, 
while the other half was prefractionated on a 6 % 1D SDS PAA gel. Both gels were stained with 
coomassie. The 12 % 1D SDS PAA gel was sliced into 23 pieces and the 6 % SDS gel into 14 
slices, as indicated in Fig. 5. Each slice was individually subjected to in-gel trypsinization and 
analysed separately by nano LC-MS/MS using an LTQ mass spectrometer.  
In total 1,923,060 MS/MS spectra were acquired and subjected to Mascot data processing using 
the bovine IPI database. Mascot data were statistically analysed using the Scaffold software 
tool. Applying a protein identification probability of > 99 % on the protein level and a minimum 
number of two different identified peptides per protein (> 95 % peptide identification 
probability), 20,053 spectra could be assigned to 4,229 different peptides, corresponding to 791 
different proteins from the 12 % gel. From the well separated high molecular mass region of the 
6 % gel, 38 additional proteins could additionally be identified from 335 peptides (2510 
additional spectra), leading to 829 identified proteins in total.  
A decoy database search led to no hits in the decoy sequences, demonstrating a false discovery 
rate (FDR) far below 1 %. The 829 IPI accession numbers of identified proteins were 
transformed into accession numbers provided by the Uniprot protein database. In the Uniprot 
database, five levels of evidence for the existence of a protein are indicated: (i) “Evidence at 
protein level” applies to proteins that have been previously identified on the protein level, (ii) 
“Evidence at transcript level” applies to proteins of which the corresponding mRNA has been 
identified, (iii) “Inferred from homology” applies to proteins of which the existence is probable 
because clear orthologs exist in closely related species, and (iv) “Predicted” applies to proteins 
which have been predicted by DNA analyses, yet for which no evidence at protein, transcript, or 
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homology levels exists. The weakest term is (v) “Uncertain”. In total 739 of the 829 identified 
proteins could be transformed into Uniprot accession numbers. From these 739 proteins, 118 
were classified as proteins with experimental evidence on the protein level, 514 as proteins with 
experimental evidence on the RNA level, 83 as entries inferred from homology from sequences 
of other species and 24 as predicted. 
In addition, the entire set of proteins was subjected to Uniprot gene ontology analysis, the result 
of which is shown in Fig. 6. Proteins were assigned to the three main categories “cellular 
component”, “biological process” and “molecular function”. Within the “biological process” 
category, most proteins (47 %) are assigned to the cluster “metabolism”. In the “molecular 
function” category most proteins are assigned to the cluster “binding” (51 %) and to the cluster 
“enzymes” (41 %). Further analysis of the catalytic activity cluster revealed that most of the 
enzymes could be assigned to oxidoreductases (77) and hydrolases (108). 
To find out in which pathways the identified proteins are involved, a so-called “David analysis” 
of KEGG Pathways was performed. This bioinformatics tool reveals pathways in which 
proteins from the input list show up more than they are expected to appear from a randomized 
protein list [123]. A total of 23 proteins were found in the KEGG Pathway term “Ribosome”, 
while 16 proteins belonged to the “oocyte meiosis pathway” (Fig. 7). 
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Fig. 5: 1 D SDS PAA gels for the 
prefractionation of a protein lysate from 
450 denuded GV oocytes 
(A) 12 % 1D SDS-PAA gel: left lane: protein 
lysate of 450 bovine GV oocytes, right lane: 
Sigma Wide Range Marker; (B) 6 % 1D SDS 
gel: left lane protein lysate of 450 bovine GV 
oocytes, right lane: Sigma Wide Range 
Marker; Red brackets: Indicate the fractions 
subjected to LC-MS/MS analysis; Bold 
rectangle: Indicates high molecular mass 
regions on the 6 % and 12 % gel, respectively. 
Fig. 6: Uniprot gene ontology analysis of 739 identified GV oocytes proteins 
The “cellular component“, the “biological process” and the “molecular function” categories of the GO database 
from the Gene Ontology project, last updated on December 9, 2008, were used. 
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Fig. 7: KEGG oocytes meiosis pathway (bta04114) 
Red Stars indicate proteins identified from 900 GV oocytes. For detailed pathway explanation please refer to 
http://www.genome.jp/kegg/document/help_pathway.html. 
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3.3 Protein identification from limited sample amounts 
The identification of around 800 proteins usually requires protein amounts of about 40 to 100 
µg. Since one oocyte or early embryo only contains approximately 90 ng protein, such an 
identification approach would require the generation of hundreds of embryos. Especially in 
cases where several biological replicates are needed, the preparation of so many embryos would 
be very cost intensive and time consuming. For this reason it was tested how many proteins can 
be identified from much smaller sample amounts corresponding to the protein amounts 
available from one oocyte up to 50 oocytes. 
The protein amounts of one, five, ten, 25 and 50 denuded GV oocytes were analysed in a 1D 
LC-MS/MS approach. Proteins were accepted as correctly identified only when they had been 
identified with at least two different peptides, which were detected within a 10 ppm mass 
accuracy range, and had a 95 % peptide probability as well as a 99 % protein probability. 
A total of 54 proteins could be identified from a single oocyte, 75 proteins from 5 oocytes, 99 
proteins from ten oocytes and 106 proteins from 25 oocytes. In contrast, the protein amount 
from 50 oocytes dropped the number of identified proteins down to 62 (Fig. 8). To find out 
whether the number of identifications from protein amounts corresponding to 25 and 50 oocytes 
can be further enhanced, a two-dimensional LC-MS/MS analysis was performed by an 
additional prefractionation step of tryptic peptides on a “strong cation exchange” (SCX) column 
prior to the reversed phase (RP) separation. SCX chromatography uses the charge state of a 
molecule as a major separation criterion and represents an orthogonal separation step to RP 
chromatography. The “base peak ion chromatograms” (BICs) in Fig. 9 demonstrate that this 
prefractionation method led to an equal distribution of peptides over all salt fractions. 
Using the 2D LC-MS/MS approach, 206 proteins could be identified from the protein amount of 
25 oocytes. The protein amount of 50 oocytes did not lead to more identifications; instead, the 
number of identified proteins was dropped down to 198 (Fig. 8). 
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Fig. 8: Comparison of protein 
numbers identified from 1, 5, 10, 
25 and 50 GV oocytes 
X-axis: numbers of oocytes 
subjected to LC-MS/MS analysis, Y-
axis: numbers of identified proteins 
(FDR < 1 %); Magenta: proteins 
identified by 1D LC-MS/MS 
analysis, Blue: proteins identified by 
2D LC-MS/MS analysis. 
Fig. 9: Base Peak Ion Chromatograms (BICs) of individual salt steps from the analysis of 25 GV oocytes by 
2D LC-MS/MS 
X-axis: elution time; Y-axis: relative signal intensity. 
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3.4 Protein quantification of limited sample amounts by iTRAQ 
A standard proteomic approach for quantification is to employ the “isobaric tag for relative and 
absolute quantitation” (iTRAQ) technique, which was applied for the quantitative analyses of 
small sample amounts. For quantification, it is necessary to obtain iTRAQ reporter ion signals 
generated by the “higher energy collision dissociation” (HCD) cell of the mass spectrometer. 
Due to longer scan times needed to acquire the HCD spectra, fewer spectra are acquired during 
an individual LC-MS/MS run. As a consequence, fewer proteins are expected to be quantified 
and identified during an individual LC run as compared to LC runs dedicated to identification 
only (see previous chapter). Therefore, an experimental series was performed to optimise the 
number of quantified proteins for a given amount of oocytes, based on sample splitting and the 
establishment of several consecutive “precursor mass exclusion lists”.  
In total 350 oocytes from the “denuded GV oocyte pool” were lysed, tryptically digested and 
cleaned up by “vivapure S mini M” devices. From this pool containing 31.5 µg peptides, two 
aliquots were prepared and labelled with iTRAQ reagent containing either the 115 reporter tag 
or the 117 reporter tag. After labelling, the samples were pooled and served as a source for 
optimisation experiments. The pool is referred to as “iTRAQ labelled GV oocyte peptides” and 
contains 31.5 µg protein (corresponding to 350 oocytes). Protein quantification was based on 
reporter ion signal intensities in HCD spectra, and protein identification was based on both 
HCD and CID spectra derived from the Orbitrap XL instrument. As an example, Fig. 10 shows 
a typical HCD MS/MS spectrum of the peptide LSDGVALVK contained in “Heat shock 60 
kDa protein”. The signal intensity ratio of reporter ions 115 and 117 is close to one, confirming 
the presence of equal amounts of 115 tag and 117 tag peptides in the “iTRAQ labelled GV 
oocyte peptides”.  
 
 
 
 
 
 
 
Fig. 10: HCD MS/MS 
spectrum of the Peptide 
LSDGVALVK derived from 
Heat shock 60 kDa Protein 1 
X-axis: m/z values; Y-axis: 
signal intensity. 
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To find out how many proteins can be quantified and identified from small protein amounts, a 
1D LC-MS/MS analysis was performed using the protein amount corresponding to 25 and 50 
oocytes (2.25 µg respectively 4.5 µg) from the “iTRAQ labelled GV oocyte peptides”. From the 
protein equivalent of 25 and 50 oocytes a total of 67 respectively 86 proteins could be identified 
and quantified (green columns in Fig. 11). In order to enhance the number of identified and 
quantified proteins, the iTRAQ labelled proteins from 25 and from 50 oocytes were split up into 
two equal parts each. In both cases, after the first aliquot had been analysed by LC-MS/MS, an 
exclusion list (EL) was generated containing all peptide masses from which MS/MS spectra had 
been successfully acquired. This EL was applied to the analyses of the second aliquots, forcing 
the instrument to ignore these masses and instead acquire MS/MS spectra from so far 
unconsidered peptide precursors. The application of the EL enhanced the number of identified 
and quantified proteins from the protein amount of 25 oocytes to 107, and from the protein 
amount of 50 oocytes to 116 (blue columns in Fig. 11). 
 
 
To find out whether the number of identified and quantified proteins can be further enhanced, 
the amount of “iTRAQ labelled GV oocyte peptides”, from 50 oocytes was divided into four 
equal parts. They were then analysed in four consecutive 1D LC-MS/MS runs and an exclusion 
list for each run was generated from all previous runs. Such a combination of four runs will be 
referred to as “run set” throughout this work. Fig. 12 shows the number of identified and 
quantified proteins from the merge of individual runs with all previous runs. As a maximum, 
150 proteins were identified and quantified from the protein amount of 50 oocytes.  
The same set up was also tested in a 2 D LC-MS/MS approach. Exclusion lists were generated 
for each run of the six salt fractions and applied to the analysis of the corresponding fraction in 
the following run. The protein equivalent of 50 oocytes from the “iTRAQ labelled GV oocyte 
peptides” was split into two equal parts which were subsequently analysed, while the six 
exclusion lists from the first run were applied to the second run. 
 
Fig. 11: Numbers of proteins identified and 
quantified by iTRAQ 1D nano LC-MS/MS 
analysis from 25 and 50 GV oocytes 
X-axis: numbers of oocytes subjected to LC-
MS/MS analysis, Y-axis: number of identified and 
quantified proteins (FDR<1 %); Green columns: no 
exclusion list applied, blue columns: exclusion list 
applied. 
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In total 300 proteins could be identified and quantified. To find out whether also this number 
can be further enhanced the amount of “iTRAQ labelled GV oocyte peptides” from 50 oocytes 
was divided into four equal parts and analysed in four consecutive 2D LC-MS/MS runs. For 
each run, six ELs (one per salt fraction) were generated from all previous runs and applied to 
the analyses of the corresponding fractions in the following run. This enhanced the number of 
identified and quantified proteins to 403. Since the analysis of one 2D LC-MS/MS run took 18 
hours, only one 2D LC-MS/MS run could be performed per day. The analysis time for a 
complete 2D LC-MS/MS run set therefore comprised four days. Fig. 13 demonstrates how 
many proteins can be identified and quantified from 50 GV oocytes using the different methods 
of spectra acquisition and chromatographic separation. 
 
 
 
 
Fig. 12: Total numbers of identified and 
quantified proteins after each 1D LC-
MS/MS run of a “run set” 
X-axis: number of nano-LCMS/MS run, 
Y-axis: number of identified and 
quantified proteins (FDR < 1 %) from the 
merge of individual runs with all previous 
runs; in total 50 GV oocytes were 
analysed. 
 
Fig. 13: Numbers of identified 
and quantified proteins from the 
protein amount of 50 oocytes 
using different nano LC-MS/MS 
approaches 
X-axis: indicates whether no EL 
(no EL), one EL (one EL) or 
multiple ELs (multiple EL) were 
applied for nano LC-MS/MS 
analysis; Multiple EL: the 
application of three subsequent ELs 
in four consecutive nano LC-
MS/MS runs (referred to as “run 
set”), Y-axis: numbers of identified 
and quantified proteins (FDR < 1 
%); Magenta columns: 1D LC-
MS/MS approach, Blue columns: 
2D LC-MS/MS approach. 
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3.5 Comparison of in vivo and in vitro matured oocytes from cows of different age 
groups by nano LC-MS/MS iTRAQ analysis. 
The in vitro maturation process of oocytes is known to produce oocytes of lower developmental 
competence compared to in vivo matured oocytes [115]. Therefore, proteome alterations 
between in vivo and in vitro matured oocytes were analysed by the nano LC-MS/MS iTRAQ 
technique. 
COCs were obtained by aspiration from ovarian follicles from heifers (10-12 months) as well as 
from young cows (three years, first lactation) and old cows (> ten years) with and without 
hormonal superstimulation by FSH (referred to as “stimulated” and “unstimulated”). Each age 
group contained five cows. The aspiration procedure was performed by the group of Prof. Wolf 
at the Moorversuchgut Badersfeld and is referred to as “OPU (ovum pick-up) session” 
throughout this work.  
From seven different OPU sessions, 95 GV COCs from unstimulated heifers, 120 GV COCs 
from unstimulated young cows and 179 GV COCs from unstimulated old cows were obtained. 
All GV COCs from unstimulated cows were matured in vitro for 22 hours to the MII oocyte 
stage. Oocytes were denuded and preserved at – 80 °C in aliquots of 7 to 39 oocytes. 
From superstimulated cows, MII oocytes were collected in four different OPU sessions. In total 
123 MII COCs from superstimulated heifers, 89 MII COCs from superstimulated young cows 
and 144 MII COCs from superstimulated old cows were obtained. All MII COCs from 
hormonally superstimulated cows were denuded immediately after aspiration and preserved at - 
80 °C in aliquots of 14 to 47 oocytes. 
A “biological replicate” within this chapter is defined as six pools containing 25 oocytes from 
each MII oocyte sample obtained from individual OPU sessions. 
For nano LC-MS/MS analysis, each sample of 25 MII oocytes was lysed and divided into two 
parts, each containing the peptides from 12.5 oocytes. As a reference, a pool of 50 denuded GV 
oocytes was treated in the same way and divided into four parts, each containing the peptides 
from 12.5 oocytes.  
The labelling was performed according to the scheme in Table 3, which allowed the multiplexed 
analysis of four different samples per run set. As established before (see chapter 3.4) each run 
set consisted of four consecutive 2D LC-MS/MS runs. Samples were combined according to the 
scheme in Table 3. This labelling and combination strategy facilitated, within an individual run 
set, the comparison of in vivo and in vitro matured oocytes obtained from an individual age 
group, as well as the comparison of oocytes obtained from different age groups. The denuded 
GV oocytes in each run set were used for standardisation efforts. Four run sets were needed for 
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the analysis of one biological replicate, consuming 16 days of LC-MS/MS instrument time. The 
complete analysis of all three biological replicates comprised 48 days. 
A total of 74 proteins were identified and quantified from the three run sets no. one, 82 proteins 
from the three run sets no. two, 53 proteins from the three runs sets no. three and 116 proteins 
from the three run sets no. four in all biological replicates (Table 3). 
 
Table 3: Labelling and run set scheme for one biological replicate of in vivo and in vitro matured oocytes 
analysed by nano LC-MS/MS iTRAQ analysis 
Numbers 1-4 indicate the run sets; Numbers 114-117 indicate the iTRAQ reporter tag masses attached to a sample 
Number of 
run set 
Old 
cows / in 
vitro 
matured 
Young 
cows / in 
vitro 
matured 
Heifers/ 
in vitro 
matured 
Old 
cows / in 
vivo 
matured 
Young 
cows / in 
vivo 
matured 
Heifers / 
in vivo 
matured 
GV 
Oocytes 
Numbers of 
identified and 
quantified 
proteins 
1  116 117   115 114 74 
2 116 117   115  114 82 
3 116  117 115   114 53 
4    115 116 117 114 116 
 
The mean values for all fold changes from the three biological replicates were calculated, and 
proteins which had an average fold change of < 0.5 or > 2 were considered as differentially 
abundant proteins. 
In the comparison of in vivo versus in vitro matured oocytes, four differentially abundant 
proteins were found in the age group of young cows (Table 5) and in each age group of old 
cows and heifers, nine differentially abundant proteins were found (Table 4, Table 6). No 
differentially abundant proteins were found in the comparison of oocytes from different age 
groups from in vivo matured oocytes. In the comparison of oocytes from different age groups of 
in vitro matured oocytes, four proteins were found to be differentially abundant in oocytes from 
old cows versus heifers (Table 7). Also four proteins were differentially abundant between in 
vitro matured oocytes from young cows versus heifers (Table 8). In the comparison from in 
vitro matured oocytes from young cows and old cows, no proteins of differential abundance 
were detected. Fig. 14 shows the mean value of abundance alterations of three proteins altered 
between in vivo and in vitro matured oocytes. 
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Table 4: Differentially abundant proteins between in vivo and in vitro matured oocytes from heifers 
Protein Name Accession Number Mean Value of Fold Change  
Ubiquitin IPI00786471 5.0 
Pterin-4 alpha-carbinolamine 
dehydratase/dimerization cofactor of hepatocyte 
nuclear factor 1 alpha 
IPI00689238 3.8 
Lysosomal-associated membrane protein 2 isoform 
2 IPI00842574 2.6 
GLO1 protein IPI00713484 2.5 
Lysosome-associated membrane glycoprotein 1 IPI00705401 2.3 
Glyceraldehyde-3-phosphate dehydrogenase IPI00713814 0.5 
22 kDa protein IPI00702336 0.5 
similar to transducin-like enhancer of split 6 IPI00716544 0.5 
Bisphosphoglycerate mutase IPI00706349 0.4 
 
 
 
 
Table 5: Differentially abundant proteins and abundance ratios between in vivo and in vitro matured oocytes 
from young cows 
Protein Name Accession Number Mean Value of Fold Change 
Ubiquitin IPI00786471 2.1 
Adenosine deaminase IPI00704185 2.0 
Bisphosphoglycerate mutase IPI00706349 0.5 
Nucleoside diphosphate kinase B IPI00686420 0.5 
 
 
 
 
 
Fig. 14: Fold changes of the abundance of 
Ubiquitin, GLO1 and LAMP2 in vivo versus 
in vitro matured oocytes from different age 
groups 
X-axis: age group of oocyte donor cows, Y-axis: 
fold change of protein abundance; Blue column: 
Ubiquitin, Yellow column: Glo1, Magenta 
column: LAMP2; GLO1 and LAMP2 were not 
altered in young cows. 
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Table 6: Differentially abundant proteins and abundance ratios between in vivo and in vitro matured oocytes 
from old cows 
Protein Name Accession Number Mean Value of Fold Change 
Ubiquitin IPI00786471 3.9 
GLO1 protein IPI00713484 2.7 
lysosomal-associated membrane protein 2 isoform 
2 IPI00842574 2.5 
Phosphatidylethanolamine-binding protein 1 IPI00704735 2.5 
Lysosome-associated membrane glycoprotein 1 IPI00705401 2.4 
HAPLN3 protein IPI00699203 2.3 
Heat shock 70 kDa protein 1B IPI00700035 2.1 
10 kDa heat shock protein. mitochondrial IPI00702858 2.0 
22 kDa protein IPI00702336 0.5 
 
 
 
 
Table 7: Differentially abundant proteins and abundance ratios between in vitro matured oocytes of old cows 
and heifers 
Protein Name Accession Number Mean Value of Fold Change 
Lysosomal-associated membrane protein 2 isoform 
2 IPI00842574 3.6 
Ubiquitin IPI00786471 2.6 
Lysosome-associated membrane glycoprotein 1 IPI00705401 2.2 
Phosphatidylethanolamine-binding protein 1 IPI00704735 2.0 
 
 
 
 
Table 8: Differentially abundant proteins and abundance ratios between in vitro matured oocytes of young 
cows and heifers 
 
 
 
 
Protein Name Accession Number Mean Value of Fold Change 
Lysosomal-associated membrane protein 2 isoform 
2 IPI00842574 2.7 
Pterin-4 alpha-carbinolamine 
dehydratase/dimerization cofactor of hepatocyte 
nuclear factor 1 alpha 
IPI00689238 2.3 
HAPLN3 protein IPI00699203 2.2 
Isoform 1 of Proactivator polypeptide IPI00718311 2.2 
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3.6 Qualitative and quantitative proteome analysis of oocytes, 2-cell stage embryos 
and morulae 
To analyse both the qualitative proteome of 2-cell stage embryos and morulae as well as 
proteome alterations during the development from the 2-cell stage embryo to the morula stage, 
qualitative and quantitative analyses based on nano LC-MS/MS were performed. 
2-cell-stage embryos and morulae for the proteome analyses were generated from 35 
slaughterhouse ovaries. On average, each ovary delivered ten COCs. COCs were matured in 
vitro and fertilized. The developed embryos were denuded and cultivated for nine hours (2-cell 
stage embryos) or for 5 days (morulae). Prior to collection, embryos were microscopically 
controlled for their blastomeric structure. Morulae were collected when they had at least 32 
blastomeres. Both compacted and not compacted morulae were collected. On average, 90 % of 
all COCs developed into 2-cell stage embryos and 60 % of all COCs developed into morulae. 
For a qualitative nano LC-MS/MS analysis, two pools of 25 2-cell-stage embryos each and two 
pools of 25 morulae each, representing two technical replicates, were generated. Embryos were 
lysed and tryptically digested prior to 2D LC-MS/MS analysis. Database search and statistical 
analysis were performed as described in chapter 2.2.2.4 and in chapter 2.2.2.6. The results from 
the two technical replicates were merged by the scaffold software. A total of 318 proteins were 
identified from 2-cell stage embryos and 348 proteins were identified from morulae.  
254 of these proteins could be identified both from two cell stage embryos and morulae, while 
64 proteins were exclusively identified from 2-cell stage embryos, and 94 proteins were 
exclusively identified from morulae. The datasets with the identified proteins from these 
embryonic stages were compared to the dataset of GV oocytes proteins described in chapter 3.2 
(Fig. 15). Although the GV oocytes dataset contains far more proteins (829), 52 proteins 
identified from 2-cell stage embryos and 73 proteins identified from morulae were not contained 
in the oocyte dataset. All three datasets were subjected individually to a gene ontology analysis. 
This comparison is shown in Fig. 16. The percentage of proteins which are assigned to the 
different gene ontology categories revealed to be similar in all three stages. 
 
 
 
 
 
Fig. 15: Proportional Venn 
diagram of identified proteins from 
oocytes, 2-cell stage embryos and 
morulae 
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The datasets from 2-cell stage embryos and morulae were subjected to a “spectral count” [87] 
analysis. The method of spectral counting enables quantitative comparisons between samples 
which have been analysed in two different LC-MS/MS runs (see chapter 1.5.2). The number of 
spectra which can be assigned to a certain proteotypic peptide – and thereby to a certain protein 
- is counted and normalized to the total number of spectra obtained from the entire sample. 
Normalized spectral count numbers between different samples are compared for relative 
quantification of the corresponding proteins. Only proteins for which (i) MS/MS spectra had 
been detected in each stage, (ii) the corresponding peptides were detected with at least ten 
MS/MS spectra in at least one of the two stages and (iii) which had a “spectral count abundance 
ratio” of at least two were considered as differentially abundant. These criteria were met by 28 
proteins, which are listed in Table 9. 
 
 
 
 
 
Fig. 16: Uniprot gene ontology analysis of the identified proteins from oocytes, two-cell-stage 
embryos and morulae 
(A) “molecular function” category of the GO database from the Gene Ontology project, last 
updated on December 9, 2008; X-axis: developmental stage, Y-axis: percentage of proteins 
assigned to a GO cluster. (B) “catalytic activity” category of the GO database from the Gene 
Ontology project, last updated on December 9, 2008; X-axis: developmental stage, Y-axis: 
percentage of proteins assigned to a GO cluster. 
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Table 9: Differentially abundant proteins between 2-cell stage embryos and morulae detected by nano LC-
MS/MS spectral count analysis 
Protein Name Accession Number 
Molecular 
Weight 
Fold 
Change 
Number of 
spectra in two-
cell stage 
Embryos 
Number of 
spectra in 
Morulae 
Similar to Tubulin, alpha 
1 isoform 1 IPI00839209 50 kDa 2.1 32 17 
Similar to transducin-like 
enhancer of split 6 IPI00716544 47 kDa 0.5 31 72 
Nuclear autoantigenic 
sperm protein IPI00703854 84 kDa 3.8 27 8 
YBX2 protein IPI00705175 38 kDa 13 24 2 
40 kDa protein IPI00837636 40 kDa 3.3 21 7 
Heat shock protein 105 
kDa IPI00705477 97 kDa 2.4 17 8 
Similar to Polyadenylate-
binding protein 1-like 
isoform 19 
IPI00715420 68 kDa 3.6 16 5 
S-formylglutathione 
hydrolase IPI00689436 32 kDa 2.8 15 6 
Isoform 1 of Proactivator 
polypeptide IPI00718311 58 kDa 2.1 15 8 
Insulin-like growth factor 
2 mRNA binding protein 
3 isoform 1 
IPI00712553 64 kDa 2.1 13 7 
Heat shock 70kDa 
protein 4 IPI00698179 95 kDa 2.2 12 7 
Programmed cell death 
protein 5 IPI00714175 14 kDa 2.8 10 4 
Chloride intracellular 
channel protein 4 IPI00717902 29 kDa 2.8 10 4 
Similar to dynein, 
cytoplasmic, heavy 
polypeptide 1 isoform 3 
IPI00726312 532 kDa 0.5 9 19 
ADP/ATP translocase 3 IPI00705378 33 kDa 0.5 9 22 
Similar to Hist1h4c 
protein IPI00691248 11 kDa 0.3 9 29 
similar to NALP13 IPI00709780 103 kDa 0.5 8 17 
Canx protein IPI00871078 68 kDa 0.5 7 15 
Similar to karyopherin 
beta 1 isoform 2 IPI00710247 97 kDa 0.5 6 14 
Myosin-10 IPI00709219 229 kDa 0.5 5 11 
Superoxide dismutase 
[Mn], mitochondrial IPI00692468 25 kDa 0.5 5 12 
Isocitrate dehydrogenase 
[NADP] cytoplasmic IPI00702781 47 kDa 0.4 5 13 
Macrophage migration 
inhibitory factor IPI00694142 12 kDa 0.4 4 10 
Alpha-enolase IPI00707095 47 kDa 0.3 4 14 
Fructose-bisphosphate 
aldolase IPI00852561 39 kDa 0.3 3 10 
Elongation factor 2 IPI00707751 95 kDa 0.2 2 11 
Similar to SCF complex 
protein cul-1 isoform 1 IPI00717794 89 kDa 0.1 1 11 
53 kDa protein IPI00714264 53 kDa 0.09 1 13 
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3.6.1 Validation of abundance alterations between oocytes, 2-cell stage embryos and 
morulae  
Spectral count is a rather simple but fairly crude method of quantification, demanding a 
validation of the results by an independent approach. For this reason, two of the differentially 
abundant proteins have been validated by the SRM technique: i) Y-box protein 2 (YBX2) and 
the (ii)“Insulin-like growth factor 2 mRNA binding protein 3 isoform 1” (IF2B3/IMP3), being 
especially interesting with respect to early embryonic development. SRM stands for “selected 
reaction monitoring” and is a method for quantification of targeted proteins. Fig. 17 
demonstrates the SRM principle: In a triple quadrupole mass spectrometer, the so-called 
“precursor ion” is selected to enter the second quadrupole (Q2) where it undergoes collision-
induced dissociation (CID). In the third quadrupole (Q3), one or more fragment ions are 
selected for quantification by the detector. These validation experiments were mainly performed 
by Thomas Fröhlich and Daniela Deutsch. 
 
Proteotypic peptides selected for quantification of IMP3 were the peptides IPVSGPFLVK 
(IMP3_1) and FTEEIPLK (IMP3_2). Proteotypic peptides selected for quantification of YBX2 
were the peptides GAEAANVTGPGGVPVK (YBX2_1) and TPGNPATAASGTPAPLAR 
(YBX2_2). Three biological replicates of 25 2-cell stage embryos and 25 morulae each were 
generated, lysed and tryptically digested. From all replicates and stages, the peptides from ten 
embryos were analysed, and the value of the area under the peak was used for quantification. In 
Fig. 18, the mean values of the areas under the curve for the peptides IMP3_2 and YBX2_2 in 
each stage are shown. The fold changes for IMP3 and YBX2 in 2-cell stage embryos versus 
morulae are 0.5 and 0.1 respectively. In Fig. 19 an example from the quantification of fragment 
ions from the three proteins in ten 2-cell stage embryos is shown.  
Fig. 17: Principle of  SRM quantification 
The targeted peptide ion (precursor ion) is selected in the first quadrupole (Q1) and enters the 
second quadrupole (Q2) where it undergoes collision-induced dissociation (CID). One or more 
fragment ions are selected in the third quadrupole (Q3) for quantification by the detector; Source: 
Nanoproteomics – Methods and Protocols, will be published in October 2011 by Humana Press 
(Springer, ISBN 978-1-61779-318-9). 
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Fig. 18: Areas under the curve 
values from the SRM 
quantification of IMP3 and YBX2 
in 2-cell stage embryos and 
morulae 
Blue: Peptide FTEEIPLK 
(IMP3_2) from IMP3, Magenta: 
Peptide TPGNPATAASGTPAPLAR 
(YBX2_2) from YBX2; X-axis: 
developmental stage, Y-axis: Area 
under the curve value. 
Fig. 19: Chromatogram of a multiplexed SRM analysis 
Example from the quantification of fragment ions from the proteins IMP3 and YBX2 in ten 2-cell stage 
embryos; X-axis: elution time; Y-axis: signal intensity; peptides represented by the individual peaks are 
indicated right of the peaks: IMP3_1 (IPVSGPFLVK), IMP3_2 (FTEEIPLK), YBX2_1 
(GAEAANVTGPGGVPVK), YBX2_2 (TPGNPATAASGTPAPLAR). 
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3.7 Differential proteome analyses of morulae and blastocysts 
To analyse the proteome alterations during the morula to blastocyst transition, a qualitative 
comparison using both a 2D gel based and a nano LC-MS/MS based technique was performed.  
Morulae and blastocysts for differential quantitative proteome analysis were generated from 150 
slaughterhouse ovaries. Each ovary delivered ten COCs on average. COCs were in vitro 
matured and fertilized. The zygotes were denuded and cultivated for five days (morulae) or for 
seven days (blastocysts). Prior to collection, embryos were microscopically controlled to their 
blastomeric structures. Morulae were collected when they had at least 32 blastomeres. Both 
compacted and not compacted morulae were collected. Blastocysts were collected when they 
showed a blastocoel as well as the partition in “inner cell mass” (ICM) and trophectoderm (TE) 
and were collected both in the expanded and not expanded stage. On average, 60 % of all COCs 
developed into morulae and 30 % of all COCs developed into blastocysts. In total, 12 biological 
replicates were prepared. One biological replicate contained 25 morulae and 25 blastocysts 
each, which originated from different animals and had been cultured in individual Petri dishes in 
groups of 40 embryos. 
For the proteomic analysis, two complementary strategies were applied: i) the 2D gel based 
“saturation DIGE” technique and ii) the LC-MS/MS based iTRAQ technique. Six biological 
replicates of both stages were analysed by each strategy.  
 
3.7.1 2D saturation DIGE analysis 
For the 2D saturation DIGE analysis, six biological replicates corresponding to 25 morulae and 
25 blastocysts (2.25 µg total protein) each were lysed. An internal pooled standard (IPS) was 
prepared consisting of 1.25 µg protein from each stage in a biological replicate (12 samples). 15 
µg IPS were labelled with 7.5 nmol fluorescent Dye Cy3. The residual 1 µg protein of each 
sample was labelled separately with 0.5 nmol fluorescent Dye Cy5 each.  
Two 2D gels (pH range four to seven) per biological replicate containing 250 ng IPS (protein 
amount corresponding to less than three embryos) and 250 ng of Cy5 labelled proteins each 
were prepared. In Fig. 20, representative Cy5 gel images of proteins from morulae and 
blastocysts are shown, demonstrating the high separation strength in both dimensions.  
Image analysis, performed by the DeCyder 6.5 Software, led to the detection of at least 2948 
signals per gel from which 2024 signals were matched and quantified in all gels. These signals 
can be considered as signals from real protein spots.  
Spots detected on all gel images which had a student’s t-test p-values lower than 0.05 were 
considered as differentially abundant protein spots. Moreover, a FDR correction according to 
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Benjamini and Hochberg [124] was applied to further minimize the detection of false positive 
proteome alterations. A total of 61 protein spots fulfilled these criteria. Out of these, 30 spots 
were altered by a fold change of < 0.5 or > 2. Fig. 21 shows a Cy 5 morula gel image in which 
the spots from differentially abundant proteins are marked. 
  
Fig. 22 contains representative 3D intensity shape plots and corresponding graph views of spots 
from differentially abundant proteins. Intensity and shape plots visualize spot intensities and 
spot boundaries, demonstrating the high reproducibility of quantification. 
For protein identification from saturation DIGE gels, a preparative gel containing several 
hundreds of microgram labelled protein is mandatory, requiring 4000 to 5000 oocytes or 
embryos. Due to high costs of embryo generation, 4444 denuded GV oocytes were used as a 
source for protein identification. To ensure a comparable running behaviour between analytical 
and preparative gels, the GV oocyte protein samples were also labelled with saturation dyes.  
The gel spots from the Cy3 readout of the preparative gel were matched to their positions on the 
analytical gels. The matching of protein spots from differentially abundant proteins was 
manually controlled, and 40 spots could be unambiguously assigned to the preparative gel. The 
spots were picked with a “spot picking” robot, tryptically digested and analysed in an Orbitrap 
XL mass spectrometer. Only Proteins which were identified with at least two peptides and a 
protein score of higher than 99 were accepted as correct identifications (corresponding to a 
mascot p-Value of < 0.05). In total 34 of the picked spots were abundant enough to lead to 
protein identification by an Orbitrap XL mass spectrometer. 
From all identified spots 18 protein spots could be unambiguously assigned to a single protein 
(Table 10), 11 spots contained two proteins (Table 11) and five spots contained three or more 
Fig. 20: 2D saturation DIGE analysis of morulae and blastocysts 
Cy5 readouts of a morula (left panel) and a blastocyst (right panel) gel image 
 
pH4.5 pH6.5 pH4.5 pH6.5
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Morulae Blastocysts
Spot 5
Fold change: 1.46
Spot 7
Fold change: 6.8
Spot 10 
Fold change: 3.19
Spot 14 
Fold change: 0.42
Spot 15 
Fold change: 2.55
Morulae Blastocysts Morulae Blastocysts Morulae Blastocysts Morulae Blastocysts
proteins (Table 12). Spots which could not be identified are listed in Table 13. In total, 11 
proteins were identified from more than one spot, indicating that corresponding spots contain 
different isoforms of the proteins, for example different post translational modifications. 
Examples of such proteins detected by this experiment are the four different isoforms of “Aldo-
keto reductase family 1 member B1” (AKR1B1), three Peroxiredoxin 2 (PRDX2) isoforms and 
two Prohibitin (PHB) and “Chloride intracellular channel protein 4” (CLIC4) isoforms. 
 
 
 
 
 
 
 
Fig. 21: De Cyder 6.5 Cy5 
readout image from a morula 
gel 
Yellow line: spot boundaries; 
Numbers: Spots differentially 
abundant in morulae and 
blastocysts, corresponding to the 
numbers used in tables 10 to 13. 
Fig. 22: Graphic representations of five protein spots differing in intensity between morulae and blastocysts 
Intensity and shape plots of five differentially abundant proteins in all six biological replicates. Spot intensities are 
depictured as the height and spot borders as the shape of the peaks; Columns: individual spots as indicated, Rows: 
individual biological replicates. 
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Table 10: Unambiguously identified spots from differentially abundant proteins between morulae and 
blastocysts from the 2D saturation DIGE analysis 
 
 
No. Protein Name IPI Accession fold 
change p-value 
Molecular 
Weight 
Mascot 
Score 
Number of 
peptides (Ions 
score>30) 
1 
Rab GDP 
dissociation 
inhibitor alpha 
IPI00698594 0.48 2.30E-03 57256 122 3 
2 PDIA3 protein IPI00852512 0.61 3.30E-04 61600 2159 22 
3 
Aldo-keto 
reductase family 
1, member B1 
IPI00700920 0.50 1.00E-03 40734 292 4 
4 
L-lactate 
dehydrogenase B 
chain 
IPI00760524 0.71 4.10E-04 40062 40062 12 
5 
Isoform Beta-3 of 
F-actin-capping 
protein subunit 
beta 
IPI00688921 1.46 1.30E-04 39098 438 4 
6 Prohibitin IPI00688006 0.66 2.80E-05 30458 940 13 
7 
Isoform 2 of 
Tropomyosin 
alpha-3 chain 
IPI00714405 6.80 3.60E-06 31704 641 6 
8 
Ubiquitin 
carboxyl-terminal 
hydrolase 
isozyme L3 
IPI00705749 0.56 7.90E-05 28182 561 4 
9 Glutathione S-transferase mu 3 IPI00702950 1.66 4.80E-03 30866 724 8 
10 Calpain small 
subunit 1 IPI00696263 3.19 2.20E-06 29258 99 3 
11 GLO1 protein IPI00713484 0.57 1.00E-06 22769 305 4 
12 Peroxiredoxin-2 IPI00713112 0.48 1.60E-05 25294 541 6 
13 Peroxiredoxin-2 IPI00713112 0.53 1.50E-05 25294 331 4 
14 Peroxiredoxin-2 IPI00713112 0.42 2.80E-05 25294 380 5 
15 
EIF5A Eukaryotic 
translation 
initiation factor 
5A-1 
IPI00704728 2.55 2.30E-06 19511 194 2 
16 
MYL12B Myosin 
regulatory light 
chain 12B 
IPI00687409 3.50 8.10E-06 20352 334 3 
17 
Ubiquitin 
carboxyl-terminal 
hydrolase 
isozyme L1 
IPI00697759 0.48 1.70E-04 33023 148 3 
18 Peroxiredoxin-6 IPI00689857 0.53 3.20E-04 25723 414 4 
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Table 11: Spots from differentially abundant proteins between morulae and blastocysts of the 2D saturation 
DIGE analysis, from which two proteins were identified 
 
No. Protein Name IPI Accession 
Fold 
change p-value 
Molecular 
Weight 
Mascot 
Score 
Number of 
peptides (Ions 
score>30) 
19 
ATP synthase 
subunit beta, 
mitochondrial 
IPI00717884 1.49 6.60E-03 56249 2136 15 
 
Hsp90 co-
chaperone Cdc37 IPI00718101 1.49 6.60E-03 50603 486 5 
20 Stomatin-like protein 2 IPI00705395 0.56 3.40E-05 40054 529 8 
 
Aldo-keto 
reductase family 
1, member B1 
IPI00700920 0.56 3.40E-05 40734 171 3 
21 
Aldo-keto 
reductase family 
1, member B1 
IPI00700920 0.58 1.00E-04 40734 399 6 
 
Stomatin-like 
protein 2 IPI00705395 0.58 1.00E-04 40054 112 3 
22 48 kDa protein IPI00717972 0.52 3.20E-04 53665 258 5 
 FDPS protein IPI00839514 0.52 3.20E-04 53681 258 5 
23 
Inositol 
monophosphatase 
1 
IPI00692819 0.65 3.30E-04 34070 404 4 
 
Eukaryotic 
translation 
elongation factor 1 
delta 
IPI00691738 0.65 3.30E-04 75032 148 2 
24 
Eukaryotic 
translation 
initiation factor 6 
IPI00699022 2.40 4.50E-04 33219 185 2 
 Clusterin IPI00694304 2.40 4.50E-04 57804 124 2 
25 
Chloride 
intracellular 
channel protein 4 
IPI00717902 0.63 2.30E-04 31398 538 6 
25 Prohibitin IPI00688006 0.63 2.30E-04 30458 243 3 
26 
Chloride 
intracellular 
channel protein 4 
IPI00717902 1.61 1.80E-03 31398 718 6 
 Prohibitin IPI00688006 1.61 1.80E-03 30458 137 2 
27 22 kDa protein IPI00702336 0.39 1.50E-06 24917 619 6 
 
Tumor protein 
D52-like 2 IPI00693729 0.39 1.50E-06 20594 125 2 
28 
Rab GDP 
dissociation 
inhibitor alpha 
IPI00698594 0.58 3.20E-03 57256 886 9 
 
FK506 binding 
protein 8, 38kDa IPI00687839 0.58 3.20E-03 49710 99 3 
29 
Ubiquitin carboxyl-
terminal hydrolase 
isozyme L1 
IPI00697759 0.46 1.60E-05 33023 231 4 
 
Rho GDP-
dissociation 
inhibitor 1 
IPI00716328 0.46 1.60E-05 24265 187 2 
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Table 12: Spots from differentially abundant proteins between morulae and blastocysts of the 2D saturation 
DIGE analysis, from which three or more proteins were identified 
No. Protein Name IPI Accession Fold Change p-value 
Molecular 
Weight 
Mascot 
Score 
Number of 
peptides (Ions 
score>30) 
30 78 kDa glucose-
regulated protein IPI00717234 0.71 6.00E-03 73700 1709 18 
 
Zona pellucida 
sperm-binding 
protein 4 
IPI00686205 0.71 6.00E-03 73281 435 4 
 TDRKH protein IPI00703713 0.71 6.00E-03 68662 353 4 
 
Zona pellucida 
sperm-binding 
protein 3 
IPI00703432 0.71 6.00E-03 57272 242 3 
 
Protein kinase C 
and casein 
kinase substrate 
in neurons 2 
IPI00708226 0.71 6.00E-03 59890 161 3 
31 78 kDa glucose-
regulated protein IPI00717234 0.44 3.30E-05 73700 2887 22 
 TDRKH protein IPI00703713 0.44 3.30E-05 68662 449 6 
 
Zona pellucida 
sperm-binding 
protein 4 
IPI00686205 0.44 3.30E-05 73281 298 3 
 
Protein kinase C 
and casein 
kinase substrate 
in neurons 2 
IPI00708226 0.44 3.30E-05 59890 201 3 
32 
Similar to 40S 
ribosomal protein 
SA (Fragment) 
IPI00699280 3.58 3.60E-06 34208 525 4 
 
Poly(ADP-ribose) 
glycohydrolase 
ARH3 
IPI00692404 3.58 3.60E-06 44575 214 4 
 SET translocation IPI00728768 3.58 3.60E-06 32098 154 2 
33 
Suppressor of G2 
allele of SKP1 
homolog 
IPI00689292 0.39 2.20E-06 40739 1109 11 
 
similar to 
Thioredoxin 
domain-
containing protein 
5 precursor 
IPI00699038 0.39 2.20E-06 53848 272 7 
 UBFD1 protein IPI00841388 0.39 2.20E-06 35140 171 2 
34 
Aldo-keto 
reductase family 
1, member B1 
IPI00700920 0.47 1.50E-06 40734 610 8 
 
Endoplasmic 
reticulum resident 
protein 29 
IPI00702891 0.47 1.50E-06 29460 334 5 
 
Isocitrate 
dehydrogenase 
[NAD] subunit 
alpha,mitochondri
al 
IPI00699016 0.47 1.50E-06 45021 221 2 
 22 kDa protein IPI00702336 0.47 1.50E-06 24917 178 2 
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Table 13: Spots from differentially abundant proteins between morulae and blastocysts which were not 
identified 
No. p-value in 
student´s t-Test Fold Change No. 
p-value in 
student´s t-Test Fold Change 
35 3.60E-05 0.48    
36 3.50E-05 0.51 49 3.70E-04 0.40 
37 8.40E-04 2.37 50 8.50E-03 2.36 
38 8.40E-07 3.45 51 2.50E-05 0.56 
39 7.90E-05 1.77 52 7.10E-03 0.72 
40 3.00E-03 2.34 53 1.00E-04 0.63 
41 5.80E-03 0.58 54 8.40E-05 0.66 
42 4.00E-04 1.73 55 2.20E-06 5.82 
43 2.20E-06 12.75 56 5.50E-05 3.22 
44 3.60E-06 7.3 57 1.30E-05 0.34 
45 4.00E-04 1.7 58 2.30E-04 0.61 
46 3.40E-06 0.52 59 1.60E-05 2.63 
47 6.80E-05 0.33 60 1.30E-04 0.68 
48 8.40E-07 0.17 61 9.50E-04 0.55 
 
 
 
3.7.2 Nano LC-MS/MS iTRAQ analysis 
For iTRAQ nano LC-MS/MS analysis, six biological replicates corresponding to 25 morulae 
and 25 blastocysts (2.25 µg total protein) each were lysed, tryptically digested and labelled with 
iTRAQ tags. The labelling was performed according to the scheme in Table 14, which allowed 
the multiplexed analysis of two replicates per run set. As established before (see chapter 3.4), 
each run set consisted of four consecutive 2D LC-MS/MS runs. In total three run sets 
corresponding to 12 days of LC-MS/MS measuring were analysed. 
 
Table 14: Labelling and run set scheme of six biological replicates from morulae and blastocysts analysed by 
nano LC-MS/MS iTRAQ analysis 
Numbers 114-117 indicate the iTRAQ reporter tag masses attached to a sample; Letters: M indicates a morula 
sample, B indicates a blastocyst sample; Numbers 1-6 indicate the numbers of biological replicates 
 
 
 
 Label 114 Label 115 Label 116 Label 117 
Run Set 1 M1 B1 M2 B2 
Run Set 2 M3 B3 M4 B4 
Run Set 3 M5 B5 M6 B6 
Results     68 
In total, 141 proteins were identified and quantified from the three iTRAQ run sets comprising 
all six biological replicates. Their log 2 fold changes in morulae versus blastocysts were 
subjected to statistical analyses by the R software. The Volcano Plot in Fig. 23 shows the 
abundance ratios and p-values of all proteins from the analysis. Proteins which had a log 2 fold 
change of > |0.6| - corresponding to an abundance ratio of 1.51 - and a p-value in the student’s t-
test of < 0.05 were considered as differentially abundant. 50 proteins fulfilled these criteria and 
are represented as red data points in Fig. 23. The corresponding protein IDs are listed in Table 
15. A total of 28 proteins was strongly affected in abundance, as indicated by a fold change of < 
0.5 or >2.  
The reproducibility of quantification within all biological replicates is exemplified in Fig. 24 on 
behalf of the HCD MS/MS spectra of the peptide LDNLVAILDINR derived from transketolase. 
Intensity ratios of iTRAQ reporter signals are highly reproducible in all cases.  
 
Fig. 23: Volcano Plot of 141 proteins identified and quantified from morulae 
and blastocysts 
Red data points represent proteins which have a log 2 fold change of > |0.6| and a 
p-value in the student’s t-test of < 0.05; X-axis: log2 fold change of proteins, Y-
axis: 1-p-values of proteins. 
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Fig. 24: Quality and reproducibility of HCD spectra 
Left panels: HCD MS/MS spectra of the transketolase peptide LDNLVAILDINR from each of the three run sets of 
the iTRAQ nano LC-MS/MS analysis of morulae and blastocysts; Right panel: the iTRAQ reporter ion peaks are 
zoomed out; X-axis: m/z values of peaks from peptide fragments; Y-axis: peak intensity. 
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Table 15: Differentially abundant proteins between morulae and blastocysts detected by the LC-MS/MS 
iTRAQ analysis 
Protein name IPI Accession Number 
Molecular 
Weight 
average fold 
change p-value 
Creatine kinase B-type IPI00716827 43 kDa 5.9 6.35E-06 
Similar to histone cluster 1. H2ag IPI00689821 14 kDa 4.8 2.94E-06 
Intestinal alkaline phosphatase VI IPI00703521 61 kDa 4.5 5.38E-05 
Annexin A6 IPI00868644 76 kDa 4.3 5.62E-05 
HIST1H1C protein IPI00699808 21 kDa 4.2 1.65E-06 
Similar to filamin B. beta (actin binding 
protein 278) isoform 7 IPI00688180 279 kDa 3.7 3.45E-05 
Transketolase IPI00904104 65 kDa 2.9 2.89E-06 
40S ribosomal protein S25 IPI00691584 14 kDa 2.9 5.95E-04 
60S ribosomal protein L27a IPI00694444 17 kDa 2.9 1.72E-05 
74 kDa protein IPI00690432 74 kDa 2.8 1.38E-05 
Guanine nucleotide-binding protein 
subunit beta-2-like 1 (RACK1) IPI00700792 35 kDa 2.8 8.01E-06 
75 kDa protein IPI00826962 75 kDa 2.8 2.73E-03 
LGALS3 protein IPI00867041 28 kDa 2.8 1.44E-05 
40S ribosomal protein S11 IPI00689811 18 kDa 2.6 1.24E-05 
Nucleophosmin IPI00689902 33 kDa 2.6 2.49E-05 
Citrate synthase. mitochondrial IPI00699260 52 kDa 2.5 8.20E-05 
Sodium/potassium-transporting ATPase 
subunit alpha-1 IPI00705159 113 kDa 2.5 6.32E-05 
40S ribosomal protein S3 IPI00685601 27 kDa 2.4 8.11E-05 
Similar to Protein FAM151A IPI00710809 64 kDa 2.4 2.56E-04 
Ezrin IPI00694641 69 kDa 2.3 1.35E-05 
Polyadenylate-binding protein 1 IPI00705440 71 kDa 2.2 6.74E-04 
Non-muscle myosin heavy chain IPI00696012 228 kDa 2.1 1.46E-04 
Heat shock protein HSP 90-beta IPI00709435 83 kDa 2.0 1.32E-05 
Elongation factor 2 IPI00707751 95 kDa 2.0 8.85E-05 
Cytochrome c IPI00717272 12 kDa 1.8 4.97E-04 
Elongation factor 1-alpha 1 IPI00712775 50 kDa 1.7 2.03E-05 
Voltage-dependent anion-selective 
channel protein 2 IPI00687246 32 kDa 1.7 4.84E-04 
Isocitrate dehydrogenase [NADP] 
cytoplasmic IPI00702781 47 kDa 1.7 2.38E-05 
Actin. cytoplasmic 1 IPI00698900 42 kDa 1.6 3.62E-03 
Cofilin-1 IPI00699700 19 kDa 1.6 1.90E-02 
ATP synthase subunit delta. 
mitochondrial IPI00707257 18 kDa 1.6 2.36E-03 
ATP synthase subunit alpha. 
mitochondrial IPI00694295 60 kDa 1.5 3.20E-04 
ATP synthase subunit beta. 
mitochondrial IPI00717884 56 kDa 1.5 1.42E-04 
Protein disulfide isomerase family A. 
member 6 isoform 7 IPI00693090 65 kDa 0.7 1.42E-04 
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Protein name IPI Accession Number 
Molecular 
Weight 
average fold 
change p-value 
Nucleoside diphosphate kinase B IPI00686420 17 kDa 0.6 1.83E-03 
Peroxiredoxin-1 IPI00686092 22 kDa 0.6 9.27E-05 
Cell division protein kinase 5 IPI00689812 33 kDa 0.6 2.39E-04 
Family with sequence similarity 62 (C2 
domain containing). member A IPI00713575 123 kDa 0.6 1.84E-03 
L-lactate dehydrogenase A chain IPI00716974 37 kDa 0.6 1.05E-04 
PDIA3 protein IPI00852512 57 kDa 0.6 2.37E-05 
78 kDa glucose-regulated protein IPI00717234 72 kDa 0.6 1.73E-03 
Peroxiredoxin-2 IPI00713112 22 kDa 0.6 2.88E-05 
Glutathione S-transferase mu 3 IPI00702950 27 kDa 0.6 4.74E-05 
73 kDa protein IPI00841750 73 kDa 0.6 2.96E-03 
Inositol polyphosphate 1-phosphatase IPI00686250 44 kDa 0.6 1.25E-05 
Retinal dehydrogenase 1 IPI00692627 55 kDa 0.6 5.95E-03 
similar to T04F3.1 IPI00686245 78 kDa 0.5 2.26E-04 
22 kDa protein IPI00702336 22 kDa 0.5 5.67E-05 
Ubiquitin carboxyl-terminal hydrolase 
isozyme L1 IPI00697759 28 kDa 0.5 7.44E-06 
Bisphosphoglycerate mutase IPI00706349 30 kDa 0.4 1.66E-04 
 
3.7.3 Comparison of results from 2D DIGE analysis and from nano LC-MS/MS analysis 
Results of the LC-MS/MS based iTRAQ analysis and 2D gel based saturation DIGE analysis 
were compared. The comparison showed that seven proteins had been identified as differentially 
abundant in both approaches. They are listed together with their fold changes in Table 16. A 
total of six out of the seven proteins showed similar abundance alterations in both approaches. 
This is demonstrated on behalf of Peroxiredoxin 2 in Fig. 25 which shows a comparison of 
HCD MS/MS spectra of peroxiredoxin 2´s peptide QVTINDLPVGR, and corresponding 3D 
intensity shape plots from the 2D DIGE analysis. In contrast, one protein spot identified as 
“Glutathione S-transferase mu3” is increased in the 2D DIGE analysis, while the majority of the 
corresponding peptides revealed to be decreased in abundance in the iTRAQ analysis.  
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Table 16: Differentially abundant proteins between morulae and blastocysts detected by both, the 
Saturation DIGE and the LC-MS/MS iTRAQ analysis 
Spot No. Protein name IPI Accession 
number 
Fold change in 
iTRAQ Analysis 
Fold change in 2D 
DIGE Analysis 
19 ATP synthase subunit beta, 
mitochondrial IPI00717884 1.5 1.5 
12,13,14 Peroxiredoxin-2 IPI00713112 0.6 0.5 
30,31 78 kDa glucose-regulated protein IPI00717234 0.6 0.6 
2 PDIA3 protein IPI00852512 0.6 0.6 
9 Glutathione S-transferase mu 3 IPI00702950 0.6 1.7 
34,27 22 kDa protein IPI00702336 0.5 0.4 
17,29 Ubiquitin carboxyl-terminal hydrolase isozyme L3 IPI00697759 0.5 0.5 
 
 
 
 
 
 
Fig. 25: Comparison of abundance alterations determined by DIGE spot intensity and iTRAQ reporter ion 
intensity 
Upper graphs in panels: iTRAQ-reporter ion zoom out of HCD MS/MS spectra of Peroxiredoxin2´s peptide 
QVTINDLPVGR from each of the three run sets of the iTRAQ nano LC-MS/MS analysis of morulae and 
blastocysts; X-axis: m/z values of peaks from peptide fragments, Y-axis: relative abundance of peak intensities; 
Lower graphs in panels: Intensity and shape plots of a differentially abundant spot identified as Peroxiredoxin 2; 
Left panel: replicates 1 and 2, middle panel: replicates 3 and 4, right panel: replicates 5 and 6. 
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3.7.4 David gene ontology analysis of differentially abundant proteins  
Results from both the 2D DIGE and the iTRAQ analyses were merged, leading to a set of 42 
different proteins with decreasing abundance alterations between morulae and blastocysts and to 
a set of 47 different proteins with increasing abundance alterations between morulae and 
blastocysts.  
These two sets were individually subjected to David gene ontology (GO) analysis. The David 
GO clustering according to the GOTERM_BP_FAT categories leads to 40 different GO terms 
within the group of proteins showing decreased abundance alterations in blastocysts. A total of 
nine proteins are associated with catabolic processes while four proteins are associated with 
biosynthetic processes. Furthermore, 12 proteins are associated with redox processes. 
Within the group of proteins showing increased abundance alterations, David GO clustering 
leads to 54 different GO Terms. A total of seven proteins are associated with biosynthetic 
processes and only two proteins with catabolic processes. A total of three proteins are assigned 
to cytoskeletal organisation and five proteins are associated with chromosome or nucleosome 
organization. A total of eight proteins are assigned to the GO term translation while seven of the 
proteins are assigned to Ion transport.  
 
 
 
 
 
Fig. 26: Comparative “David” GO analysis 
Results from the comparative David Gene Ontology analysis between increased (magenta) and decreased (blue) 
proteins in morulae versus blastocysts; X-axis: Gene Ontology category, Y-axis: percentage of increased/decreased 
proteins within the indicated category. 
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4 Discussion 
4.1 Qualitative proteome analysis of 900 bovine GV oocytes 
Developmental competence of oocytes impacts nearly all important steps in embryonic 
development [22, 23]. It is acquired during the growth of oocytes in folliculogenesis and during 
the oocyte maturation process [22]. Developmental competence is characterized by the oocyte’s 
ability (i) to resume meiosis, (ii) to cleave following fertilization, (iii) to develop to the 
blastocyst stage, (iv) to induce a pregnancy and (v) to develop to term in good health [23]. 
During the growth phase of oocytes, large stores of mRNAs and proteins that function after 
fertilization are produced [22]. Deficiencies in mRNA and protein accumulation are thought to 
lead to failures in cytoplasmic maturation, which occurs besides the nuclear maturation process 
[22]. A part of the cytoplasmic maturation process is the molecular maturation process. It is 
assumed that specific mRNAs and proteins are produced and added to the oocyte’s stockpile in 
the last few days before ovulation [23].  
To get an overview of the kind of these stored proteins, a qualitative proteome profile was 
performed by analysing the proteins contained in GV oocytes. GV oocytes are easily available 
from slaughterhouse ovaries and have a large cytoplasmatic part containing approximately 90 
ng protein. In contrast, MII oocytes are more difficult and time consuming to obtain and have 
the major disadvantage that their biology is altered by either in vitro maturation or by FSH 
stimulation of donor cows. 
In the middle of the nineties it became possible to identify large numbers of proteins by the 
ongoing development of protein mass spectrometry. A powerful technique applied for this 
purpose is the nano LC-MS/MS technique, in which peptides are the basis of protein 
identification (see chapter 1.5.2). Usually, the protein subset of a cell, organ or organism, 
containing peptides which are easily ionisable, can be detected and identified by mass 
spectrometry. Protein identification by MS/MS works by the probability based comparison of 
experimentally acquired peptide MS/MS spectra with in silico generated theoretical spectra 
deduced from protein databases. At least two different peptides of a protein should be 
identified, since a protein identification based on just a single peptide may in many cases 
represent a false positive identification. The false discovery rate (FDR) of a dataset should be 
limited to 1 % [66]. This can be checked by a search, against a so-called decoy database, 
generated by scrambling the amino acids from each database entry in a random manner. If the 
number of protein IDs obtained from the decoy database search doesn’t exceed 1 % of the 
number of IDs in the dataset containing the identified proteins, an FDR of lower than 1 % can 
be assumed [125]. The application of these criteria for protein identification became more and 
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more accepted during the last years. For example, an experiment leading to a protein dataset of 
bovine GV oocytes containing 1092 identified proteins published by an American group in 
2007 was repeated in 2010. Although during the repeated experiment almost three times as 
many mass spectra as before were acquired, a decoy database search and the statistical 
evaluation dropped the number of identified proteins down to 811. From this list still only 329 
GV oocyte proteins were identified by at least two peptides [106, 126]. 
To obtain a sufficient protein amount for qualitative nano-LC-MS/MS analysis, 900 GV oocytes 
(containing 81 g protein) were lysed. To decrease the complexity, the protein lysate was split 
into two equal parts which were prefractionated on a 12 % and on a 6 % 1D SDS PAA gel (Fig. 
5) prior to nano LC-MS/MS analysis. The criteria to be at least identified by two peptides while 
the dataset has an FDR of lower than 1 %, confirmed by a decoy database search, were fulfilled 
by 791 proteins from the oocyte lysate prefractionated on the 12 % SDS PAA gel. Additionally, 
38 mostly high molecular weight (> 100 kDa) proteins were identified from the lysate 
prefractionated on the 6 % SDS PAA gel, due to the enhanced separation power for high 
molecular weight proteins on low percentage gels. In total 829 proteins were identified. 
The existence of many proteins in genomic databases has not been validated by protein 
identification but is deduced from corresponding DNA/RNA sequences. In the Uniprot 
database, five levels of evidence for protein existence are indicated: (Uniprot Level I) 
“Evidence at protein level” applies to proteins that have been previously identified, (Uniprot 
Level II) “Evidence at transcript level” applies to proteins of which the corresponding RNA has 
been identified, (Uniprot Level III) “Inferred from homology” applies to proteins of which the 
existence is probable because clear orthologs exist in closely related species, and (Uniprot Level 
IV) “Predicted” applies to proteins which have been predicted by the DNA analyses yet for 
which no evidence at protein, transcript, or homology levels exists. The weakest term is 
(Uniprot Level V) “Uncertain”. 
The level of protein existence of the 829 proteins from the GV oocyte dataset was checked in 
the Uniprot database. The evidence for the majority of the identified proteins (75 %) was not 
confirmed on the protein level in the bovine system prior to this experiment. For 515 proteins, 
there was at least experimental evidence on the RNA level (Uniprot Level II), but for 83 
proteins, the existence was only assumed from homology with sequences of other species 
(Uniprot Level III) and 24 proteins were only predicted to exist (Uniprot Level IV).  
To find out which biological and molecular functions might be executed by the identified 
proteins, they were clustered according to their gene ontology (GO) terms (Fig. 6). Proteins 
were assigned to the three main categories “cellular component”, “biological process” and 
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“molecular function”. In the biological process category most proteins (47 %) are assigned to 
the cluster “metabolism”. This is coherent with the fact that the oocyte’s ability to correctly 
control metabolism is of special importance for the developmental potential [22].  
An 18 % fraction of the identified proteins is assigned to the cluster “biological regulation”: 
One can assume that within this group, proteins important for the correct initiation of oocyte 
meiosis, first cleavages and the correct maternal embryo transition (MET) can be found. This 
hypothesis is strengthened by the fact that it contains for example the proteins Peroxiredoxin 2 
and 3. Peroxiredoxin 3 is already known to be altered during the bovine in vitro maturation 
process [74]. Peroxiredoxin 2 (PRDX2) was found to decrease during the morula to blastocyst 
transition (see chapter 3.7). Another protein found in this group is YBX2, which functions in 
storage maintenance of maternal mRNA and was found to be differentially abundant between 2-
cell stage embryos and morulae (see chapter 3.6). 
A 41 % fraction of the proteins contained in the “molecular function” category is assigned to 
the cluster catalytic activity, wherein most of the proteins could be assigned to oxidoreductases 
(77) and hydrolases (108). These proteins can also be considered to play a role for oocyte 
developmental competence since it is influenced by oxygen tension and by the concentration of 
ROS species [22]. Furthermore, redox enzyme variants were shown to be altered during the 
oocyte maturation process [74]. 
To find out in which pathways the identified proteins are involved, a David analysis of KEGG 
Pathways was performed. This bioinformatic tool reveals pathways in which proteins from the 
input list show up more than they are expected to appear from a randomized protein list [123]. 
A total of 23 proteins were found in the KEGG Pathway term “Ribosome”, indicating the 
ongoing translation of proteins eventually important for developmental competence. A total of 
16 proteins were found to take part in the oocyte meiosis pathway (Fig. 7), demonstrating the 
accumulation of proteins important for this initial step of embryonic development. 
In general, this experiment reflects the impact of generating qualitative protein lists. They can 
not only provide evidence for many proteins to exist but moreover give hints to pathways and 
processes which might be important for biological events, like for example the early embryonic 
development. 
 
4.2 Protein identification and quantification of limited sample amounts by nano LC-
MS/MS 
As described in the previous chapter, the identification of ~ 800 proteins requires protein 
amounts of about 40 to 100 g. Since one oocyte or early embryo contains only approximately 
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90 ng protein, such an identification approach would require the generation of hundreds of 
embryos. Especially in cases where several biological replicates are needed, the preparation of 
so many embryos would be very cost intensive and time consuming. For this reason, it was 
tested how many proteins can be identified from much smaller sample amounts corresponding 
to the protein amounts of one oocyte up to 50 oocytes. The same strict identification criteria as 
described in the previous chapter were applied, and a FDR < 1 % was confirmed by decoy 
database searches. 
Even from a single oocyte, 54 proteins could be identified. Using 25 bovine oocytes led to the 
highest number of 106 identified proteins. In contrast, the protein amount from 50 oocytes 
dropped the number of identified proteins down to 62 (Fig. 8).  
This decrease in the number of identified proteins, despite the higher protein amount subjected 
to nano LC-MS/MS analysis, can be explained by column overloading: Column overloading 
usually occurs when the peptide amount loaded onto a reversed phase (RP) column is beyond 
its capacity, leading to peak broadening and lower separation strength. As a consequence, the 
number of identified peptides, respectively proteins, is decreased. 
To find out whether the number of identifications from protein amounts corresponding to 25 
and 50 oocytes can be further enhanced, a two-dimensional (2D) LC-MS/MS analysis was 
performed by an additional prefractionation step of tryptic peptides on a “strong cation 
exchange” (SCX) column prior to RP separation. SCX chromatography uses the charge state of 
a molecule as a major separation criterion and represents an orthogonal separation step to RP 
chromatography. The base peak ion chromatograms (BICs) in Fig. 9 demonstrate that peptides 
were evenly distributed over all salt fractions. Due to the lower complexity of protein mixtures 
after SCX prefractionation and an extended time of spectra acquisition, the number of identified 
proteins from a sample amount corresponding to 25 oocytes could nearly be doubled to 206 
compared to the 1D LC-MS/MS approach. Like in the 1D approach, it was not beneficial to 
analyse the larger protein amount of 4.5 µg corresponding to 50 oocytes. This protein amount 
dropped the number of identified proteins down to 198, most likely also due to column 
overloading occurring within the analysis of single salt fractions. 
These experiments created the basis for (i) the adaptation of an iTRAQ quantification approach 
for small sample amounts (see chapter 4.3) and (ii) for the analysis of 2-cell stage embryos and 
morulae (see chapter 4.5). 
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4.3 Protein quantification of limited sample amounts by iTRAQ 
Protein quantification by nano LC-MS/MS is relatively complex. The quantitative comparison 
of MS signals between different LC-MS runs is not reliable since even small irregularities in the 
composition of samples and replicates may influence retention times and ionization rates of 
single peptides. Therefore, a common strategy is (i) to label the samples with chemically 
identical reagents differing in their isotopic composition but not in their molecular mass, (ii) to 
pool samples after labelling and (iii) to perform LC-MS experiments with these pools. Since 
this procedure ensures that the retention time of differentially labelled peptides remains 
unaffected, peptides derived from different samples co-elute and reach the mass spectrometer 
simultaneously. Hence, signal intensities of corresponding peptides from different samples can 
be quantitatively compared and assigned to the sample by their isotopic label [77]. 
There are several possibilities of sample labelling differing in the level of sample procession (in 
vivo/ on the protein level/ on the peptide level) at which the label is attached. For a more 
detailed description of these different techniques please refer to chapter 1.5.2. 
Using the so-called “isobaric tag for relative and absolute quantification” (iTRAQ) four plex 
approach, the label is introduced on the peptide level. It was the method of choice for these 
experiments due to the facts that the protein cleavage process is not biased and that nearly all 
peptides can be labelled in contrast to the ICPL and the ICAT approach (see chapter 1.5.2). 
After lysis and tryptic digestion, thepeptides were labelled with an isobaric tag on each lysine 
chain and on each N-terminal group. As shown in Fig. 27, this tag consists of a reporter group 
which differs in its mass between 114 and 117 Dalton and a balancer group, which has a mass 
between 31 and 28 Dalton so that the total tag mass is 145 Dalton in each case.  
 
 
 
 
 
 
 
Up to four different samples can be labelled, each with a tag containing a different reporter 
group. Samples are then pooled and passed through an LC-MS/MS run. During fragmentation, 
reporter and balancer groups are split from the peptide in the so-called “higher energy collision 
dissociation” (HCD) cell of the mass spectrometer. The iTRAQ reagent reporter group ions that 
Fig. 27: Composition scheme of the 
iTRAQ tag 
Source: Applied Biosystems iTRAQ™ 
Reagents - Chemistry Reference 
Guide, Applied Biosystems, 2004. 
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are generated appear as peaks in the low-mass region between m/z 114 and m/z 118 of the 
MS/MS spectra. Because this region is free of other common fragment ions, signals found in 
this region are not influenced by random noise and their intensity relationships represent those 
of peptides from different samples. 
Due to the fact that HCD spectra need an extended scan time in the mass spectrometer, fewer 
proteins are expected to be quantified and identified during an individual LC run compared to 
LC runs dedicated to identification only (see previous chapter). Therefore, an experimental 
series was performed to optimise the number of quantified proteins for a given amount of 
oocytes.  
To find out how many proteins can be quantified and identified from small protein amounts, a 
1D LC-MS/MS analyses was performed using 2.25 µg and 4.5 µg pooled iTRAQ sample 
corresponding to 25 and 50 oocytes, respectively. From the protein equivalent to 25 and 50 
oocytes of the “iTRAQ labelled GV oocyte peptides”, 67 and 86 proteins could be identified 
and quantified, respectively. In order to enhance the number of identified and quantified 
proteins, the iTRAQ labelled proteins from 25 and from 50 oocytes were split into two equal 
parts each. In both cases, after the first aliquot had been analysed by LC-MS/MS, an exclusion 
list (EL) was generated, containing all peptide masses from which MS/MS spectra had been 
successfully acquired. This exclusion list was applied to the analyses of the second aliquots, 
forcing the instrument to ignore these masses and instead acquire MS/MS spectra from so far 
unconsidered peptide precursors. The application of the exclusion list enhanced the number of 
identified and quantified proteins from the protein amount of 25 oocytes to 107, and from the 
protein amount of 50 oocytes to 116 (Fig. 11). In order to further enhance these numbers, the 
pool of iTRAQ labelled GV oocyte peptides from 50 oocytes was divided into four equal parts, 
which were analysed in four consecutive 1D LC-MS/MS runs, and an exclusion list for each run 
was generated from all previous runs. Such a combination of four runs is referred to as “run set” 
throughout this work. As a maximum, 150 proteins were identified and quantified from the 
protein amount of 50 oocytes. Fig. 12 shows the numbers of identified and quantified proteins 
from the merge of individual runs with the previous runs. The fact that the number of identified 
and quantified proteins is enhanced about 45 % by the application of the first EL, but is only 
enhanced about 13 % by the application of the last EL, demonstrates a saturation effect after the 
4th run. One can assume that splitting 50 oocytes in more than four parts followed by a 
subsequent analysis in a run set consisting of more than four runs would enhance the number of 
identifications to only a few more. Instead, this set up was tested in a 2D LC-MS/MS approach. 
Six exclusion lists for each run (one per salt fraction) were generated from all previous runs and 
applied to the analyses of the corresponding fractions in the following run. This enhanced the 
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number of identified and quantified proteins to 403. Since the analysis of one 2D LC-MS/MS 
run took 18 hours, only one 2D LC-MS/MS run could be performed per day. The analysis time 
for a complete 2D LC-MS/MS run set therefore comprised four days. 
Fig. 13 shows the number of identified and quantified proteins from the protein amount 
corresponding to 50 GV oocytes using different approaches. It clearly demonstrates that the 
iTRAQ approach leads to the highest number of identified and quantified proteins when 
multiple exclusion lists in connection with a 2D LC-MS/MS set up are applied. This set up 
facilitated the analysis of in vivo versus in vitro matured oocytes (see next chapter) and was also 
applied to the analysis of morulae versus blastocysts like it is described in chapter 4.6. 
 
4.4 Comparison of in vivo and in vitro matured oocytes from cows of different age 
groups by nano LC-MS/MS iTRAQ analysis 
Assisted reproduction techniques using IVP become more and more important both in human 
and in veterinary medicine. However, in vitro produced embryos still show more developmental 
abnormalities than in vivo produced embryos. The abnormalities are reflected by increased rates 
of early embryonic death and abortion, production of large size foetuses, abnormal organ 
growth as well as failures in the placenta development summarized as the “large offspring 
syndrome” (LOS) [1]. During IVP of embryos the first step is oocyte maturation. This can be 
performed in vivo or in vitro. Especially in human medicine, it is desirable to mature oocytes in 
vitro in order to avoid, or to drastically reduce, the use of gonadotrophins for ovarian 
hyperstimulation [115]. However, IVM has the disadvantage of a significantly lower efficiency 
compared to the usage of in vivo maturation of oocytes in terms of “developed embryos per 
collected oocyte” and “offspring per collected oocyte” [115]. This is also the case for IVM of 
cattle embryos. While approximately 50-80 % of in vivo matured oocytes develop to the 
blastocyst stage, a typical blastocyst rate of 15-40 % is reached with IVM oocytes [1]. Although 
more and more publications suggest failures in epigenetic reprogramming as the main reasons 
for these phenomena, the molecular mechanisms underlying these drawbacks are still 
unresolved [1]. As already mentioned in chapter 4.1, the proteome analysis of oocytes is 
promising, since they contain a maternal protein storage which functions in fertilization and 
early embryonic development and might therefore play an important role for the developmental 
competence of oocytes [22]. 
To evaluate the alterations in the quantitative protein expression profile between in vivo and in 
vitro matured MII oocytes, a nano-LC-MS/MS iTRAQ analysis was performed. Given that the 
age of oocyte donors is a significant factor for the oocyte’s developmental competence [127], 
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oocytes were split into three groups according to their donor cow’s age (heifers, young cows 
and old cows). Each age group contained five cows. All oocytes were aspired in vivo in so 
called “OPU sessions”. During one OPU session, in vivo aspiration from all five cows of an age 
group was performed. Oocytes were either aspired from unstimulated cows in the GV oocyte 
stage or from FSH stimulated cows in the MII oocyte stage. GV oocytes from unstimulated 
cows were matured in vitro immediately after the OPU session and developed to the MII oocyte 
stage. Oocytes obtained during this experiment were not only used for proteome analyses but 
also for evaluation studies in which different cleavage and blastocyst rates were analysed [128]. 
For each of the age groups, three biological replicates were generated, each consisting of 25 in 
vivo and 25 in vitro matured MII oocytes. Usually, more than one OPU session was necessary 
to collect the 25 oocytes needed for a biological replicate. The experiment was performed by 
nano LC-MS/MS based iTRAQ quantification using a 2D LC-MS/MS approach in combination 
with the application of multiple exclusion lists, as established before (see chapter 4.3). For the 
labelling procedure, four different iTRAQ tags were available which enabled the multiplexed 
analysis of several samples, within one “run set” (for definition of “run set” please refer to 
chapter 4.3). Each analysis of one biological replicate comprised four run sets. As demonstrated 
in Table 3, this multiplexing facilitated for example the comparative analysis of stimulated 
oocytes from heifers, young cows and old cows in one run set as well as the comparison of in 
vivo and in vitro matured oocytes within individual age groups. 
The numbers of proteins identified and quantified in each run set can be found in Table 3. 
Reasons for the relatively large differences (up to 40 %) in numbers of identified and quantified 
proteins per run set are most likely based on different methods of sample storage. Oocyte 
aspiration for this experiment was started at a date when the optimal way to store very small 
numbers of approximately ten oocytes per sample was not finally established. Therefore some 
samples were stored in small glass capillaries while others were stored in sample cups. Hence, 
different protein amounts may have been obtained during the lysis procedure causing the 
alterations in numbers of identified and quantified proteins. 
 
4.4.1 Glyoxylase 1, Ubiquitin and Bisphosphoglycerate mutase are candidate proteins 
for affecting the developmental potential of in vitro matured oocytes 
The comparison of in vivo versus in vitro matured oocytes revealed nine proteins to be 
differentially abundant in the heifers group (Table 4), and nine proteins in the old cows group 
(Table 6). Four proteins, LAMP1, LAMP2, GLO1 and Ubiquitin, are altered by a fold change 
of > 2 in in vivo versus in vitro matured oocytes in the heifers as well as in the old cows group. 
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Since in vitro matured oocytes are known to be impaired in their developmental competence, a 
fact which was moreover confirmed by the evaluation of blastocysts and cleavage rates of 
oocytes from this experiment [128], the higher levels of these proteins in IVM oocytes are 
considered to be involved in affecting their developmental potential. 
Ubiquitin usually carries out two different activities, namely modifying proteins, which will in 
the following either be degraded by the proteasome and serves to attract other proteins for 
initiating signalling cascades [129]. Since no peptides besides the C terminal end of Ubiquitin 
were identified, it is not possible to decide whether Ubiquitin was identified as a free molecule 
or covalently bound to other proteins. Its abundance increase in IVM oocytes could indicate 
higher abundance levels of proteins that are either misfolded or need to be replenished. A 
similar phenomenon was regarded during an analysis of murine COPD lung tissues, in which 
animals with severe emphysema had a higher accumulation of ubiquitinated proteins as 
compared to lower affected animals [130].  
Glyoxylase 1 (GLO1) is an enzyme responsible for the degradation of methylglyoxal [131]. 
Methylglyoxal represents the aldehyde form of pyruvic acid and is a side product of glycolysis. 
Considering that glucose metabolism plays a pivotal role in determining the developmental 
competence of oocytes [132], a higher activation of glycolysis in in vitro than in in vivo matured 
oocytes can be supposed. It was already stated by Rieger et al. in 1995 that high rates of glucose 
metabolism may be unfavourable for development, after it was found that the metabolism of 
glucose was significantly greater in embryos which reached the 16-cell stage a whole day later 
than those with a lower glucose metabolism [133]. Moreover, it is already known that poor 
maternal health, resulting in increased intra-follicular glucose levels, like it is the case in 
diabetic mothers, is associated with poor oocyte viability [132]. Therefore, the increase of 
GLO1 could be a hint to an altered metabolic status inducing a loss of developmental 
competence of in vitro compared to in vivo matured oocytes. 
During the evaluation experiments of cleavage and blastocyst rates, in vitro matured oocytes 
from young cows had higher cleavage and blastocysts rates than those from the other age 
groups [128]. Therefore, further evaluation of differentially abundant proteins between in vivo 
and in vitro matured oocytes within this age group is of special interest with respect to the 
developmental competence. Four proteins were found to be differentially abundant between in 
vivo and in vitro matured oocytes from young cows (Table 5). One of these proteins is 
Bisphosphoglycerate mutase (BPGM), which was two times more abundant in in vivo than in in 
vitro matured oocytes. Moreover, it was also found to be of lower abundance in in vivo versus 
in vitro matured oocytes from heifers. Usually, BPGM is found in erythrocytes, where it 
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synthesises 2,3-bisphosphoglycerate, which regulates the oxygen affinity of haemoglobin [134-
136]. In 2006, it was demonstrated that its expression is not only limited to erythrocytes, since it 
was also found to be synthesized in non-erythroid cells of the human placenta [137]. 
Interestingly, BPMG seems to be a so called “maternal house keeping protein” (MHKP). 
MHKPs were defined as proteins, which are newly synthesized from maternal mRNA during 
oocyte maturation and also during the development of preimplantation embryos up to the 8-cell 
stage [113]. This indicates that the translation maintenance of these proteins is of special 
importance for correct embryonic development. During meiotic maturation, the time of protein 
synthesis is limited to the period of metaphase I until it declines to a basal level in metaphase II 
[138]. Due to the lower levels of BPMG in in vitro matured oocytes, it can be assumed that 
translation of BPMG is impaired or that its degradation is enhanced during the in vitro 
compared to the in vivo maturation process. Since in vitro matured oocytes are of lower 
developmental potential than in vivo matured oocytes, BPGM could be a protein executing 
crucial functions during early embryo development. Therefore, the low abundance of BPGM in 
in vitro matured oocytes could be involved in affecting their developmental potential. 
In the comparison of in vitro matured oocytes from different age groups, the protein 
“Lysosomal-associated membrane protein 2 isoform 2” (LAMB2) was higher abundant in 
heifers than in young cows (fold change 2.7) and in old cows (fold change 3.6). Since the 
developmental competence of oocytes depends not only on the maturation process (in vivo 
versus in vitro) but also on the age of oocyte donors [127], LAMP2 could be involved in 
altering the developmental potential. Due to the fact that during the evaluation of cleavage and 
blastocyst rates from in vitro matured oocytes a higher blastocyst rate in young cows than in 
heifers was observed, one could assume that high LAMP2 concentrations are detrimental to the 
developmental competence of oocytes [128]. This hypothesis would be supported by the fact 
that LAMP2 was also increased in in vitro matured oocytes from heifers and old cows 
compared to their in vivo matured counterparts. However, only a slight increase in blastocyst 
rates in oocytes from old cows compared to that from heifers was observed [128], although 
LAMP2 was increased nearly by the same fold change in heifers versus old cows as in heifers 
versus young cows. Therefore, it is also possible that higher LAMP2 concentrations in oocytes 
from heifers are not associated with the developmental competence of oocytes. 
The evaluation experiment of cleavage and blastocyst rates revealed that age associated 
differences could not be observed in in vivo matured oocytes, in contrast to in vitro matured 
oocytes [128]. This is consistent with the finding from the proteome analysis, that no 
differentially abundant proteins were found in the comparison of oocytes from different age 
groups in the group of in vivo matured oocytes. This result suggests, that age associated 
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differences are either not as abundant on the protein level in in vivo matured oocytes, or that 
they are evened out by FSH superstimulation, which was used for their generation.  
For the statistical evaluation of differentially abundant proteins, it would have been beneficial if 
more than three biological replicates were analysed. Since oocytes (i) were not only obtained 
for proteomic experiments but also for IVP studies and histological analyses, and (ii) since in 
case of in vivo matured oocytes, a collection interval of four to five weeks was mandatory to 
follow a correct FSH stimulation protocol, the period of oocyte aspiration endured for about 1.5 
years. The generation of more than the three replicates would have required employing new 
animals, due to the fact that animals did not match the age group criteria anymore after 1.5 
years of their use in the experiment. Due to these limitations in the statistical analysis protein 
candidates from this experiment will have to be further validated, for example by targeted 
quantification using the SRM technology.  
 
4.5 Qualitative and quantitative proteome analysis of oocytes, 2-cell stage embryos 
and morulae  
The development from a 2-cell stage embryo into a morula takes about three days. During this 
period, the embryonic genome is activated (maternal embryo transition (MET)) and the first 
cell fate decisions are made. Within a morula, the outer cells, which have contact to the Zona 
pellucida, are already determined to develop into the trophectoderm cells, which are the 
progenitor cells of the placenta, while the inner cells will form the inner cell mass (ICM), from 
which the embryo develops (for detailed description see chapter 1.3.2). To detect protein 
alterations coming along or are even induced by these processes, 50 2-cell stage embryos and 
50 morulae were compared by 2D nano LC-MS/MS analysis. A total of 318 proteins were 
identified from 2-cell-stage embryos and 348 proteins were identified from morulae. These 
protein lists represent the first qualitative proteomic dataset from bovine 2-cell stage embryos 
and from morulae in general. The impact of these datasets to biological knowledge has been 
already discussed in chapter 4.1.  
The identified proteins from these embryonic stages were compared to those of oocyte proteins 
(Fig. 15). Although the oocyte dataset contains far more proteins (829), there are still 94 
proteins which have been identified from morulae and/or from 2-cell stage embryos but not 
from oocytes. 223 proteins could be identified from all stages. The overlap of only 223 proteins 
in all three stages is a clear hint to intensive proteome alterations during the developmental 
period from the GV oocyte to the morula stage. A total of 52 proteins were detected in 2-cell 
stage embryos, but not in GV oocytes. These proteins could become either (i) accumulated 
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during the time of GVBD when translation is enhanced during the maturation process [138] or 
(ii) translated from stored mRNA after fertilization due to the fact that transcription is relatively 
silenced until the onset of MET [36]. Furthermore, 254 of the identified proteins could be found 
both in 2-cell stage embryos and morulae. A total of 64 proteins were exclusively identified in 
2-cell stage embryos while 94 proteins were exclusively identified in morulae. These 
differences are coherent with the subsequent degradation of maternal proteins and with the 
MET, leading to transcription and translation of genes from the embryonic genome [36]. 
The datasets from GV oocytes, 2-cell stage embryos and morulae were subjected to a GO 
analysis, the result of which is shown in Fig. 16. The percentage of proteins which are assigned 
to the different gene ontology categories is similar in all three stages. As demonstrated in Fig. 
16, proteins assigned to binding and catalytic activity represent the biggest fraction in the 
molecular function category. Within the proteins of catalytic activity, especially 
oxidoreductases and hydrolases are overrepresented. Therefore, corresponding processes seem 
to be important during early embryonic development. Especially proteins associated to redox 
processes are already known to play a role during early embryonic development [139] and are 
furthermore subjects to alterations during the morula to blastocyst transition as discussed in 
chapter 4.6. 
To quantitatively compare the datasets from 2-cell-stage embryos and morulae they were 
subjected to a so called “spectral count” analysis. The method “spectral counting” is based on a 
connection between a protein’s abundance and the number of MS/MS spectra assigned to an 
identified protein [86, 87, 140]. This rather simple method facilitates a quantitative comparison 
between unlabelled samples which have been measured in two different LC-MS/MS runs (see 
chapter 1.5.2). As listed in Table 9, 28 proteins were altered in abundance by a “spectral count 
fold change “of < 0.5 or > 2.  
However, spectral count is a rather simple but fairly crude method of quantification, demanding 
a validation of the results by an independent approach [141].  
For this reason, the abundance alterations of two of the differentially abundant proteins, being 
especially interesting with respect to early embryonic development, were validated by the so-
called “SRM” technique. SRM stands for “selected reaction monitoring” and is a mass 
spectrometry based method for a precise and highly specific quantification of proteins. In 
contrast to protein quantification by the holistic spectral count approach, SRM is used for the 
targeted quantification of known candidate proteins. The abundance alterations of i) Y-box 
protein 2 (YBX2) and ii) the IGF 2 mRNA-binding protein 3 (IF2B3/IMP3) between 2-cell 
stage embryos and morulae were analysed in three biological replicates, each containing ten 
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embryos per stage. In Fig. 19 an example of the quantification of the two proteins in ten 2-cell 
stage embryos is shown, demonstrating high signal intensities sufficient for quantification.  
 
4.5.1 The decrease of YBX2 in morulae could rely on its maternal RNA storage 
function  
YBX2 is an mRNA binding protein, which is the major and functional component of 
“messenger ribonucleoprotein complexes” (mRNPs). It protects the maternal mRNA storage 
from translation and degradation in mouse and Xenopus oocytes [142-144]. YBX2 mRNA and 
protein expression levels had already been analysed in bovine oocytes and preimplantation 
embryos [145, 146]. Both in mouse and in Bos taurus, YBX2 is highly abundant in the cortex of 
early oocytes and early cleavage stages. It decreases after the MET, which occurs between the 
8- and 16-cell stage in the cow. This expression pattern was explained by YBX2’s function in 
storage maintenance of maternal mRNA, which is no longer required in a transcriptional active 
stage [145]. The results presented here do not only confirm those findings but moreover specify 
the relative abundance of YBX2 in morulae to 10 % of its abundance in 2-cell stage embryos. 
 
4.5.2 The decrease of IMP3 in morulae could be involved in first cell determinations 
The protein IMP3 (IGF 2 mRNA-binding protein 3) belongs to a family of foetal proteins, the 
IMP family, that are capable of strong and specific mRNA binding. So far the mRNAs of -
actin, VG1, C-MYC, H19, TAU and Insulin like growth factor 2 (IGF2) have been reported as 
IMP binding targets [147-152]. Similar to YBX2, members of this protein family can mainly be 
found in mRNP complexes [153] and take part in translational control as well as RNA stability 
and trafficking [151, 154]. Moreover, they are also involved in forming cell polarity, migration 
and proliferation [154] and are expressed in various cancer cell lines [155-157]. The IMP 
expression levels decrease soon after birth, and in adults they have been detected only in testis 
and placenta [158]. Taken together, these facts indicate an important role for IMPs during 
embryonic development, yet this role is controversially discussed. For example, IMPs 
specifically bind and repress translation of the IGF-2 - mRNA , which is known to enhance 
proliferation. However, IMP expression is also positively correlated with cell proliferation 
[158].  
The results presented here are the first analyses of an IMP family member abundance alteration 
during bovine embryo development. In the morulae IMP3 is decreased to half of its abundance 
in 2-cell stage embryos. Like the expression pattern of YBX2, the decrease of IMP3 can be 
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explained with its function in storage maintenance of maternal mRNA, which is no longer 
required in a transcriptional active stage.  
This role was more specified by Nielsen et al.[151]: IMP mRNA levels have been analysed 
during embryonic development in mice and showed a sharp increase until day E.12.5 followed 
by a decline towards birth. The increase of IMP1 was also confirmed on the protein level. 
However, Nielsen et al. did not analyse the abundance alterations of IMPs in embryonic stages 
occurring prior to E.8.5. Therefore, the decrease of IMP3 as in the results presented here is not 
contrary to the results of Nielsen et al. Moreover, a similar tissue-specific distribution of IMPs 
and IGF2 was observed which led the authors, especially on the background of their findings of 
the IMPs´ ability to suppress IGF2, to the suggestion that IMPs participate in the physiological 
regulation of IGF2’s foetal production. Therefore, the authors assumed that IMPs might prevent 
a too early initiation of the expansion or differentiation of a particular cell line [151]. When 
considering that Igf2-/- mutants are indeed infertile and smaller than the normal phenotype, 
whereas mice with high IGF2 levels express severe malformations this becomes even more 
likely [159]. The decrease of IMP3 in morulae to the half of its abundance in 2-cell stage 
embryos as detected by the experiment performed for this thesis, is also coherent with the 
hypothesis of Nielsen et al.: A role in the prevention of too early induction of cell 
determinations between the 2-cell and the morula stage can be assumed for the bovine species 
as well. Hence, the decrease of IMP3 in morulae, where first cell determinations are definitely 
known to be already made (see chapter1.3.2) would mean that prevention of cell determinations 
through IMP3 is no longer needed. If this was the case, further analyses about a more exact 
course of IMP3 alterations between the bovine 2-cell and the morula stage (which was not 
analysed by Nielsen et al.) could be helpful to determine the developmental stage of first cell 
differentiations. Moreover, this would be interesting because IMPs are known to be involved in 
the forming of cell polarities [154]. Cell polarities in turn are important for the induction of the 
first lineages decisions in the early embryo (see chapter 1.3.2).  
 
4.6 Differential proteome analyses of morulae and blastocysts 
The morula to blastocyst transition is a crucial step in early embryonic development. During 
this period the presence of two different cell populations in the embryo becomes 
morphologically obvious. One cell population consisting of a flat cell layer forms the 
trophectoderm (TE) and the other one forms the “inner cell mass” (ICM). TE cells are 
progenitor cells of the placenta, while the ICM cells are progenitor cells of the embryo. A fluid 
filled cavity, the blastocoel, is also formed by merging of intercellular spaces (for a more 
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detailed description see chapter 1.3.2). In ARTs, the morula to blastocyst transition is usually 
performed in vitro. However, on average only two thirds of all morulae develop into blastocysts 
[160-162]. To further deepen the knowledge about the underlying biochemical processes, 
quantitative differences in protein expression levels between morulae and blastocysts were 
analysed. To maximize the analytical depth, two different techniques were applied, based on 
either 2D gel electrophoresis and spot intensity quantification, or mass spectrometry and peptide 
ion intensity quantification. 
 
4.6.1 Saturation DIGE analysis of morulae and blastocysts revealed several protein 
isoforms of different abundance alterations 
For the saturation DIGE analysis of morulae and blastocysts, 12 2D gels containing 500 ng 
protein each (corresponding to five embryos) were prepared. In Fig. 20 representative Cy5 gel 
images from morulae and blastocysts demonstrate the high separation strength of these gels in 
both dimensions. Moreover, these gels are free from under- or overlabelling artefacts, 
demonstrating the use of a correct dye/protein ratio (see chapter 1.5.1). 
In total, 2024 signals were detected and quantified in all gels and can therefore be considered as 
signals from real protein spots. Differentially abundant spots had to be detected in all gel 
images. The analysis of six biological replicates enabled a valid statistical evaluation of these 
spots [163]. In an analysis where thousands of analytes are quantified, false positive detections 
of abundance alterations usually occur due to statistical reasons. To avoid these detections of 
false positive proteome alterations, a FDR correction of p-values according to Benjamini and 
Hochberg [124] was applied. Therefore, the small p-values below 0.05 represent significant 
abundance alterations. The quantification of these protein spots was highly reproducible as 
demonstrated in Fig. 22. This figure contains representative 3D intensity shape plots and from 
differentially abundant proteins which are similar in all biological replicates. 
For the identification of protein spots, preparative 2D gels containing several hundreds of 
micrograms protein (corresponding to several thousands of embryos) are needed. Since the 
preparation of such high numbers of embryos is rather time and cost intensive, 4444 GV 
oocytes were used instead. Although the 2D gel spot patterns from oocyte and blastocysts are 
similar, aberrations in the intensity of singular spots occur. Especially spots containing proteins 
which have very low expression levels in oocytes cannot be visualized and picked. In total, 40 
spots, which could unambiguously be matched between analytical embryo and preparative 
oocyte gels, were picked, from which 34 were identified. The remaining six protein spots did 
not contain enough protein for a successful identification by LC-MS/MS. In 18 protein spots, a 
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single protein was unambiguously identified (Table 10), in 11 spots two proteins (Table 11) and 
in five spots three or more proteins (Table 12) were identified. These multiple identifications 
can be explained by the fact that not all proteins can be separated from each other by isoelectric 
focussing and SDS PAA gel electrophoresis and are therefore detected from the same position 
(see chapter 1.5.1). In these cases of non-unique identifications from a single spot, it is 
impossible to decide which of the proteins is responsible for the detected intensity alteration.  
Eleven proteins could be identified in more than one spot, most probably representing different 
isoforms of the corresponding proteins. Isoforms which were individually altered by different 
abundance alterations were for example detected from “Aldo-keto reductase family 1 member 
B1” (AKR1B1), Peroxiredoxin 2 (PRDX2), Prohibitin (PHB), “Chloride intracellular channel 
protein 4” (CLIC4) and “Stomatin-like protein 2” (STOML2). 
 
4.6.2 The iTRAQ analysis led to 141 quantified and identified proteins 
For the nano LC-MS/MS analysis of morulae and blastocysts, three 2D nano LC-MS/MS run 
sets as described in chapter 4.3 were performed. This setup enabled the multiplexed analysis of 
two biological replicates per run set (Table 14) leading to 141 proteins identified and quantified 
in all biological replicates. Differentially abundant proteins had (i) to be identified and 
quantified in all biological replicates and (ii) to have an intensity alteration of more than 1.5. 
The analysis of six biological replicates enabled a valid statistical evaluation of these proteins 
[163]. Student’s t test p-values lower than 0.05 represent significant abundance alterations. In 
total, 50 proteins were found to be differentially abundant (Table 15). The reproducibility of 
quantification of these proteins is demonstrated in Fig. 24 in which HCD MS/MS spectra of the 
peptide derived from the protein Transketolase are shown. The intensity ratios of iTRAQ 
reporter signals are similar in all biological replicates. Moreover, the intensity distributions 
within the entire spectra are highly reproducible. The distribution of these spots according to 
their p-values and fold changes is shown in the Volcano Plot in Fig. 23. 
To ensure correct identifications only proteins which were identified with at least two peptides 
were accepted. Furthermore a decoy search was performed. As described in chapter 4.1, this 
procedure leads to valid datasets with a FDR below 1 %. 
 
4.6.3 The complementary characteristics of the saturation DIGE and the iTRAQ 
analyses are reflected by the comparison of morulae and blastocysts 
Both the Saturation DIGE and the iTRAQ approach have been performed with six biological 
replicates containing 25 morulae and 25 blastocysts each. It was already demonstrated that more 
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than 2000 protein spots can be quantified from 2D gels containing only 500 ng protein by 
Berendt et al. [74]. In chapter 4.3 the method adaptation for the iTRAQ quantification of around 
400 proteins from protein amounts obtained from 50 oocytes was already discussed. The results 
obtained by the application to the comparative proteome analysis of morulae and blastocysts of 
both techniques were compared: 
Around 2024 protein spots have been quantified in each 2D gel, while 141 proteins have been 
quantified in each run set from the iTRAQ analysis. The obvious differences concerning the 
numbers of quantifications can be explained by the fact that quantification from 2D gels is 
performed on the protein level, while quantification in the iTRAQ analysis is performed on the 
peptide level. The 141 proteins correspond to a number of averagely 1000 quantified peptides, 
generated by tryptic hydrolysis of the proteins. Therefore, a number of 1000 quantified analytes 
(peptides in iTRAQ analysis) is the correct comparison to the number of 2024 analytes (protein 
spots in Saturation DIGE analysis). As a consequence of tryptic protein hydrolysis during the 
iTRAQ analysis, no information concerning the molecular weight and the isoelectric point (IP) 
of the protein can be acquired. Thus, the detection of protein isoforms is much less likely by 
iTRAQ based quantification. Yet, many isoforms are quantified as single spots on 2D gels what 
explains the double number of quantified analytes in the 2D DIGE approach. However, the 
main advantage of the iTRAQ approach is that the 141 quantified proteins were simultaneously 
quantified and identified, while the main disadvantage of the 2D DIGE analysis is the difficult 
protein identification requiring preparative gels. This was especially problematic in this analysis 
of early embryos, since a different developmental stage (GV oocytes) of sample material had to 
be used due to cost reasons. It led to the problem that some spots from proteins, which were too 
low abundant in oocytes, could not be assigned to their counterparts on the analytical gels and 
that spot identification was biased by the abundance alteration. Spots from proteins decreasing 
in abundance from oocytes to the blastocysts stage are more likely to be identified than spots 
from proteins increasing from oocytes to the blastocysts stage. Hence, the fact that 76 % of all 
identified protein spots showed decreased abundance alterations between morulae and 
blastocysts, cannot be interpreted as a biological phenomenon. In contrast, the fact that 66 % of 
all differentially abundant proteins from the iTRAQ analysis are higher abundant in blastocysts 
than in morulae allows a biological interpretation since protein identification is not biased by 
the abundance alteration. Furthermore, the problem of non-unique protein identifications from a 
single spot makes the interpretation of identified proteins even more difficult. 
In total, 18 differentially abundant proteins were detected and unambiguously identified by the 
2D DIGE analysis. This number could be enhanced by 47 proteins from the iTRAQ analysis. 
Seven proteins were detected in both approaches. They are listed together with their fold 
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changes in Table 16. Fig. 25 shows a comparison of HCD MS/MS spectra of Peroxiredoxin 2’s 
peptide QVTINDLPVGR and corresponding 3D intensity shape plots from the 2D DIGE 
analysis, demonstrating the similarity of abundance ratios measured by both techniques. 
Furthermore, Fig. 25 demonstrates the reproducibility of quantification in both approaches. In 
contrast to six proteins which have similar abundance alterations in both approaches, one 
protein spot identified as “Glutathione S-transferase mu 3” (GSTM3) is increased by a factor 
1.7 in the 2D DIGE analysis while the majority of the corresponding protein’s peptides are 
decreased in abundance by a factor of 0.6 as reflected by the iTRAQ analysis. This again 
demonstrates the advantage of the 2D DIGE analysis in detecting abundance alterations of 
single protein isoforms. Opposing abundance alterations for Glutathione S-transferase mu 5 
isoforms were also previously described in a 2D gel based analysis of GV and in vitro matured 
MII oocytes [74]. 
 
4.6.4 Gene ontology clustering of proteins indicates a switch from a catabolic to an 
anabolic stage as well as cell proliferation during the morula to blastocyst transition 
David GO protein clustering shows in which functional categories proteins from an input list 
show up more than they are expected to appear from a randomized protein list. Thus the results 
indicate in which molecular and functional processes these proteins are involved [123]. 
Within this experiment, the David GO clustering revealed that nine proteins decreased in 
abundance in blastocysts are associated with catabolic processes, while only four proteins are 
associated with biosynthetic processes. In contrast, in the group of proteins increased in 
blastocysts, seven proteins are associated with biosynthetic and only two proteins are associated 
with catabolic processes. These findings indicate a switch from a catabolic to an anabolic state 
during the morula to blastocyst transition. This is also confirmed by the abundance alteration of 
single proteins. The two proteins “Suppressor of G2 allele of SKP1 homolog” (SUGP1) and the 
“UBFD1 protein”, both involved in ubiquitination initiated protein degradation [164, 165], were 
identified from the same spot in the saturation DIGE analysis. The spot was altered in intensity 
by a factor 0.4 between morulae and blastocysts. The decrease of these proteins is a further hint 
to the termination of the degradation process of maternal proteins. These hypotheses can be 
strengthened by a study in which the overall protein content of bovine oocytes and pre-
elongation stage embryos was measured. From the results it was concluded that the early 
cleavage stage bovine embryo has a higher rate of protein degradation than that of synthesis 
until initiation of compaction at the morula stage [166]. Besides this, especially ATP 
biosynthesis seems to increase between the morula to blastocyst transition since four of the 
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proteins increased in blastocyts are assigned to ATP biosynthetic processes. This is coherent 
with a finding of Thompson et al. that ATP production starts to increase with compaction of the 
morula and peaks at the blastocysts stage [167].  
The increase of several other proteins in blastocysts can be considered as a result of the ongoing 
proliferation during blastocyst development. These are, for example, the four proteins which 
cluster into terms of chromosome or nucleosome organization. This can be explained by the 
rising number of cell nuclei during embryo development. Furthermore, the analysis also 
revealed that proteins involved in cytoskeletal organization are increasing. The three proteins 
from the analysis within this class are (i) Ezrin, which is involved in connections of major 
cytoskeletal structures to the plasma membrane [168], (ii) the “F-actin-capping protein subunit 
beta “(CAPZB) which binds to the fast growing ends of actin filaments [169] and (iii) 
“Cytoplasmic actin”. This could reflect the enhanced production of cytoskeletal structures.  
 
4.6.5 Proteome analysis of morulae and blastocysts reflects increasing translation 
during the morula to blastocyst transition 
Embryogenesis is characterized by a gradual degradation of maternally inherited messenger 
RNAs and activation of the embryonic genome, for example, initiation of embryonic 
transcription and translation of embryonic proteins (MET) [35-37]. The enhanced translation 
after the MET is also reflected in the proteome analysis between morulae and blastocysts on 
several levels: First, 66 % of all differentially abundant proteins from the iTRAQ analysis are 
increased in blastocysts. This is visualized in the Volcano Plot in Fig. 23. Second, in the GO 
clustering of proteins increased in blastocysts, eight proteins are assigned to the GO term 
translation. And third, proteins responsible for translation initiation like (i) Nucleophosmin 
(NPM1), (ii) the protein “Receptor of activated protein kinase C 1” (GNB2L1/RACK1) and (iii) 
the “Eukaryotic translation initiation factor 6” (EIF6) as well as (iv) the “Eukaryotic translation 
initiation factor 5A-1” (EIF5A) are increased in blastocysts in the analysis. NPM1, which 
directs the nuclear export of the ribosomal subunits leading to increased rates of protein 
synthesis [170] is increased by a factor 2.6 in blastocysts. RACK1 is increased in blastocysts by 
a factor 2.8. It is a ribosomal protein which recruits activated protein kinase C to the ribosome, 
leading to the stimulation of translation by phosphorylation of the EIF6 [171]. Interestingly, 
EIF6 was identified together with Clusterin from a mixed spot increased by a factor 2.4 in the 
saturation DIGE analysis. Since both proteins were unambiguously identified in the spot, it is 
not possible to decide which of the proteins is responsible for the intensity alteration. Yet, this is 
an example for a case in which regarding the biological context of such proteins can be a hint to 
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a likely responsibility for the abundance alteration to one of the proteins. The ongoing 
translation and the increase of RACK1 allow assuming, that EIF6 is at least involved in the 
increased abundance alteration of this spot between morulae and blastocysts.  
 
4.6.6 Creatin kinase B (CKB) and Annexin A6 are promising candidates in the 
molecular studies of the morula to blastocyst transition  
CKB is of special interest due to the fact that it was found to be by a factor 5.9 higher abundant 
in blastocysts than in morulae in the iTRAQ analysis. It belongs to the proteins which show the 
highest abundance alterations of all differentially abundant proteins. Interestingly, in other 
tissues, especially in the rat uterus, CKB mRNA expression is induced by oestrogen [172, 173]. 
Since the media surrounding the embryos was not changed during the embryo culture process, 
the CKB expression was not induced by additional external oestrogen. Hence, an early onset of 
oestrogen production by the developing embryo might have induced the rapid increase of CKB. 
Especially the trophectodermal tissues from later embryonic stages are already known to 
produce placental estrogens, the role of which is still not understood in cattle [174]. To further 
evaluate this hypothesis, localisation studies which could reveal whether CKB expression is 
restricted either to the TE or to the ICM would be helpful. However, it is also possible that 
blastomeres become reactive to oestrogen, already contained in the medium, during the morula 
to blastocyst transition. This connection as well as the connection of CKB and oestrogen 
expression in general, could be studied by measuring the CKB expression at different 
developmental stages before and after oestrogen supplementation. 
Another interesting candidate protein for further functional analyses during the ongoing 
blastocyst development is Annexin A6. It was found to be increased in blastocysts by a factor of 
4.3 in the iTRAQ analysis. As reviewed by Grewal et al. [175], this protein has several 
functions which could play important roles in preimplantation embryonic development. It (i) 
provides a scaffold to form membrane-bound multifactorial signalling complexes, (ii) it is able 
to regulate transient membrane-actin cytoskeleton interactions during endocytosis, (iii) it 
stabilises the protein/lipid composition during membrane microdomain formation and (iv) it 
regulates secretory events. Especially interesting would be to further evaluate its role in spatio-
temporal signalling during embryogenesis. 
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4.6.7 The increase of the LGALS3 protein, RACK1 and Ion transport associated 
proteins could reflect the embryo remodelling during blastocyst development 
At the morula stage, the embryo starts a remodelling process: Cells change their shape with a 
remodelling of membrane lipids and become much more tightly apposed, a process known as 
compaction. Shortly afterwards, the embryo starts its first differentiation process by forming a 
flat layer of TE cells, a group of cells representing the ICM and a fluid-filled blastocoel by 
merging of intercellular spaces (see chapter1.3.2). 
The process of merging intercellular spaces happens by mechanisms that regulate intracellular 
osmolarity and cell volume through the controlled release of osmolytes from the cytoplasm via 
ion channels. Therefore, the increase of seven proteins, which were associated with ion 
transport (according to David GO clustering) in blastocysts, is coherent with the ongoing 
blastocyst development [38]. 
The “LGALS3 protein” is increased in blastocysts by a fold change of 2.8. It is a carbohydrate-
binding-protein [176], named Galectin 3 in other species. It was shown to be involved in the 
prevention of apoptosis by being translocated to the mitochondria and blocking changes in the 
mitochondrial membrane potential [177]. Interestingly, Galectin 3 can especially prevent an 
apoptosis form induced by the loss of cell anchorage (anoikis). Such cells have been shown to 
undergo cell cycle arrest instead [176]. During the embryo remodelling process at the morula to 
blastocyst transition at least the transient loss of cell anchorages seems possible. High Galectin 
3 levels might be essential to prevent so caused apoptosis, thereby keeping these cells alive until 
their function can be replaced by new cells. Especially the cellular environment of TE cells is 
affected by the remodelling process, since they form a flat single cell layer in the blastocyst, 
inwards facing the fluid filled blastocoel, instead of being surrounded by blastomeres from three 
sides in the compacted morula. The survival of the blastocysts depends on the correct forming 
of “tight junctions” between the TE cells which prevents water leakage from the blastocoel. 
Therefore apoptosis of one of the single layer TE cells would probably impair the embryo 
survival. Considering Galectin 3’s function in apoptosis, this could be the reason that galectin 3 
mRNA expression in the mouse embryo is known to occur during the fourth day of gestation in 
TE cells of blastocysts [178]. To further evaluate a cellular restriction to TE cells in the bovine 
embryo localisation studies would be interesting. 
The protein RACK1 is increased in blastocysts by a factor 2.8. Its involvement in translation 
initiation has been discussed above. Besides that it regulates several processes that involve 
contact with the extracellular matrix, such as cell spreading, the establishment of focal 
adhesions and cell–cell contacts [171]. Since it is known that first cell fate decisions in the 
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embryo partly depend on the location of the blastomeres (inside or outside the morula), and on 
the cellular connections [13, 39, 53, 179, 180], these processes seem to be important during 
embryo development. Therefore, it could well be that RACK1 is involved in blastocyst 
formation, which involves the loss of intercellular contacts as well as the establishment of 
contact to the fluid-filled blastocoel cavity.  
 
4.6.8 The protein NPM1 could be involved in first lineage decisions 
As mentioned above, NPM1 is increased in blastocysts by a factor of 2.6 and is involved in 
translational processes. Besides that, also its involvement in cell proliferation [181] is coherent 
with ongoing cell divisions during blastocyst development. Even more interesting is that NPM1 
was recently found to be involved in embryonic stem cell (ESC) maintenance and ESC fate 
determination: It can form complexes with OCT4, SOX2 and NANOG [182] which are 
essential factors for maintenance of pluripotency [183] and are involved in the first lineage 
decisions (see chapter 1.3.2). NPM1 downregulation leads to mesoderm and ectoderm 
differentiation [182]. For these reasons, the increase of NPM1 in blastocysts could be both 
involved in the cell fate’s decisions to become a TE or an ICM cell and prevent the 
preimplantation embryo’s cells from too early differentiation into the different germ layers. 
  
4.6.9 The reduction of redox enzymes may alter HIF dependent gene regulation 
In the group of proteins decreased in blastocysts, 12 proteins associated with redox processes 
were found. It is already known that the embryo possesses several antioxidant systems which 
have two main functions: fine-tuning of “reactive oxygen species” (ROS) levels for signalling 
purposes and protection from oxidative stress [184]. 
Concerning the signalling aspects of fine tuning ROS levels, a hypothesis would be that this 
alters gene regulation over a transcription factor family, the so-called “hypoxia inducible 
factors” (HIFs). They regulate gene expression in dependence of the cell’s redox state, yet can 
be also altered under normoxic conditions by ROS. Its gene activity leads to the up-regulation 
of a variety of genes which are, beside others, involved in energy metabolism and cell 
proliferation [139]. Since these are important processes in early embryonic development, it is 
possible that the reduction of redox enzymes in blastocysts is required for a HIF induced gene 
regulation over ROS species. This hypothesis is supported by Harvey et al. who already 
supposed that the activation of HIF might be important for bovine in vitro embryos to adapt to a 
reduced oxygen environment normally encountered in vivo [139].   
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Moreover, within the group of redox enzymes, the three PRDX isoforms 1, 2 and 6 are found to 
be decreased by a factor between 0.4 and 0.6 in morulae versus blastocysts. Peroxiredoxin 
enzymes are ubiquitously present in various cell types and contain a conserved cysteine residue 
in the N-terminal region that is the primary site of oxidation. Mammalian cells express six 
isoforms of PRDX (PRDX1 to 6) which are thought to remove low levels of peroxides 
produced as a result of normal cellular metabolism [185]. An abundance alteration of PRDX3 
during in vitro maturation of bovine oocytes has previously been observed [74], already 
indicating the involvement of this enzyme class in developmental processes. Furthermore, 
PRDX mRNA expression was previously quantified in early bovine embryos of different 
developmental stages [184]. While this analysis revealed the existence of PRDX1 transcripts in 
all analysed stages (from oocyte to blastocyst), PRDX2 and PRDX6 transcripts could not be 
detected in 9- to 16-cell stage embryos, but again at the morula stage. From this result, the 
authors concluded a complete degradation of stored maternal PRDX2 and PRDX6 transcripts 
prior to the MET which occurs between the 8-cell and the 16-cell stage (see chapter1.3.2). In 
contrast to that, our analysis clearly shows a decrease of PRDX2 and PRDX6 up to the 
blastocysts stage, demonstrating that the increase of PRDX2 and PRDX6 mRNA is not 
reflected on the protein level at these stages. This could be due to a delay between transcription 
and translation as well as an enhanced degradation of PRDX2 and PRDX 6. It is imaginable that 
also the timing of this delay between transcription and translation is important for correct 
blastocyst development, possibly also for correct HIF regulation over ROS. Moreover, PRDX2 
has been identified from three different protein spots, all decreasing but differing in their 
abundance alteration. These different spots most probably represent different isoform variants 
of this protein. Therefore, this finding could indicate that especially a correct concentration of 
each PRDX2 isoform has an impact for the morula to blastocyst transition. 
Although the reduction of redox enzymes might be needed to increase ROS levels for HIF 
regulation, high ROS levels can induce lipid peroxidation-derived lipid aldehydes and their 
glutathione-conjugates which are in the following reduced by “Aldo-keto reductase” (AKR1B1) 
to corresponding alcohols mediating inflammatory signals [186]. Hence, low levels of AKR1B1 
can prevent these signals from being transmitted, which might be the reason for its decrease in 
blastocysts as detected by the saturation DIGE analysis. This hypothesis is supported by a study 
in which AKR1B1 mRNA levels were found to be of higher abundance in biopsies derived from 
blastocysts, leading to resorption and pregnancy failure than from biopsies leading to calf 
delivery [187]. Besides that, AKR1B1 has two different activities, namely metabolizing 
progesterone and synthesizing PGF2 [188], both processes with the ability to terminate 
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pregnancy, so that high AKR1B1 concentrations seem not to be beneficial for a successful 
pregnancy in general.   
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5 Perspectives 
During this work, several proteins were discovered to be altered in abundance between in vivo 
and in vitro matured oocytes and between different stages of the preimplantation embryo 
development. These proteins are considered to be interesting candidates for further studies, 
concerning their participation in molecular processes underlying the developmental competence 
of oocytes and the first cell fate decisions after fertilization. It is imaginable that further hints on 
an involvement in cell fate decisions could be gained through localisation studies by 
immunofluoresence microscopy in blastocysts. If any of the proteins, like for example “Creatin 
kinase B” or the “LGALS3 protein” are specifically localised to trophectoderm cells, a further 
evaluation of their stage dependent localisation could lead to new insights into lineage 
decisions. Moreover, the protein “Bisphosphoglycerate mutase” (BPMG) was detected with 
higher abundance in in vivo than in vitro matured oocytes, which are known to have an impaired 
developmental competence compared to in vivo matured oocytes. Hence, the functional analysis 
of BPMG in embryo development could help to evaluate the developmental potential of 
oocytes. However the abundance alteration of BPMG will have to be validated by the selected 
reaction monitoring (SRM) technique, due to the fact that the three biological replicates 
available for analysis did not allow a valid statistic evaluation. 
Furthermore, the SRM technique will be used to assign the abundance alterations of interesting 
candidate proteins not only to a developmental period, like for example between 2-cell stage 
embryos and morulae, but to shorter periods like day to day intervals. This could help to 
understand whether abundance alterations of proteins do occur as a consequence of certain 
biological events (for example the maternal embryo transition or cell fate decisions) or are 
involved in their induction. Moreover, the SRM technique will be employed for absolute protein 
quantification and could thus lead to the determination of physiological expression levels for 
certain proteins. Since targeted protein quantification by SRM needs lower protein amounts for 
valid quantifications than a holistic approach, it is possible to also analyse abundance alterations 
of proteins in human samples, which are available in very limited numbers only. 
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6 Summary 
Assisted reproduction techniques (ARTs) become increasingly important both in veterinary and 
in human medicine. Since ARTs are still associated with low conception and birth rates, it is 
necessary to improve the understanding of underlying biochemical processes. The presented 
work addresses, on the proteome level, the oocyte maturation process as well as the early 
embryonic development up to the blastocyst stage, since both oocyte quality and a faultless 
development of the early embryo is crucial for the success of assisted reproduction. 
As a model organism, the bovine system was used since it reflects crucial parameters of the 
female human reproductive system. Besides, the bovine reproductive system is of particular 
interest with respect to basic research as well as to aspects targeting the efficiency enhancement 
of ARTs for cattle production. 
The correct storage of mRNAs and proteins is an important feature in determining oocyte 
quality. To find out which proteins are stored after their production during oogenesis, a 
comprehensive qualitative proteomic dataset was generated from 900 bovine GV oocytes. The 
dataset consisted of 829 proteins, covering a broad spectrum of different molecular functions 
and processes. For a total of 621 proteins within this dataset the evidence of protein existence 
was not demonstrated in the bovine system prior to this experiment. Moreover, it was revealed 
that proteins involved in oocyte maturation and such proteins which are stage dependently 
altered during the development up to the blastocyst stage can already be found in GV oocytes. 
In addition, experimental data addressing protein abundance alterations during oocyte 
maturation and early embryogenesis are crucial to deepen the understanding of underlying 
biochemical processes. However, the quantitative analysis of proteomes from mammalian 
oocytes and early embryos is challenging due to the very small sample amounts available (one 
oocyte/early embryo contains only 90 ng protein). Therefore, techniques for proteome analyses 
were successfully downscaled to facilitate identification and relative quantification of up to 403 
proteins from the protein amount corresponding to only 50 oocytes/early embryos. These 
methods were then applied to the quantitative proteome analyses of oocytes and early embryos: 
Due to the negative effect of hormonal superstimulation to maternal health in humane medicine 
it is tried to replace traditional “in vitro fertilization” (IVF) based on in vivo matured oocytes of 
superstimulated donors, by the use of IVF with in vitro matured oocytes. However, low success 
rates suggest an impaired developmental competence of in vitro matured oocytes. Hence, 
quantitative differences between the proteomes of in vivo and in vitro matured oocytes were 
investigated. Amongst several differentially abundant proteins, “Bisphosphoglycerate mutase”, 
known as a “maternal house keeping protein“ was found to be of decreased abundance in in 
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vitro matured oocytes, while for example “Glyoxylase 1” and Ubiquitin were higher abundant 
in in vitro versus in vivo matured oocytes. These results suggest an altered metabolic status as 
well as an increased abundance of proteins, which were incorrectly processed or should be 
replaced due to other reasons. 
A key process in a successful pregnancy is a correct pre-implantational embryonic 
development. For this reason, the proteome signatures of relevant stages of early embryonic 
development were quantitatively analysed: 
The developmental interval between 2-cell stage embryos and morulae, which comprises the 
“maternal embryo transition”, was analysed by an LC-MS/MS spetral count approach. In total, 
28 proteins were found to be differentially abundant. The abundance decrease of the proteins 
“Y-box protein 2” and the “IGF 2 mRNA-binding protein 3” between 2-cell stage embryos and 
morulae, being particularly interesting with respect to early embryonic development due to their 
roles in translational control, was validated by the “selected reaction monitoring” (SRM) 
technique.  
The most comprehensive experiment was performed on morulae and blastocysts. During the 
developmental interval between these stages, the first cell fate determinations become 
morphologically obvious. Morula and blastocyst proteomes were compared using two 
complementary methods, the 2D gel based saturation DIGE technique and the LC-MS/MS 
based iTRAQ technique. In six biological replicates, 61 spots from differentially abundant 
proteins were found by the 2D DIGE approach and 50 differentially abundant proteins by the 
iTRAQ analysis. In particular, proteins associated with translation and biosynthetic processes 
were increased during the morula to blastocyst transition. Several interesting candidate proteins 
which represent promising candidates for functional studies and localization experiments were 
discovered. For example, “Creatin kinase B” was increased in blastocysts by a factor of 5.9, 
which could indicate an early onset of oestrogen expression by trophectodermal cells. Within 
the group of proteins being decreased in blastocysts, a notably high number of proteins 
associated to redox processes were found. These proteins could alter genes of energy 
metabolism and cell proliferation by the regulation of the “hypoxia inducible factor” by fine 
tuning of “reactive oxygen species”. 
These experiments represent the most comprehensive holistic proteome analyses of bovine 
oocytes and preimplantation embryos available so far. The results facilitate now to analyse 
interesting protein candidates by localisation studies and targeted quantification by SRM to 
elucidate a possible involvement of these proteins in cell fate decisions and the induction of 
certain biological events (e.g., embryonic genome activation). 
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7 Zusammenfassung  
Qualitative und quantitative Proteomanalyse von bovinen Oozyten und frühen 
Embryonalstadien 
Die Bedeutung Assistierter Reproduktionstechniken (ARTs) nimmt sowohl in der Tier- als auch 
in der Humanmedizin mehr und mehr zu. Da diese jedoch immer noch mit niedrigen 
Konzeptions- und Geburtenraten verbunden sind, ist es notwendig, das Verständnis zugrunde 
liegender biochemischer Prozesse zu verbessern. Die hier präsentierte Doktorarbeit adressiert 
sowohl den Oozytenreifungsprozess als auch die frühe Embryonalentwicklung bis zum Stadium 
der Blastozyste, da sowohl die Oozytenqualität wie auch die fehlerfreie Embryonalentwicklung 
entscheidende Schritte für den Erfolg von ARTs darstellen. 
Als Modell wurde das bovine System verwendet, da dieses entscheidende Parameter der 
weiblichen humanen Reproduktionsbiologie widerspiegelt. Darüber hinaus ist das bovine 
System von großem Interesse für die Grundlagenforschung sowie für angewandte Studien zur 
Verbesserung der Effizienz von ARTs. 
Die korrekte Speicherung von Proteinen und mRNA ist ein wichtiges Charakteristikum der 
Oozytenqualität. Um herauszufinden, welche Proteine nach ihrer Produktion in der Oogenese 
gespeichert werden, wurde ein umfangreicher qualitativer proteomischer Datensatz aus 900 
bovinen GV Oozyten generiert. Dieser Datensatz enthält 829 Proteine, die ein breites Spektrum 
verschiedener molekularer Prozesse und Funktionen abdecken. Für insgesamt 621 Proteine aus 
diesem Datensatz wurde zuvor kein Nachweis ihrer Existenz im bovinen System auf 
Proteinebene geführt. Darüber hinaus wurde gezeigt, dass sowohl Proteine, die an der 
Oozytenreifung beteiligt sind, als auch solche, die in der Entwicklung bis zur Blastozyste 
stadienabhängig in ihrer Abundanz verändert werden, bereits in der GV Oozyte vorhanden sind. 
Daneben sind vor allem Experimente, welche die Abundanzveränderungen von Proteinen 
während der Oozytenreifung und frühen Embryonalentwicklung erfassen, entscheidend, um das 
Verständnis zugrunde liegender biochemischer Prozesse zu vertiefen. Aufgrund der geringen 
Verfügbarkeit von Probenmaterial (eine Oozyte/ein früher Embryo enthält nur 90 ng Protein) 
stellt die quantitative Proteinanalyse von Säugeroozyten und frühen Embryonen jedoch eine 
Herausforderung dar. Deshalb wurden im ersten Teil dieser Arbeit Techniken zur 
Proteomanalyse erfolgreich an die Analyse von geringen Probenmengen angepasst, so dass bis 
zu 403 Proteine aus einer Proteinmenge, die der von 50 Oozyten/frühen Embryonen entsprach, 
identifiziert und quantifiziert werden konnten. Diese Techniken wurden dann zur quantitativen 
Proteomanalyse von Oozyten und frühen Embryonalstadien herangezogen. 
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Wegen des negativen Effekts von hormoneller Superstimulation auf die mütterliche Gesundheit 
wird versucht, die traditionelle „in vitro Fertilisation“ (IVF) mit in vivo gereiften Oozyten von 
superstimulierten Spendern durch IVF mit in vitro gereiften Oozyten zu ersetzen. Die niedrigen 
Erfolgsraten deuten jedoch auf eine beeinträchtigte Entwicklungskompetenz von in vitro 
gereiften Oozyten hin. Daher wurden die Unterschiede in der Proteinexpession zwischen in vivo 
und in vitro maturierten Oozyten untersucht. Innerhalb mehrerer differentiell abundanter 
Proteine wurde das Protein „Bisphosphoglycerat Mutase“, welches als “maternales house 
keeping Protein” bekannt ist, mit erniedrigter Abundanz in in vitro gereiften Oozyten detektiert, 
während beispielsweise „Glyoxylase 1“ und Ubiquitin höher abundant in in vitro als in in vivo 
gereiften Oozyten waren. Diese Befunde deuten sowohl auf einen veränderten metabolischen 
Status als auch auf die erhöhte Präsenz von Proteinen, die entweder nicht korrekt prozessiert 
wurden oder aus anderen Gründen ersetzt werden sollten, in in vitro gereiften Oozyten hin. 
Eine Schlüsselrolle für eine erfolgreiche Trächtigkeit spielt der korrekte Ablauf der 
Embryonalenwicklung während der Preimplantationsphase. Deshalb wurden die proteomischen 
Signaturen relevanter früher Embryonalstadien quantitativ analysiert.  
Zunächst wurde das Entwicklungsintervall zwischen 2-Zell-Embryonen und Morulae, welches 
den Start der embryonalen Genomaktivierung beinhaltet, mittels eines LC-MS/MS basierten, so 
genannten „Spectral Count“ Ansatzes, verglichen. Insgesamt wurden 28 differentiell abundante 
Proteine zwischen 2-Zell-Embryonen und Morulae detektiert. Die abnehmende Abundanz 
zwischen 2-Zell-Embryonen und Morulae der zwei Proteine „Y-box protein 2“ und „IGF 2 
mRNA-binding protein 3“, welche aufgrund ihrer Funktion in der Translationskontrolle im 
Kontext der frühen Embryonalentwicklung besonders interessant sind, wurde mit der „Selected 
Reaction Monitoring“ (SRM) Technik validiert. 
Das umfangreichste Experiment wurde anhand von Morulae und Blastozysten durchgeführt. In 
dem Entwicklungsintervall zwischen diesen Stadien werden die ersten Zelldifferenzierungen 
morphologisch sichtbar. Die Proteome von Morulae und Blastozysten wurden mit zwei 
komplementäre Methoden, (i) der 2D Gel basierten „Saturation DIGE“ Technik und (ii) der LC-
MS/MS basierten „iTRAQ“ Technik, vergleichend quantitativ analysiert. In sechs biologischen 
Replikaten wurden 61 Protein Spots von differentiell abundanten Proteinen mit der 2D DIGE 
Technik und 50 differentiell abundante Proteine durch den Einsatz der iTRAQ Technik 
detektiert. Insbesondere waren solche Proteine, die mit Translations- und biosynthetischen 
Prozessen assoziiert sind, in ihrer Abundanz in Blastozysten erhöht. Einige interessante 
Proteine, welche vielversprechende Kandidaten für Lokalisations- und funktionelle Studien sein 
könnten, wurden entdeckt. Zum Beispiel war die „Kreatin Kinase B“ in Blastozysten gegenüber 
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Morulae um einen Faktor von 5.9 erhöht, was auf einen frühen Beginn der Östrogenproduktion 
in den trophektodermalen Zellen hindeuten könnte. Innerhalb der Gruppe von Proteinen, die in 
ihrer Abundanz in Blastozysten gegenüber Morulae erniedrigt sind, war eine große Anzahl mit 
Redoxprozessen assoziiert. Diese Proteine könnten die Expression von Genen, die für 
Metabolismus und Zellproliferation relevant sind, über eine Beeinflussung der „Hypoxie 
induzierten Faktoren“ durch eine Feinregulierung von reaktiven Sauerstoffspezies verändern. 
Die in dieser Arbeit vorgestellten Experimente stellen die bisher umfangreichsten holistischen 
Proteomanalysen boviner Oozyten und früher Embryonen dar. Diese Ergebnisse ermöglichen 
nun die weitere Untersuchung von entdeckten Kandidatenproteinen in Lokalisationsstudien und 
durch gezielte Proteinquantifizierung mit der SRM Technologie, um herauszufinden, ob diese in 
die ersten Zelldifferenzierungen und in die Auslösung von bestimmen biologischen Ereignissen 
(z.B. embryonale Genomaktivierung) involviert sind. 
. 
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